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Abstract
The adult testis consists of two compartments, the seminiferous tubules and interstitium;
the seminiferous tubules contain Sertoli cells (SC) each in close association with a
complement of germ cells (GC) and are the site of GC maturation from diploid
spermatogonia to haploid spermatozoa. The interstitium contains Leydig cells (LC),
peritubular myoid cells (PTM), macrophages and blood vessels. In addition to
producing haploid GC, the other essential function of the testis is synthesises of steroids
hormones (primarily androgens and oestrogens). Sertoli cells are essential for support of
GC development, but support of spermatogenesis is dependent upon expression ofAR in
SC, which they express in a stage-specific pattern. The SCs also express oestrogen
receptor P (ER(S). The association between SC and adjacent GC and SC are mediated by
junctional complexes, including gap junctions, tight junctions, ectoplasmic
specialisations, and tubulobulbar complexes.
The aims of this thesis were; 1) to investigate androgen and oestrogen responses in SC
using the immortalised SKI 1 cell line, 2) determine the effectiveness of an adenoviral
vector for introduction of transgenes into SC in vivo and in vitro, and 3) investigate
androgen-dependent gene and protein expression in testosterone depleted testes of EDS-
treated rats.
SKI 1 cells had detectable expression of ER/3 mRNA, and activated an ERE-luciferase
reporter construct in response to a range of oestrogenic ligands. In contrast endogenous
AR expression was low, but transfection with mouse AR cDNA resulted in sufficient
AR expression to activate a luciferase reporter under control of the Rhox5 proximal
promoter in response to androgen treatment. However transfected SKI 1 cells could not
stimulate endogenous Rhox5 mRNA expression under similar conditions. Infection of
SKI 1 cells with an adenoviral construct in vitro resulted in efficient transgene
expression in 80-100% of cells, and was associated with excellent cell survival. In vivo
infection in mouse testes with an adenoviral vector containing a GFP transgene,
IV
performed by injection via the efferent ductules, resulted in SC-only transgene
expression. When a dose of 4x108 pfu was introduced the seminiferous tubule's
architecture was severely damaged, invasion by macrophages and neutrophils occurred,
plus expression of markers of hypoxia (Hifla) and apoptosis (activated caspase-3 and
5 r\1
positive Tunel assay staining) was detected. Infection with lower doses (1x10 -1x10
pfu) resulted in disruption to the seminiferous epithelium consisting of loss of pachytene
germ cells and formation of intra-epithelial vacuoles. Formation of vacuoles may be due
to interaction of adenovirus with the coxsackie/adenoviral receptor (CAR) in SC-SC
junctions. Androgen-depletion in rats using a single dose of EDS to ablate the LC
population that synthesis testosterone caused reduced expression of AR, Rhox5, espin
and P3-tubulin mRNA and AR protein 6 days after treatment, but the expression and
distribution of the junctional proteins espin, Cx43, zona occludins 1, and N-cadherin
were unaffected.
From these studies we can conclude that SK11 cells lack vital factor/s required for
activation of response elements by androgens in their endogenous promoter regions,
which raises the possibility that association with other testicular cell types (GC or PTM)
may be required for normal SC function to be maintained. Adenoviral vectors appear
good for efficient introduction of transgenes into SC in vitro but not for use in vivo.
Finally, testosterone depletion using the EDS-rat model revealed reduced mRNA
expression of putative androgen responsive genes identified in previous array studies,
and provides a valuable model for validation of other putative targets identified in other
studies.
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Chapter 1 Literature Review 1
1 Literature review
1.1 Introduction
The mammalian testis has two functions; the first is the synthesis and secretion of
steroid sex hormones (most importantly androgens and oestrogens), which impact upon
the reproductive tract and other organ systems around the body. The second is the
regulation and support of genn cell maturation (spermatogenesis) to achieve the release
of fully formed spermatozoa.
1.2 Organisation of the testis
The adult testis contains two distinct compartments the seminiferous tubules and the
interstitium. Germ cell (GC) maturation takes place within the seminiferous tubules and
is dependent upon functional support of the Sertoli cells (SC) whereas the interstitium
contains the Leydig cells (LC) that express the steroidogenic enzymes essential for
androgen biosynthesis.
The adult testis is closely associated with other structures in the urogenital tract, in
particular the epididymis and vas deferens (Robaire and Hermo, 1988; Setchell et ah,
1994). Spermatozoa released from the apical surface of SC into the lumen of
seminiferous tubules are carried by the flow of tubule fluid to the rete testis, pass
through the efferent ductules and thereafter enter the epididymis (Leblond and Clermont,
1952b). As spennatozoa transit through the epididymis from the caput to the cauda they
mature and gain the capacity for fertilisation (Bedford, 1966). The distal end of the
epididymis connects to the vas deferens that links the epididymis to the urethra, and is
the tubule through which mature spermatozoa in seminal fluid pass at the point of
ejaculation.
The adult testes are maintains at between 2°C and 8°C below core body temperature by
virtue of being located in the scrotum (Ivell, 2007), the reduced temperature is
maintained by dissipation of heat from scrotum and by a counter-current heat exchange
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mechanism conducting heat from the incoming arterial blood to the outgoing venous
supply (Glad Sorensen et al., 1991). These mechanisms are required because an
elevation in testicular temperatures in patients or animals reduces germ cell survival
(Ivell, 2007; Paul et al., 2008).
1.2.1 Seminiferous tubules
Seminiferous tubules consist of a single layer of SC associated with multiple types of
germ cell organised into numerous layers. Initially the only GC present are gonocytes,
but in mice between birth and 5 days postpartum they differentiate into spermatogonia
prior to the first wave of spermatogenesis (Bellve et al., 1977). In the adult testes each
SC is associated with a complement ofGC at different stages ofmaturation (as shown in
Figure 1-1). The lumen within the seminiferous tubules develops following formation of
the blood testis barrier (BTB, see section 1.2.4.1), which occurs on or around day 14 in
the mouse and day 16-19 in rats (Byers et al., 1991; Vitale et al., 1973).
In rodents the GC complement associated with each SC is the same around the full
circumference of the seminiferous tubule, and the complement changes as
spermatogenesis progresses. Changes in GC complement are associated with changes in
SC structure and gene expression (as described in section 1.2.3). The changes in the
GC-complement and structure of the epithelium follow a cyclic pattern, which is divided
into the stages of spermatogenesis (see Figure 1-2). In mice the cycle is divided into 12
stages (Oakberg, 1956), whilst the rat cycle is divided into 14 (Leblond and Clermont,
1952b) and in human there are only 6 (Schulze and Rehder, 1984). In man and some
primates, including the Common marmoset (Millar et al., 2000) SC within the same
tubule cross-section are associated with different GC complements, in contrast to rodent
tubules, the alternative arrangement has been suggested to be due either to a helical
arrangement of stages within the tubule (Schulze and Rehder, 1984) or organisation of
spermatogenesis into clones (Ehmcke et al., 2005). In all species each stage of the
seminiferous epithelial cycle has a precise duration. Throughout successive cycles the
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GC remain attached to the same SC and migrate along its surface from the basement
towards the lumen from where they are eventually released, as a result the least mature
diploid germ cells are positioned at the basement membrane and the most mature are
found at the luminal surface (Figure 1-1, Figure 1-2). The cycles of the seminiferous
epithelium, i.e. the time to progress once through stages I to VI in man or stages I to XII
in mice, last approximately 16 days in man and 8.6 days in the mouse. The whole
process of spermatogenesis from the time a spermatogonium becomes committed to
differentiation until it is released from the seminiferous epithelium as a mature
spermatozoa takes 74-76 days in man and 35 days in mice, therefore 4.6 and 4.06 cycles
are required in the human and the mouse respectively (Leblond and Clermont, 1952b;
Sharpe, 1994).
Tight junctions (TJ) that contribute to the blood-testis barrier (BTB) form between
adjacent SC at a location between the first and second row of GC (arrow in Figure 1-1).
The BTB separates the seminiferous tubule into basal and adluminal compartments,
within the basal compartment spermatogonia develop up to and including the leptotene
spermatocyte stage (Dym and Fawcett, 1970; Russell, 1977a). Tight junctions are not the
only junctions formed within the seminiferous epithelium and gap junctions, adhering
junctions (including adherens junctions (AJ), ectoplasmic specialisations (ES)),
tubulobulbar complexes and desmosome-like junctions have all been described. The
structure and function of these cell-cell interactions are described in more detail in
section 1.2.4.
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Spermatocyte*
Figure 1-1: Schematic diagram of a Sertoli cell and associated germ cells. Figure shows a
single SC with germ cells at various stages of spermatogenesis as indicated. Arrowhead
indicates the location of the tight junctions (taken from Cooke and Saunders, 2002).
1.2.1.1 Sertoli cells
The number of SC present in adult testes is fixed; proliferation of the SC population
occurs in fetal, neonatal and prepubertal periods and ceases at puberty (Sharpe et al.,
2003). The number of GC associated with each SC depends on its capacity to support
their development and is species-specific. Proliferation of SC in the prepubertal period
is stimulated by FSH, so in mice lacking a functional FSH receptor there are fewer SC
(Allan et al., 2004; Johnston et al., 2004). Androgens have also been reported to
influence SC numbers in studies on mice (Johnston et al., 2004). Once SC have full
germ cell complement they become functionally mature, they no longer proliferate, they
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between adjacent SC and GC (Sharpe et al., 2003). The shape of SC nuclei change from
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Figure 1-2: Stages of spermatogenesis in mouse seminiferous epithelium. In the figure
stages of the seminiferous epithelium are presented as roman numerals, and the phases of GC
development associated with each stage are presented above. Spermatogenesis progresses
from left to right, and proceeds from stage XII to stage I in the row immediately above. mln - Bm
are spermatogonia, PI - m2°m are spermatocytes, and 1-16 are the stages of spermatid
development (taken from summary in Russell et al., 1990).
Both maturational state and GC complement influence the proteins expressed by SC (see
(Sharpe et al., 2003)), expression of anti-mullerian hormone (AMH) and aromatase
decline with differentiation of SC, however Wilms' tumour gene (WT-1) expression is
maintained in SC during fetal and adult life (Beau et al., 2000; Li et al., 1998;
Munsterberg and Lovell-Badge, 1991; Orth and Jester, 1995; Palmero et al., 1995;
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Turner et al., 2002). Indeed continued expression of AMH in adulthood signals failure
of SC to mature (Sharpe et al., 2003). Expression of GATA-4 is associated with fetal
and adult SC but only mature adult SC express GATA-1, which along with p27kipl
expression are markers of initiation of spermatogenesis and cessation of proliferation
(Beumer et al., 1999; Ketola et al., 2002; Yomogida et al., 1994).
SC function in the adult testis is influenced by GC complement. Features altered by GC
complement include the shape of the nucleus and the pattern of gene expression (see
section 1.2.3). For example, in rats at stages IX to XIV 90% of the nuclei are stretched
parallel to the basement membrane (parallel-type), the remaining nuclei are stretched
towards the lumen (perpendicular-type). Between stages I and VIII the number of
parallel nuclei declines to approximately 60%, and perpendicular nuclei rise to 40%.
The switch in nuclear orientation between stages VIII and IX is very rapid and is
associated with release of mature elongated spermatids into the tubule lumen (Leblond
and Clermont, 1952a).
1.2.1.2 Germ cells
The somatic cells of the fetal testis develop from the coelomic epithelium and
mesonephros (Tilmann and Capel, 2002), whilst the germ cells differentiate from cell
clusters within the extra-embryonic proximal epiblast (Saitou et al., 2002). The
coelomic epithelium gives rise to SC and interstitial cells (Brennan and Capel, 2004;
Karl and Capel, 1998) and the mesponephros contributes interstitial somatic cells that
become part of the peritubular myoid cell and Leydig cell populations (Buehr et al.,
1993; Merchant-Larios and Moreno-Mendoza, 1998; Tilmann and Capel, 2002).
Primordial germ cells (PGC) proliferate and migrate to the gonad via the embryonal
endoderm, where they associate with SC precursors and become enclosed within
seminiferous cords. Once within the gonad they are known as gonocytes and in mice
they undergo two periods of proliferation, the first in fetal life and the second in the
early neonatal period resulting in formation of self-renewing spermatogonia! stem cells
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(As) (Clermont and Perey, 1957; Dettin et al., 2003)). In the human, proliferation and
differentiation are not synchronous so a mixture of gonocytes and spermatogonia are
present during fetal life (Anderson et al., 2007; Gaskell et al., 2004).
Spermatogenesis is an important process, as without the production of spermatozoa,
genetic information would not be passed on (Sharpe, 1994). The adult testis contains
totipotent stem cells, which continually repopulate the testis with germ cells (Huckins,
1971; Oakberg, 1971). Spermatogenesis can be split into three phases: 1) proliferative
(spermatogonial), 2) meiotic and 3) spermiogenesis.
Proliferative phase
In the mouse A stem spermatogonia (As) divide into both new As cells and A paired
spermatogonia (Apr), which through a series of 3-4 mitotic divisions generate a
population of aligned spermatogonia (Aai) (see Figure 1-3). The steps in the
proliferation and differentiation of As to Apr and Aai spermatogonia are not restricted to
specific stages of the cycle in seminiferous epithelium but occur at random (Huckins,
1971; Oakberg, 1971) in the early and late stages of the cycle (stages X-II). The
population of Aai spennatogonia differentiate during stage VII and form Ai
spermatogonia, which undergo mitotic divisions to generate A2-4, intermediate (Ain), and
Ab spermatogonia. The five successive mitotic events required to generate Ab
spermatogonia from the Ai spermatogonia are each restricted to specific stages of
spermatogenesis, during stages XI-IV in mice (reviewed in Clermont and Leblond,
1953; De Rooij, 2001; Huckins, 1971; Oakberg, 1971).







Figure 1-3: Summary of the differentiation of germ cells during the proliferative phase in
the mouse. Development from a self-renewing spermatogonia! stem cell (As, shown in red)
through the stages of the proliferative phase of spermatogenesis to the point of forming pre-
leptotene spermatocytes (based on De Rooij, 2001).
The proliferative phase of spermatogenesis takes place in the basal intratubular
compartment of the testis. Germ cells enter the meiotic phase of spermatogenesis when
Ab spermatogonia divide and become preleptotene spermatocytes during stage VI in the
mouse (Russell et al., 1990; Sharpe, 1994).
Meiotic phase
The meiotic phase involves two cell divisions (meiosis I and II), during the first division
the chromosome number halves, and is maintained at this haploid number following the
second division (Figure 1-4). Meiosis I consists of four stages: prophase I, metaphase I,
anaphase I, and telophase I. The longest stage, prophase I, can be divided further into 5
phases: leptotene, zygotene, pachytene, diplotene and diakinesis (reviewed in Cohen and
Pollard, 2001). Each stage is defined by the appearance of the chromosomes in the cell,
and occur at specific stages of the spermatogenic cycle. During prophase I genetic
recombination occurs between homologous chromosomes at sites of synapse, which
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requires a protein structure called the synaptonemal complex. Recombination at the
synapse site generates additional genetic variation between the gametes formed in
meiosis (reviewed in Clermont, 1972; Sharpe, 1994).
©1998 Encyclopaedia Britannica, Inc
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Figure 1-4: Chromosome behaviour during meiosis. Pictorial representation of the locations
and structures of chromosome during Meiosis I and Meiosis II resulting in formation of haploid
gametes. (Online Art. Encyclopaedia Britannica Online, <http://www.britannica.com/eb/art-1688).
Spermiogenesis
The small round haploid spermatids generated at the end of meiosis II are extensively
remodelled during the final phase of spermatogenesis known as spermiogenesis.
Spermiogenesis can be subdivided into three phases: first development of the acrosome,
second nuclear condensation and elongation and third release of the mature
spermatozoon from the surface of the epithelium into the lumen. Development of the
acrosome begins with formation of the pro-acrosomal vesicle by fusing together of small
vesicles from the Golgi (Dooher and Bennett, 1973). The vesicle attaches to the
spermatid's nuclear envelop and recruits further vesicles to enlarge its size (Russell et
al., 1990; Tang et al., 1982) and spreads to cover two thirds of the nuclear surface
becoming flattened in the process.
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The DNA in the head of mature spermatozoon is significantly more condensed than in
somatic cells, requiring six times less volume (Ward and Coffey, 1991). Condensation
of the spermatozoon's DNA is achieved by changes to the DNA-binding proteins
present in the cell's nucleus. The histones typical of somatic cells are replaced
sequentially by testis-specific histones, and then transition proteins. Finally transition
proteins are replaced by basic arginine-rich cysteine-rich proteins called protamines 1
(PI) and 2 (P2) (Balhorn et al., 1999; Oliva and Dixon, 1991). As a consequence of
DNA condensation, transcriptional activity ceases early in spermiogenesis, and the germ
cell must store mRNAs for proteins required later in spermiogensis in an inactive form.
The mRNAs are inactivated by transcript specific RNA-binding proteins that prevent
their translation for several days until they are required (Han et al., 1995; Kwon and
Hecht, 1993). Elimination ofwater from the nucleus and cytoplasm of early elongating
spermatids also contributes to nuclear condensation and reduction in cytoplasmic
volume (increased density) (Sprando and Russell, 1987). The cyclic degradation and
reformation of tubulobulbar complexes (described below, section 1.2.4.4) is also
associated with reducing cytoplasmic and acrosomal volume (Sprando and Russell,
1987). The final process is elimination of cytoplasm and release of spermatozoa into the
tubule lumen. Excess cytoplasm is released from elongated spermatids as the residual
body (Leblond and Clermont, 1952b; Sprando and Russell, 1987).
1.2.2 Interstitium
The interstitium contains Leydig cells (LC), peritubular myoid cells (PTM), blood
vessels and immune cells such as macrophages. Steroidogenesis is a key function of the
testis and happens predominantly in the LC (see section 1.3.1). LC express all the
steroidogenic enzymes necessary for biosynthesis of testosterone and oestradiol (Ge and
Hardy, 1998; Turner et al., 2002). There are two populations of LC, fetal and adult
(Dufau et al., 1981), the fetal population is responsible for secreting high levels of
testosterone during the fetal period and is reported to be independent of LH action (El-
Chapter 1 Literature Review H
Gehani et al., 1998; Majdic et al., 1998). Peripheral and local hormone signals influence
function of adult LC, which express LH receptors (Shan and Hardy, 1992) and AR
(Bremner et al., 1994; Zhai et al., 1996). Rodent LC also contain ERa and ERB (Zhou et
al., 2002) but human LC appear to lack ERa (Sierens et al., 2005).
PTM cells are located around the perimeter of the seminiferous tubules outside the
basement membrane, and provide a partial barrier to diffusion of materials from the
interstitium into the seminiferous tubules (Dym and Fawcett, 1970). These cells have
contractile capacity and resemble the smooth muscle cells of other organs (Clermont,
1958; Ross, 1967). The location of the PTM cell layer around the periphery of the
seminiferous tubules suggests a role in driving elongated spermatids released into the
lumen of the tubules towards the rete testis (Clermont, 1958; Ross, 1967). In common
with LC in mice they express AR, ERa and ER(3 (Zhou et al., 2002). Evidence for
interaction between SC and PTM cell functions have been presented by Skinner and co¬
workers, who report that secretion of 'P-Mod-S' by PTM cells alters SC functions
including androgen-binding protein (ABP) and transferin secretion (Skinner and Fritz,
1985a; Skinner and Fritz, 1985b).
Blood vessels in the interstitium supply the testis with nutrients and signalling
molecules, such as LH and FSH, carried in the bloodstream. The walls of the blood
vessels do not constitute a significant barrier to the passage of substances into the testis
(Dym and Fawcett, 1970). Within the interstitium there is also a resident population of
macrophages, which may constitute around twenty-five percent of the interstitial cells in
rats (Niemi et al., 1986). The size of macrophage population and size of the cells
themselves increases as the testis matures; it has been suggested that the increased size
of the cells may be consistent with the macrophage adopting a testis-specific
morphology associated with an impact on steroidogenesis (Hutson, 1990). These
immune cells retain their capacity to phagocytose bacterial within the interstitium (Wei
et al., 1988).
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1.2.3 Sertoli cell - germ cell interactions
Each Sertoli cell is physically linked to its complement of germ cells via a diverse range
of junctional complexes including ectoplasmic specialisations (ES), desmosome-like
junctions, gap junctions and tubulobulbar complexes (TBC) (McGinley et al.. 1979;
Russell, 1977a; Russell, 1977b; Russell and Clermont, 1976). Some of these junctions
form alongside tight junctions, and constitute part of the blood-testis barrier, as
described in section 1.2.4.1. A summary of the arrangement of the junctions is show in
Figure 1-5 and the functions of each of the junctions are described in section 1.2.4.
Germ cell complement influences the pattern of gene expression in the SC, and factors
secreted by SC in turn influence GC maturation. For example, the SC products activin,
steel factor (kit ligand) and GDNF are reported to have an impact on spermatogonial
renewal, proliferation, differentiation and adhesion (Marziali et al., 1993; Matsui et al.,
1991; Meehan et al., 2000; Meng et al., 2000). Germ cell complement has a significant
influence on SC function ensuring the stage-dependent expression of key SC products,
examples include AR (Bremner et al., 1994), FSHR (Kliesch et al., 1992) and cyclin
protein 2 (CP-2) (Maguire et al., 1993). Ablation of GC with methoxyacetic acid
(MAA) in rats has revealed that expression of SC proteins including transferrin
(Maguire et al., 1997), inhibin (Maddocks et al., 1992; Pineau et al., 1990) SGP-1, SGP-
2 and CP-2 (McKinnell and Sharpe, 1997) ABP and AR (Tirado et al., 2003) are all
influenced by a SC's meiotic and post-meiotic GC complement.




























Figure 1-5: Summary of the junctional complexes described within the testis. Locations of
junctional complexes between adjacent SC and adjacent SC and GC within the testis, including
the multiple complexes included in the blood-testis barrier formed between adjacent SC at the
border between the basal and adluminal compartment (taken from Mruk and Cheng, 2004).
1.2.4.1 Blood-testis barrier (BTB)
The blood-testis barrier is predominantly composed of tight junctions between adjacent
SC found towards the base of the seminiferous epithelium that separates the tubule into
the basal and adluminal compartments. Formation of the BTB around the perimeter of
the adluminal compartment allows the SC to regulate composition of seminiferous
tubule fluid. For example, within the adluminal compartment concentrations of
androgen-binding protein, inhibin, potassium and chloride ions are higher than in
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peripheral blood (Johnson and Setchell, 1968; Setchell et ah, 1969; Turner et ah, 1979).
In contrast, the concentrations of immunoglobulins, sodium, bicarbonate, phosphate,
calcium, and magnesium ions are lower (Johnson and Setchell, 1968; Setchell et ah,
1969; Turner et ah, 1979). The BTB also renders the adluminal compartment an
immune privileged site by restricting entry of immune cells (Johnson and Setchell, 1968;
Setchell et ah, 1969).
Formation of the BTB is complete between postnatal days 16-19 in rats (Russell et ah,
1989; Vitale et ah, 1973) and around day 14 in mice (Byers et ah, 1991); the formation
of the BTB is associated with a dramatic increase in lumen size. Low permeability of
the BTB has been demonstrated by infusion of molecular tracers such as lanthanum,
horseradish peroxidase and filipin. These were excluded from the adluminal
compartment and accumulated in the basal compartment when introduced into the
bloodstream or the interstitium (Dym and Fawcett, 1970; Pelletier and Friend, 1983;
Vitale et ah, 1973).
Tight junctions in the testis consist of both integral and peripheral membrane proteins.
Integral membrane tight junction proteins identified in the BTB ofmice and rats include
occludins (Moroi et ah, 1998), claudin3 (Meng et ah, 2005), claudinll (Morita et ah,
1999), Jam-1 (Yan and Cheng, 2005), and the coxsachie adenoviral receptor (CAR)
(Wang et ah, 2007). Associated peripheral proteins include zona occluddens 1 (ZO-1)
(Byers et ah, 1991; Stevenson et ah, 1986) and ZO-2 (Jesaitis and Goodenough, 1994).
ZO-1 is localised to the cytoplasmic region of the tight junctions (Stevenson et ah, 1986)
and, in common with ZO-2 possess binding domains for both the actin cytoskeleton and
associated tight junction proteins (Fanning et ah, 1998). ZO-1 has the capacity to bind
the following tight junction components: ZO-2 (Fanning et ah, 1998), occludins (Moroi
et ah, 1998), claudins (Itoh et ah, 1999) and Jam-1 (Bazzoni et ah, 2000). ZO-1 links the
tight junction complex to the actin cytoskeleton (Fanning et ah, 1998). Within TJ
complexes ZO-2 and occludin interact directly, binding each other and actin side-chains
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(Wittchen et al., 1999) and interactions between ZO-2 and claudins are also reported
(Itoh et al., 1999).
The BTB also includes adherens junctions (AJ), called basal ectoplasmic specialisations
(ES), that consist of a cadherin-catenin structure (section 1.2.4.2). Expression of N-
cadherin, a-catenin, P-catenin, y-catenin and pl20ctn (Byers et al., 1994; Johnson and
Boekelheide, 2002a; Johnson and Boekelheide, 2002b), which are key constituents of
the cadherin-catenin complexes, have all been detected at basal ES of the BTB.
Sertoli cell jAMs Sertoli cell
Figure 1-6: Tight junction complexes between adjacent Sertoli cells. Three tight junction
complex adaptor proteins associated with ZO-1 (blue subunit), ZO-2 (pink subunit), and afadin
(red subunit) present between adjacent SC within the testis (taken from Lee and Cheng, 2004)
Claudins interact with ZO-1, ZO-2, ZO-3 (ZO-3, has not been shown to be expressed in
testis). Claudinl 1 is highly expressed in brain, testis, and can be found in the kidney. In
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the testis claudinl 1 is an important constituent of TJ between SC. (Lui et al., 2003). The
BTB must allow passage of GC from the basal to adluminal compartment of the
seminiferous tubule without diminishing its barrier function and this may be achieved by
dissociation between TJ and AJ adaptors, and dissociation of AJ. The stability and
barrier function of the BTB is maintained during these dynamics changes by increased
TJ expression (Yan and Cheng, 2005).
1.2.4.2 Ectoplasmic specialisation
Ectoplasmic specialisations (ES) are specialised forms of AJ found uniquely in the
testes. They consist of cistern of endoplasmic reticulum and the SC plasma membrane
on alternate sides of actin filaments bundles, linked through complex protein
associations. The structure is symmetrical in SC-SC junctions, but asymmetrical in SC-
GC with microfilaments bundles only in SC (Grove and Vogl, 1989). The ES within the
seminiferous tubules are separated into two groups based upon the compartment in
which they are expressed: basal or adluminal. The ES junctions at each site consist of at
least one of the following three distinct complexes of proteins: a cadherin-catenin
complex, a nectin-afadin-ponsin (NAP) complex or an integrin-laminin complex
(Chapin et al., 2001; Mruk and Cheng, 2004; Ozaki-Kuroda et al., 2002; Siu and Cheng,
2004; Wine and Chapin, 1999).
Basal ES form part of the BTB between adjacent SC; the junctions formed at this site
consist of cadherin-catenin complexes that interact with the underlying actin
cytoskeleton. The cadherin-catenin complex involves cadherins interacting with (3-
catenin/y-catenin, which initiates interaction of the N-terminal of P- or y-catenin with a-
catenin. The a-catenin C-terminal interacts with actin either directly or via actin-binding
molecules (a-actinin, vinculin, or zyxin) (Grove and Vogl, 1989; Lee et al., 2004; Li and
Trueb, 2001; Mruk and Cheng, 2004; Vogl et al., 2000)
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Two complexes are believed to exist at the apical ES; these are the NAP and integrin-
laminin complexes (Siu and Cheng, 2004). The presence of cadherin-catenin complexes
at this site is controversial, with conflicting reports on the expression of N-cadherin, [3-
catenin and pl20ctn. The nectin/afadin/ponsin complex, consists of nectin in association
with L-afadin. Nectin-3 is expressed strongly in spermatids, nectin-2 is expressed in SC.
They are expressed at junctions between SC and spermatids in a pattern typical of
proteins in the apical ES (Ozaki-Kuroda et al., 2002).
ES in the adluminal compartment are associated with GC from the mature pachytene
spermatocytes stage (late in stage VII rat epithelium) up to and including late spermatids
(stage 19, stage VII in rats) (Russell, 1977b). The ES associated with spermatids at
stage 7 or later are believed to retain GC association with SC by maintaining recesses in
which spermatid heads are held. Recesses are lost at stage VII and loss is associated
with altered ES position (Russell, 1977b). ES are associated with 1) GC as their position
changes within the seminiferous epithelium, and 2) microtubules, which suggests SC
controls GC movement via ES and microtubules (Russell, 1977b).
The ES closely associated with the BTB are basal ES, they consist of actin filaments
associated with endoplasmic reticulum close to the internal surface of the plasma
membrane and interacting proteins including ZO-1, vinculin, N-cadherin, (31-integrin,
integrin linked kinase (ILK) and espin (Bartles et al., 1996; Dym and Fawcett, 1970;
Grove and Vogl, 1989; Mulholland et al., 2001; Pfeiffer and Vogl, 1991). Identification
of a6(3l integrin in a basal location associated with BTB implicates the integrin-laminin
complex in basal ES, this complex breaks down when the preleptotene spermatocytes
cross the BTB (Salanova et al., 1995).
Espin is a testis specific protein expressed exclusively by SC in the seminiferous
epithelium, it is localised to both basal and adluminal ES between adjacent SC and SC
and GC, respectively. In the adluminal compartment, espin is localised between SC and
the heads of elongate spermatids from mid to late spermiogenesis. The expression of
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espin follows the typical pattern of ES formation and then breakdown seen during
spermiogenesis. Basal expression of espin is seen between SC in a pattern characteristic
of basal ES. Espin was shown to be capable of binding F-actin (Bartles et al., 1996).
ZO-1 is localised to ES with round and elongating spermatids but expression is lost prior
to spermiation (Byers et al., 1991). CAR is co-localised with espin at apical ES between
SC and elongating spermatids in stage VIII rat tubules (Wang et al., 2007). Fimbrin and
vinculin are strongly associated with ES enriched fractions in rat testes, and vinculin is
immunolocalised to SC-SC and SC-spermatid junctions. Fimbrin is an actin-binding
protein.
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Figure 1-7: Ectoplasmic specialisation complexes between Sertoli cells and germ cells.
The three adherens junction complexes present in ES within the testis: integrin- laminin,
cadherin-catenin, nectin-afadin-ponsin plus associated proteins. The figure also indicates the
components contributed by the SC and GC at SC-GC ectoplasmic specialisations (taken from
Lee and Cheng, 2004)
1.2.4.3 Gap junctions
Gap junctions are channels that connect the cytoplasm of adjacent cells; each channel is
composed of two subunits (connexons) made up of six connexin proteins. Gap junctions
allow the passage of small molecules and ions (Kumar and Gilula, 1996; Musil and
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Goodenough, 1993). At least twenty connexins have been identified, of which eleven
have been identified in testes (Pointis et al., 2005; Risley, 2000). Of the eleven
connexins in testes, eight are expressed in SC and nine in GCs. The most abundant of
these, connexin43 (Cx43), is expressed in SC, GC and LC (Risley et al., 1992; Roscoe et
al., 2001). In adult testes expression of Cx43 is found between adjacent SC and between
SC and GC, from spermatogonia up to and including pachytene spermatocytes (Batias et
al., 1999; Batias et al., 2000). The SC-SC gap junctions co-localise with ZO-1 and are
associated with the BTB (Batias et al., 1999; Giepmans and Moolenaar, 1998). In rats
expression of Cx43 within the SC is stage-specific, expression is weak during stages V-
VI, reaching a peak in stage VII and declining again at stage IX of spermatogenesis
(Batias et al., 1999; Batias et al., 2000; Risley et al., 1992). The importance of Cx43 has
been confirmed using targeted gene deletion in mice. Connexin 43 null mutant mice
have a germ cell deficiency that develops during fetal development and persists into the
early neonatal period during which the mutant mouse dies (Juneja et al., 1999). If
neonatal development of the testis is extended in grafting experiments the germ cell
deficiency is maintained resulting in a postnatal "Sertoli cell only" phenotype (Roscoe et
al., 2001). When Cx43 expression is knocked out specifically in SC, studies reveal
spermatogenesis arrests at the spermatogonial stage, and can result in SC-only syndrome
with clusters of intratubular SC are observed in the testes (Brehm et al., 2007).
1.2.4.4 Tubulobulbar complexes
The tubulobulbar complex is a structure that originates from the acrosomal membrane of
elongated spermatids and projects into the cytoplasm of associated SC. The TBC
consists of tubules with a bulbous mid-section that interact with the SC via bristle-coated
pits (Russell and Clermont, 1976; Russell and Malone, 1980). In rats, and the majority
of other species, the TBC is maintained until the point of spermiation, but in mice the
TBC cannot be identified (Russell and Malone, 1980). The TBC occupy the same sites
as the apical ES between SC and elongating spermatids and have been suggested to play
a role in the removal of apical ES by internalisation of the junctions, and to replace the
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ES in maintaining spermatids at the luminal surface of SC until they are released to the
lumen (Guttman et al., 2004; Russell and Malone, 1980). There is also evidence that
cycles of TBC formation and phagocytosis by the SC result in elimination of cytoplasm
from the acrosome of the spermatids (Russell and Malone, 1980; Tanii et al., 1999).
TBC are also present at basal locations between adjacent SC in the seminiferous tubules
where they may play a role in gap junction elimination indicated by loss of Cx43
expression (Risley et al., 1992; Russell and Clermont, 1976; Tanii et al., 1999).
1.2.4.5 Desmosome-like junctions
Desmosome-like junctions are involved in adherence of spermatogonia, spermatocytes
and round spermatids to the SC in the seminiferous epithelium and in the transfer of GC
from the basal to adluminal compartment of the seminiferous tubules (Russell, 1977a).
These are actin-associated anchoring-junctions. During migration of spermatocytes
across the BTB barrier into the adluminal compartment, desmosome-like structures
develop between the SC and pre-leptotene spermatocytes. These junctions attach the
spermatocytes to the SC resulting in the cell being drawn away from the basal
membrane and ultimately crossing the BTB (Russell, 1977a). Desmosome-like
junctions interact with intermediate filaments (Mulholland et al., 2001). N-cadherin is
expressed in a stage independent manner in desmosome-like junctions and is co-




Leydig cells are the site of testosterone synthesis (Christensen and Mason, 1965; Eik-
Nes and Hall, 1965; Hall et al., 1969), and oestrogen is synthesised in the following
testicular cells that express the aromatase enzyme: LC, immature SC, and
subpopulations of GC (Kurosumi et al., 1985; Turner et al., 2002). The key steps,
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intermediate products and enzymes of the steroidogenic pathway in LC are shown in
Figure 1-8.
Cholesterol is the initial substrate for the process of steroidogenesis, so must accumulate
in mitocondria at the site of the first enzyme reaction (Miller, 2007). The initial
transport of cholesterol into the mitochondria requires cholesterol to be mobilised from
cellular stores and transported to the outer mitochondrial membrane, a further
translocation of cholesterol to the inner mitochondrial membrane is required to reach the
first site of cholesterol's conversion to steroids (Stocco and Clark, 1996). Initial
intracellular transport of cholesterol appears to involve the StarD4, 5, and 6 proteins
(Soccio and Breslow, 2003). Cholesterol transport within the mitochondria to the inner
mitochondrial membrane is mediated by StAR (steroidogenic acute regulatory) protein
(Clark et al., 1994; Stocco and Sodeman, 1991), and is the rate limiting step during
steroidogenesis and the point at which acute regulation of steroidogenesis occurs
(Crivello and Jefcoate, 1980; Miller, 2007). Synthesis of the StAR protein in LC is in
response to hormone stimulation, by LH and human chorionic gonadotrophin, StAR is
initially synthesised as 37 then 32 kDa precursor proteins which are processed to four
forms of 30 kDa proteins that are localised to the inner mitochondrial membrane (Clark
et ah, 1994; Stocco and Sodeman, 1991). The mechanism for import of cholesterol to
the inner mitochondrial membrane has not been determined, but it has been determined
that StAR is only functional transiently at the cytoplasmic surface of the outer
mitochondrial membrane and not at its final destination in the matrix (Bose et al., 2002).
Investigations have identified potential interactions at the outer mitochondrial membrane
between StAR and TSPO, PAP7, and PKAIa. These four units function together in
mitochondrial cholesterol import (Liu et al., 2006).
Chronic regulation of steroidogenesis is via expression of the steroidogenic enzymes that
catalyses the conversion of cholesterol to pregnenolone, through to androstenedione, and
onwards to androgens and oestrogens; control that is mediated by LH action (Miller,
2007; Payne and Youngblood, 1995). The steps of steroidogenesis are catalysed by a
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series of enzymes including cytochrome P450s, hydroxysteroid dehydrogenases (HSD)
and 5a-reductase. The initial conversion of cholesterol to prenenolone is the rate
limiting enzyme reaction (Karaboyas, 1965) located at the inner mitochondrial
membrane and catalysed by P450scc (side-chain cleavage) on the mitochondrial matrix
side of the membrane (Churchill and Kimura, 1979). The action of P450scc catalyses 3
reactions 1) 22-hydroxylation, 2) 20-hydroxylation, and 3) scission of 20-22 carbon-
carbon bond (Hall, 1994)}(Miller, 2002; Simpson, 1979; Yago and Ichii, 1969):
Cholesterol —> 22-OH Cholesterol —> 20,22-Di-OH-Cholesterol —> Pregnenolone
The synthesis of androstenedione from pregnenolone occurs in the microsomes of the
mitochondria (Hall, 1994) and can be achieved through two alternative pathways
(reviewed in (Conley and Bird, 1997)) dependent upon the order in which the
pregnenolone undergoes a) hydroxylation and lysis by P450cl7 and b) dehydrogenation
by 3P-HSD type I (Bain et ah, 1991). If dehydrogenation precedes P450cl7 actions,
steroidogenesis follows the A4 pathway:
Pregnenolone —> Progesterone (catalysed by 3(3 HSD)
Progesterone —> 17-OH Progesterone —> Androstenedione (catalysed by P450cl7)
If P450cl7 acts first the A5 pathway is followed:
Pregnenolone —> 17-OH Pregnenolone —> Dehydroepiandrosterone
(catalysed by P450cl7)
Dehydroepiandrosterone —> Androstenedione (catalysed by 3fj HSD)
Both yield the same product but there are species differences between which pathways
are utilised. Rats use the A4 pathway almost exclusively (Hall, 1994), whilst pigs,
rabbits, dogs and man use the A5 pathway (Hall, 1994). The importance of A4 versus
A5 pathway in different species is dependent upon variations in the properties of 3P
HSD and P450cl7, including relative affinity of the enzymes for their substrates,
relative expression levels, and efficiencies of the reactions (Conley and Bird, 1997). In
the case of humans the A5 pathway is used because of an inability to catalyse 17-OH
Chapter 1 Literature Review 24
Progesterone —> Androstenedione in the A4 pathway (Conley and Bird, 1997).
Androstenedione is the precursor of testosterone and the conversion is catalysed by 17(3
HSD type III, which is detected in the mouse testis within the microsomes (Penning,
1997; Sha et al., 1997). Testosterone generated in the testis can be converted further to
form the more potent androgen DHT (Dihydrotestosterone) a conversion catalysed by
5a-reductase type I in mice (O'Shaughnessy et al., 2002). Aromatase (P450arom) is
expressed in mature testes by LC and some GCs (Turner et al., 2002) (Levallet et al.,
1998), this enzyme converts testosterone to oestradiol and this conversion is stimulated
in LC by LH/hCG (Valladares and Payne, 1979; Valladares and Payne, 1981).

















Figure 1-8: Synthesis of sex steroids. Pathway for biosynthesis of androgens and oestradiol
from cholesterol, indicating the substrates, enzymes and products of each step, based upon
figure in (Conley and Bird, 1997).
1.3.2 Steroid receptors
1.3.2.1 Structure and signalling
The sex steroid receptors are members of a super-family of genes that typically function
as ligand-activated transcription factors (Bain et al., 2007) although some NR
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superfamily members are reported to act in the absence of a cognate ligand. The
members of the family have a conserved arrangement of functional domains depicted in
Figure 1-9. The generalised structure of a nuclear sex steroid receptor consists of six
domains, called A to F. The A/B domain contains the activation function (AF)-l region,
domain C is the highly conserved DNA-binding domain (DBD), D is the hinge domain
and is proximal to the E/F domain that contains the ligand-binding (LBD) domain and
AF-2 region (Olefsky, 2001). The DBD is the site of interaction between steroid
receptors and their hormone response elements (FIRE) within promoter regions of
responsive genes, and contains two zinc-finger regions. The first zinc finger ensures that
interaction between the DBD and response elements are sequence specific, whilst the
second zinc finger determines the spacing between units of the response element to
which the domain can bind (Bain et al., 2007; Ribeiro et al., 1995). The LBD is less
conserved than the DBD but includes a binding pocket that confers ligand specificity
and the second activation function (AF-2 region). (Bain et al., 2007). In the
progesterone receptor mutations within the AF1 and hinge domains result in loss of
transcriptional activity (Dobson et al., 1989).
Binding of ligand to sex steroid receptors causes a change in the LBD from an inactive
to an active conformation (Beekman et al., 1993; Kuil et al., 1995) and dissociates the
receptor from a complex of chaperone proteins including Hsp90, Hsp70 and Hsp56.
Numerous proteins have been reported to interact with the region AF2, some of which
have the properties of transcriptional coactivators including those shown in Figure 1-10.
For example, studies by Parker and coworkers have demonstrated that recruitment of the
p 160 co-activators to the ER is dependent on the integrity of a C-terminal helix, referred
to as helix 12 (Heery et al., 1997), which structural analysis suggests is realigned during
binding of ligands to the LBD domains of several receptors (Renaud et al., 1995;
Schulman et al., 1996). In the ER it is misaligned in the presence of an antiestrogen,
raloxifene, which blocks AF2 activity (Brzozowski et al., 1997).
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Figure 1-9: Steroid receptor structure. Schematic diagram of the generalised structure of a
steroid receptor including sites of key functional domains (taken from Olefsky, 2001).
The human androgen receptor (AR/NR3C4) cDNA was cloned in 1988, and localised to
the X chromosome (Lubahn et al., 1988; Trapman et al., 1988); rat and mouse
homologues have also been cloned (Chang et al., 1988; Faber et al., 1991). There are
two oestrogen receptors known as ERa (ESRl) and ERfi (ESR2); ERa was cloned from
human MCF-7 in 1985 (Walter et al., 1985) and from the mouse uterus in 1987 (White
et al., 1987). ERfi, was identified a decade later in rats and humans (Kuiper et al., 1996),
and the cDNA sequence in the mouse was published in 1997 (Tremblay et al., 1997).
The ERa and ER(3 proteins both possess DBD and LBD with significant homology (97%
and 60%, respectively), but the N-termini are not homologous (Tremblay et al., 1997).
ERfi has two splice variants in mice ERfi 1 and ERfi2, the (12 variant contains an
additional eighteen amino acids within its LBD. The affinity and transcriptional
capacity of the ER(32 variant is significantly reduced compared to the ER[31 form, this is
proposed to be due to reduced interactions with transcription co-factors (Zhao et al.,
2005). Multiple splice variants of ERfi have been identified in human none of which are
homologous to the mouse variants (Moore et al., 1998).
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Figure 1-10: Nuclear partners of steroid hormone receptors. Co-factors associated with
steroid hormone receptors required for induction of transcription by the activated steroid
receptor. Factors are group by function, (taken from Beato and Sanchez-Pacheco, 1996).
The steroid receptors either function as homo- or hetero-dimers; dimerisation is
dependent upon sequences within both the DBD and LBD, with the C-terminal of the
LBD exerting the greatest influence (Tsai and O'Malley, 1994). Monomelic AR is
unable to bind to androgen response elements (AREs) in gene promoters and can only
function as a dimer. Deletion studies have shown that homo-dimerisation of AR is
inhibited in the absence of bound androgens by the N-terminal domain. The binding of
the ligand counteracts the inhibition by altering the conformation of the receptor
resulting in DNA-binding by AR dimers (Wong et al., 1993). A classical ARE sequence
was identified by Roche et al (Roche et al., 1992) and described as consisting of two
half-sites (inverted repeats) separated by a 3 base-pair region. The ARE sequence (5'-
GGA/TACANNNTGTTCT-3') bears significant homology to the glucocorticoid
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response element (GRE) that is recognised by the glucocorticoid and mineralocorticoid
receptors. The size of the spacer region between half-sites is important to maintaining
the function of the ARE and an increase or decrease of just one nucleotide prevents
formation of the receptor-DNA complex (Kallio et al., 1994). Binding of androgens by
rat and human AR via the LBD of the receptor protein is required for intramolecular
interaction between the C-terminal LBD and N-terminal transactivation domain,
including the AF-1 site (Doesburg et al., 1997; Ikonen et al., 1997). The intramolecular
interactions and resultant activity of the complex both require the involvement of
nuclear co-factors including CBP and F-SRC-1 (Doesburg et al., 1997; Ikonen et al.,
1997). CBP in particular has been identified as recruiting RNA polymerase II and
transcription factor IIB (Doesburg et al., 1997).
The Rhox5 gene expressed in the SC and epididymis contains two AREs (ARE-1 and
ARE-2) that differ slightly from the consensus ARE. For example, the half-sites of
ARE-1 consist of two direct repeats separated by five nucleotides and ARE-2 also
consists of half-sites with a structure that approximates direct repeats separated by three
nucleotides. The process of AR binding to ARE-1 and -2 within Rhox5's proximal
promoter is dependent upon the right half-sites, which suggested AR binding to the right
half-site is the first step in a two-step ARE-binding process, the second step being
binding to the other half-site which is dependent on binding to the right half-site
(Barbulescu et al., 2001).
1.3.3 Impact of hormones on male reproduction
Hormones are central to the regulation of male fertility; an overview of the hormones
involved in regulating adult male reproduction is shown in Figure 1-11. Regulation is
dependent upon stimulation of the testis by the pituitary gonadotrophins LH and FSH
and negative feedback by steroids and proteins (e.g. inhibin) produced by the testis.
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1.3.3.1 Gonadotrophins
The gonadotrophins LH and FSH are synthesised and secreted by the gonadotropes
within the anterior lobe of the pituitary gland. The gonadotrophins are heterodimeric
hormones consisting of a common alpha protein chain and a beta chain that identifies the
hormone, and determines interactions with the hormone receptor (Combarnous, 1992;
Haisenleder et ah, 1994). Secretion of LH and FSH from the anterior pituitary is
stimulated by the hypothalamus via a ten amino acid peptide called gonadotrophin-
releasing hormone (GnRH), which is secreted in regular pulses (Haisenleder et al.,
1994). The LH receptor is expressed by LC, and FSH receptor by SC within testes
(Kliesch et al., 1992; Shan and Hardy, 1992). The importance of FSH in determining
the final number of SC within testes is demonstrated in mice in which FSH signalling is
disrupted, at five days postpartum these mice have normal SC numbers but they are
reduced by 40% in adult testes at 20 days postpartum (Johnston et al., 2004). The
importance of gonadotrophins in male fertility has been demonstrated in models such as
the Hpg mouse, and mice with targeted disruption of LH or FSH signalling. The
hypogonadal {Hpg) mouse carries a mutation in the GnRH gene (Mason et al., 1986)
which causes a permanent reduction of both LH and FSH levels and consequentially
failure of SC and GC to mature (Myers et al., 2005). Treatment ofHpg mice with LH
can reinstate steroidogenesis (Scott et al., 1990) and treatment with FSH plus androgens
restores qualitatively normal spermatogenesis (Haywood et al., 2003; Singh and
Handelsman, 1996). LH and FSH can be withdrawn in adulthood by hypophysectomy
(surgical or via GnRH antagonist), animals undergoing these treatments exhibit reduced
testis weight, and after three weeks reduced numbers of spermatocytes, and loss of
spermatids (El Shennawy et al., 1998). Deletion of the LH receptor in mice (LuRKO
mice) results in abnormal development of their LC, which are reduced in size and
number, and is associated with disruption of spermatogenesis in round spermatids
(Zhang et al., 2001). The testes of mice with disruption of FSH signalling due to
absence of a functional FSH receptor (FORKO) or FSH beta chain (FSH(3KO) contain a
reduced number of SC, and retarded development with puberty and appearance of
spermatocytes delayed in these animals (Johnston et al., 2004; Krishnamurthy et al.,
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2001). Introduction of 1) a constitutively active FSHR transgene or 2) a transgene
containing tandem alpha and beta chains of FSH, into Hpg mice can overcome the
disrupted Hpg phenotype increasing testis weight and supporting development of germ
cells up to the round spermatid stage, however few elongated spermatids are generated
(Allan et al., 2004).
Androgens and oestrogens produced by the testis are important for normal
spermatogenesis (see evidence below) and together with inhibin also provide negative
feedback on the anterior pituitary to regulate gonadotrophin secretion (Figure 1-11,
(Cooke and Saunders, 2002; Haisenleder et al., 1994)). Inhibin consists of two subunits
a and p (Pa or Pb), which results in two forms of inhibin, inhibinA (a.pA) and inhibinB
(ocPb) (de Kretser et al., 2002; Ling et al., 1985). Both a and P subunits are synthesised
in the adult testis, with greatest expression in SC and limited quantities in LC (Majdic et
al., 1997). Feedback of inhibin released from the testis acts upon the anterior pituitary
cells to reduce secretion of FSH independently of GnRH signalling from the
hypothalamus, providing feedback between SC function and numbers, and the FSH
which influences them (de Kretser et al., 2002; Ling et al., 1985; Tilbrook et al., 2001).
Steroids may exert feedback effects on gonadotrophin (LH and FSH) secretion at the
hypothalamus and anterior pituitary (Shupnik and Schreihofer, 1997). Feedback of
testosterone and oestrogen on gonadotrophin secretion is demonstrated in castrated male
animals which display elevated LH subunit expression in pituitary, which is reduced by
oestrogen or testosterone treatment (Keri et al., 1994). Action at the hypothalamus alters
amplitude and frequency of the GnRH pulses that act upon the anterior pituitary
gonadotropes that secrete LH and FSH (Shupnik and Schreihofer, 1997). In rats
increased expression of LH mRNA caused by orchidectomy can be suppressed by both
DHT and Antide (GnRH antagonist) which implicates GnRH signalling in the feedback
mechanism (Fallest et al., 1995). In addition, castration in animals including rams and
mice causes increased GnRH neurone activity and increased frequency of GnRH pulses.
Increased GnRH neurone activity and pulse frequency is reduced by separate treatments
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with testosterone or oestradiol, and is associated with altered pattern of LH secretion by
gonadotropes (Jackson et al., 1991; Pielecka and Moenter, 2006). At the anterior
pituitary steroids act to alter numbers of GnRH receptors expressed so altering
sensitivity to these hormones (Shupnik and Schreihofer, 1997). During in vitro
experiments in a gonadotrope cell line (aT3) testosterone acts to reduce expression of
the gonadotrophin a-subunit thereby impacting expression of both LH and FSH,
testosterone acts directly on the gonadotrope by repressing transcription of this gene
(Heckert et al., 1997). Castration in rats increases expression of GnRH receptor mRNA
in the anterior pituitary, in association with increased LH and FSH mRNA and serum
levels, these increases can be reversed by treatment with testosterone (Kaiser et al.,
1993). Pituitary cells treated with oestradiol in vitro also exhibit a reduced number of
GnRH receptors (McArdle et al., 1992).
In monkeys and sheep, in which the majority of research on steroid effects at the
hypothalamus and pituitary has been conducted, impact of testicular steroids is
predominantly on the hypothalamus, with minimal impact on the anterior pituitary
(Tilbrook et al., 2001).





Figure 1-11: Hormone regulation within the male reproductive system. Gonadotrophins are
secreted under the influence of GnRH from the hypothalamus. Gonadotrophins (LH and FSH)
secreted by the pituitary act upon Leydig and Sertoli cells of the testis supporting fertility. Within
the testes factors such as testosterone, oestradiol and inhibin are synthesised and signal locally
as well as feeding back on the anterior pituitary inhibiting LH and FSH secretion completing the
negative feedback system (taken from Cooke and Saunders, 2002).
Chapter 1 Literature Review 34
1.3.3.2 Androgens
Expression of AR is restricted to the somatic cells within the testis and the protein has
been immunolocalised to LC, PTM and SC (Bremner et ah, 1994; Saunders et ah, 1996;
Suarez-Quian et ah, 1999; Zhou et ah, 2002). In rats (Bremner et ah, 1994), mice (Zhou
et ah, 2002) and human (Suarez-Quian et ah, 1996) the intensity of AR immunostaining
in SC varied between stages. For example, in rats highest levels of AR protein
expression were detected in SC nuclei at stages VII and VIII whereas in situ
hybridisation revealed that FSH receptor mRNA was highest during stages IX and X
followed by a decrease of signal intensity in stages XI-XII (Kliesch et al., 1992). There
have been sporadic reports that AR are also expressed in GC (Vornberger et ah, 1994)
however full spermatogenesis has been achieved following transplantation of GC from
mice lacking a functional AR into recipients suggesting that (at least in the mouse)
expression ofAR in GC is not necessary (Johnston et ah, 2001).
Androgens are required for normal development of the male reproductive tract. In mice
lacking a functional AR (Tfm or ARKO sections 1.3.3.2.1, 1.3.3.2.2 respectively) testes
fail to descent and their size is dramatically reduced. In addition the prostate,
epididymis, vas deferens and seminal vesicles fail to develop. Cell-selective KO of AR
in different cell types within the testis has also been carried out and results point to a key
role for AR expression in SC in maintenance of fertility (section 1.3.3.2.3).
The necessity of high intra-testicular testosterone (ITT) concentrations for maintenance
of full spermatogenesis in rats has been investigated by depletion of LC with ethane
dimethane sulphonate (EDS) (Bartlett et ah, 1986) or administration of testosterone and
oestradiol (T+E) implants to suppress LH secretion (O'Donnell et ah, 1994), both of
which deplete ITT. In EDS-treated rats, germ cell loss is first observed in seminiferous
tubules at stages VII and VIII, which coincides with the tubules in which the most
intense AR immunoexpression is detected in SC (Bartlett et ah, 1986; Bremner et ah,
1994; Hill et ah, 2004). Within 4-8 days of EDS treatment, a significant increase in the
incidence of pyknotic GC indicative of apoptosis is observed at stages VII and IX-XI,
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testosterone supplementation can rescue the GC within 2 days, but only in stage VII
tubules (Kerr et al., 1993a). EDS treatment also has an impact on protein secretion by
SC (McKinnell and Sharpe, 1995), and reducing the quantity of seminiferous tubule
fluid they secrete (Sharpe et al., 1994). Passage of round spermatids between stages VII
and VIII of the spermatogenic cycle and the numbers of elongated spermatids present,
were both dramatically reduced in the seminiferous tubules of rats treated with T+E-
implants for 11 weeks to suppress ITT (O'Donnell et al., 1994). In this model, the
failure of spermatogenesis in round spermatids following ITT depletion was reported to
be due to stage-specific breakdown of the ectoplasmic specialisations between stages
VII and VIII causing detachment of the spermatids (O'Donnell et al., 1996).
1.3.3.2.1 Tfm mouse
Male testicular feminised, Tfm, mice possess a XY genotype but a female phenotype
with a vagina, a female ano-genital distance, cryptorchid testes of diminished size and
no other sex-specific structures, neither male or female (Lyon and Hawkes, 1970). In
Tfm testis spermatogenesis fails before meiosis is complete resulting in a diminished GC
complement with no GC developing beyond spermatocytes, and whilst SC and LC are
present, the LC appeared enlarged (Lyon and Hawkes, 1970). The genetic explanation
for the Tfm phenotype is a single base-pair deletion in the AR gene resulting in a
frameshift mutation that produces a truncated AR protein that lacks the steroid- and
DNA-binding domain and consequentially the capacity to activate androgen response
elements in any cell (He et al., 1991). The initial disruption in Tfm is the loss of AR
signalling during fetal development, however the consequences of the disruption also
impact upon synthesis of testosterone and DHT in the LC of adult testes (Goldstein and
Wilson, 1972). The disruption of steroidogenesis in adult testes occurs at points in
androgen synthesis catalysed by 17a-hydroxylase (P450cl7) and 17-ketosteroid
reductase (17J3HSD) (seen in Figure 1-8), these deficiencies are a consequence of the
requirement for androgen signalling for development of an adult population of
functional LC (Murphy et al., 1994).
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1.3.3.2.2 Androgen receptor knockout (ARKO)
In the ARKO mouse model AR is ablated from all tissue by virtue of crossing mice
expressing Cre-recombinase under the control of the ubiquitous PGK promoter (PGK-
Crem) with those expressing an AR gene floxed at the 2nd exon (Chang et ah, 2004; De
Gendt et al., 2004).
The phenotype of ARKO males closely resembles that of the Tfm mice with a female
phenotype and no formation of epididymis, vas deferens, seminal vesicles or prostate.
The testes are not located in the scrotum but remain in either the abdomen or inguinal
region and are drastically reduced in size (De Gendt et al., 2004). Within the testes the
lumen is absent, there are reduced numbers of SC and multiple layers of PTM cells
around the perimeter of seminiferous tubules (De Gendt et al., 2004). Spermatogenesis
was severely disrupted with no evidence of meiotic germ cell maturation and reduced
capacity to support spermatogonial maturation in adulthood (Tan et al., 2005).
1.3.3.2.3 Sertoli cell specific androgen receptor knockout
Mice in which AR was selectively deleted only in SC, have been reported by three
independent groups and reported as SCARKO (Sertoli cell androgen receptor knockout)
(De Gendt et al., 2004), S-AR(-/y) (Chang et al., 2004) mice or A/,ox(exI'neo)/Y; Amh-cre
(Holdcraft and Braun, 2004). SCARKO and S-AR(-/y) mice were both generated by
crossing females with an AR allele floxed at the second exon of the gene with male mice
that express Cre-recombinase under the control of the AMH promoter to ensure SC-
specific deletion (De Gendt et al., 2004). In the third model a hypomorphic allele was
generated by floxing exon 1 of AR, which resulted in reduced expression of AR in SC
and other cell types in the absence of Cre recombinase. Androgen receptor expression
was ablated specifically in SC by crossing mice bearing the floxed AR gene with mice
expressing AMH-Cre recombinase. In these mice germ cells completed meiosis, in
contrast to other SC-specific AR knockout models, but development of round spermatids
into elongate spermatids failed. In addition serum testosterone was raised in the
jfjiox/exi-neoj/r. y[mjl_cre mice (Holdcraft and Braun, 2004).
Chapter 1 Literature Review 37
In contrast to ARKO mice, in SCARKO mice testes descended into the scrotum and the
epididymis, vas deferens, seminal vesicles and prostate developed normally although
testis size was reduced compared to wild-type littermates (Chang et ah, 2004; De Gendt
et ah, 2004). Spermatogenesis in SCARKO mice reached a more advanced stages than
in ARKO animals, but still was not completed, due to failures in meiosis between stage
VI and XII of the cycle. Although a few GC developed as far as becoming round
spermatids no elongate spermatids were detected, these changes were associated with
increased germ cell apoptosis and grossly reduced expression of genes specific for late
spermatocyte or spermatid development (De Gendt et al., 2004). The size of the SC
population in SCARKO mice is not reduced compared to wild-type testes, despite the
lack of direct androgen signalling on SC (De Gendt et al., 2004; Tan et al., 2005).
Expression of markers of SC maturation was normal in the SCARKO (Tan et al., 2005)
and although FSH levels were 34% higher, circulating levels of LH and testosterone
were normal (De Gendt et al., 2004). The pattern of GC loss observed in S-AR(-/y)
mice appeared identical to that in SCARKO (Chang et al., 2004), however in contrast to
SCARKO mice, elevated levels of LH and testosterone and delayed SC maturation were
reported.
An array was conducted on SCARKO testes to identify potential androgen-responsive
genes, and the SC protein Rhox5 was identified amongst several differentially regulated
genes (Denolet et al., 2006a) (discussed in section 1.4.3). Within the testes of SCARKO
mice LC were also affected, although the number of LC were normal at 12 days post
partum, at later ages the LC population was depleted by >40%. In addition, these adult
LC were enlarged and contained more lipid droplets and mitocondria than in wild-type
testes (De Gendt et al., 2005). These studies on SCARKO testes reveal that androgen
signalling in SC has consequences not just for GC development through
spermatogenesis, but also development of the LC population, potentially via PDGF-A
and/or oestrogen signalling (De Gendt et al., 2005).
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1.3.3.3 Oestrogens
Aromatase, the enzyme required for oestrogen synthesis, is encoded by the Cypl9 gene
(Akingbemi, 2005), and is expressed in rodent testes in LC, immature SC and some but
not all adult GC (Levallet et al., 1998; Rosselli and Skinner, 1992; Turner et al., 2002).
In adult rats and mice ERa has been localised to LC (Pelletier et al., 2000; Zhou et al.,
2002), the epithelial cells lining both the epididymis and efferent ductules that link the
epididymis to the rete testis, but not to SC or GC (Fisher et al., 1997; Hess et al., 1997b;
Sar and Welsch, 2000; Zhou et al., 2002). Positive immunoexpression for ER(3 has been
detected in somatic and germ cells in the testes of mice, rats, primates and humans
(Saunders et al., 1997; Saunders et al., 2001; van Pelt et al., 1999; Zhou et al., 2002),
including fetal GC of mice and rats (Jefferson et al., 2000; van Pelt et al., 1999). In rats,
protein and mRNA expression was detected in all type A spermatogonia, though
expression was weak, and was not detected in intermediate A-type or B-type
spermatogonia. ER[3 was not expressed again until pachytene spermatocytes during
stages VII-XIV and round spermatids in stages I-VIII (Shughrue et al., 1998; van Pelt et
al., 1999). In mice, ER(3 protein was detected in all stages of spermatogonia and was
abundant in spermatocytes not undergoing meiotic division (Jefferson et al., 2000; Zhou
et al., 2002).
1.3.3.3.1 Aromatase KO
Aromatase knockout mice (ArKO) were generated by introducing the Neo gene into
exon IX of the Cypl9 gene (Fisher et al., 1998; Robertson et al., 1999). Male ArKO
mice were initially fertile with a normal testis structure. However within a year of birth
spermatogenesis was disrupted and although numbers of spermatogonia and
spermatocytes were not reduced numbers of round and elongate spermatids were
diminished (Robertson et al., 1999). The loss of spermatids was not associated with
reduced SC numbers or change in fluid balance within the tubules, which did not differ
significantly from wild types mice of the same age. GC loss was associated with
increased apoptosis, abnormal acrosome development and sloughing of spermatids from
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the seminiferous epithelium (Robertson et al., 1999). The epididymes of ArKO mice
contained few or no sperm at a year old, and they were infertile in mating studies
(Robertson et ah, 1999). In younger animals, fourteen weeks old, reduced fertility (50%
success) was observed, the spermatozoa produced were less motile and mating
behaviour was disrupted (Robertson et ah, 2001) GC loss was partially rescued by
feeding animals with a diet rich in phytoestrogens (Robertson et ah, 2002).
1.3.3.3.2 ERa knockout
Mouse lines with disruption to ERa have been generated, the first involves disruption of
the gene's reading frame by insertion of the Neo gene into exon 2 of (Lubahn et ah,
1993). A second ERaKO was generated by excising exon3 of ERa using loxP sites
either side of the exon and cre-recombinase expression, resulting in a truncated protein
(Dupont et ah, 2000). In adult male ERaKO mice there is a late onset phenotype with a
reduction in testicular weight associated with a dramatic reduction in epididymal sperm
count (Eddy et ah, 1996; Lubahn et ah, 1993). Disruption of ERa, results in dilated
lumens in the seminiferous tubules and rete testis within twenty days of birth, initially
this does not affect spermatogenesis, however ten weeks after birth spermatogenesis and
sperm count began to decline (Dupont et ah, 2000; Eddy et ah, 1996). The dilation of
the tubule lumens appears to be as a secondary consequence of reduced fluid
reabsorption in the efferent ductules (Hess et ah, 1997a). Not only were the numbers of
sperm reduced, their motility and capacity for in vitro fertilisation was also impaired
(Eddy et ah, 1996).
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1.3.3.3.3 ERp knockout
The first ER(3KO mice were generated by two different laboratories who introduced the
Neo gene, in the reverse or correct orientation respectively, into exon 3 of the ERjB gene
disrupting its function (Dupont et al., 2000; Krege et ah, 1998). Investigations of
fertility and testis morphology in both ERPKO mouse lines revealed that these animals
are fertile and exhibit no disturbance to form or function of the testes (Dupont et al.,
2000; Krege et al., 1998). There were reports of hyperplasia in the collecting ducts of
the prostate and bladder in one study (Krege et al., 1998), but they were not found in the
mice of the second study (Dupont et al., 2000). A later study using ER(3KO mice,
reported an increase in the population of gonocytes present during the neonatal period by
as much as 50%. The increase in gonocyte numbers during the early neonatal period
was reported to be due to decreased apoptosis of the cells, accompanied by a less
significant increase in proliferation. The altered behaviour of the gonocytes may reflect
a delay in their maturation. The effect of oestrogen via ERP is proposed to be directly
on the GCs (Delbes et al., 2004). In a study using the more robust stratergy of floxing
the ERJ3 allele, mice lacking functional ERJ3 were infertile although there was no
disturbance to the testicular morphology and accessory tissue such as the prostate were
also not adversely affected (Antal et al., 2008).
1.3.3.3.4 ERaP double knockout
Heterozygous (ER a ~ER/3' ) mice were generated by crossing two mouse lines, the
first bearing a disrupted ERa and the other a disrupted ERJ3 allele. Inbreeding between
the ERct'-ERp'- mice generated the ERocpKO mice (Couse et al., 1999; Dupont et al.,
2000). The consequences of knocking out both ERa and ERP were similar to those in
ERaKO mice, the testes remained intact but there was swelling within the seminiferous
tubules and rete testes. Spermatogenesis was present but incomplete and the
concentration and motility of sperm in the epididymis were reduced, a phenotype that
mirrored that in ERaKO (Couse et al., 1999; Dupont et al., 2000).
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1.4 Androgen responsive genes identified in SC
Despite the considerable evidence of stage dependent expression of AR in SC, and
detrimental effects on GC development of disrupting production or action of androgens,
very few androgen-responsive genes have been identified in testicular cells. The
situation may change with development of new models and further analysis of existing
models, such as through array analysis (described below in section 1.4.3) although
analysis will often be complicated by changes in GC complement and therefore
secondary effects on SC-GC interaction. There follows a description of the limited
number of androgen-responsive genes identified in SC.
1.4.1 AR
The expression of AR has been shown to be regulated in vitro and in vivo by factors
including androgens themselves. The expression of AR in cultured immature SC is
increased two- to three-fold by treatment with androgens and FSH (Verhoeven and
Caillaeu, 1988). In rats treated with EDS for 6 days, which depletes LC derived factors
including testosterone, expression of AR protein is absent from all cells of the testis,
including SC of stage VII tubules in which AR expression is strongest in untreated
animals. The androgen dependence of AR expression in testes is demonstrated by the
expression of AR in a pattern indistinguishable from untreated animals, in EDS-treated
rats in which exogenous testosterone is administered to maintain intra-testicular
testosterone levels (Bremner et al., 1994; Turner et ah, 2001). Loss of AR expression
within SC, LC and PTM cells following EDS treatment corresponds with the severe
drop in T caused by LC depletion, further supporting the dependence of AR expression
on androgens (Atanassova et al., 2006). Following partial restoration of T by a new
population of LC, 2 weeks after EDS-treatment, AR expression was reinstated in the
testis. However stage-specific expression of AR in SC only occurred when T was back
within the normal adult range (Atanassova et al., 2006). High affinity binding of
androgens to the AR slows the rate of receptor degradation in vitro, providing evidence
of one mechanism by which androgens support AR protein expression (Kemppainen et
al., 1992).
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1.4.2 Rhox5
Rhox5, also known as Pem, is a reproductive homeobox gene expressed in fetal and
postnatal periods that encodes a transcription factor first identified in 1990 (Lindsey and
Wilkinson, 1996a; Lindsey and Wilkinson, 1996b; Sasaki et al., 1991; Wilkinson et al.,
1990). Rhox5 is expressed in male and female reproductive tissues (testes, epididymis,
ovary and placenta) in rodents (Lindsey and Wilkinson, 1996b; Maiti et ah, 1996).
Rhox5 is a member of cluster of 12 reproductive homeobox genes (Rhoxl - Rhoxl2)
identified on the X-chromosome in mice, whose expressions are predominantly
restricted to reproductive tissues. Within the testis most Rhox genes are expressed by
t
SC during specific stages of spermatogenesis (Maclean et ah, 2005). In addition to the
Rhox genes identified in mice, 10 Rhox genes have been identified on the X-
chromosome of rats and 2 Rhox genes (hPEPPl and hPEPP2) have been identified on
human X-chromosome (Maclean et ah, 2006; Wayne et ah, 2002a)
Within the testis of rats and mice Rhox5 is expressed specifically in SC, and expression
begins prior to puberty (Lindsey and Wilkinson, 1996b; Maiti et ah, 2001). In adult
mouse testes the protein is most abundant at stages VII and VIII co-inciding with the
most intense expression of AR (Lindsey and Wilkinson, 1996b). Loss of expression
from the epididymis and SC of rodents in which androgen signalling is disrupted, by
hypophysectomy or hypogonadism (eg Hpg mice), is consistent with regulation of
Rhox5 expression by androgens (Lindsey and Wilkinson, 1996a; Lindsey and
Wilkinson, 1996b). Expression of Rhox5 in hypophysectomised or Hpg mice, could be
restored by treatment with LH or testosterone (Lindsey and Wilkinson, 1996b).
The Rhox5 promoter contains two elements; the proximal promoter regulates expression
in testes and epididymis whilst the distal promoter is associated with expression in other
tissues and plays a less significant role in testis expression (Maiti et ah, 1996; Sutton et
ah, 1998). The proximal promoter is androgen responsive, and contains two response
elements (described in section 1.3.2.1) that are highly specific to androgen receptor
binding, and not stimulation by other steroids (Barbulescu et ah, 2001). In mice
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expression in the testis is regulated from the proximal promoter from nine days post¬
partum that is just after expression of AR can be detected in SC (Tan et al., 2005) and
the distal promoter has a limited function. In rats the distal promoter regulates Rhox5
expression from twelve to thirty days after birth but thereafter expression appears
dependent on the proximal promoter (Sutton et al., 1998).
The androgen sensitivity and stage-specific expression of Rhox5 suggest a role in
translating androgen signalling at SC into a response in GC development. Two mouse
models have been developed, in the first Rhox5 is expressed at all stages of the
spermatogenic cycle, the second model is a Rhox5 null mutant (Maclean et al., 2005;
Wayne et al., 2002b). When Rhox5 is expressed in SC at all stages there is an increase
in DNA strand breakage at two specific steps in spermatogenesis. In pre-leptotene
spermatocytes double-strand breaks occur and in step 9 and 10 round spermatids single-
strand breaks occur (Wayne et al., 2002b). Both these steps are associated with
remodelling of DNA and chromatin for entry into meiosis and condensation of the
nucleus for spermatid elongation, and occur during stages VII and VIII when Rhox5 is
normally expressed. The DNA damage does not affect fertility or spermatogenesis
because the damage is short-lived and repaired by stage XI in both cases. These effects
could reflect a role for Rhox5 in dynamic changes to DNA and chromatin (Wayne et al.,
2002b). Rhox5 null mice have reduced fertility due to reduced numbers of round
spermatids and elongate spermatids at stage VII and elongated spermatids in the final
stages of differentiation (Maclean et al., 2005). The frequency of GC apoptosis is
increased, and occurs prematurely in spermatocytes in stages VIII-XI. Fertility was
further reduced by increased proportions of sperm in the epididymis whose motility is
deficient (Maclean et al., 2005).
1.4.3 Further androgen responsive genes
An array on gene expression within the dlO testes of wild-type (WT) and SCARKO
mice revealed forty genes which were differentially expressed, by at least two-fold,
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between these mouse lines. The androgen-responsiveness of nine of these genes were
further analysed by RT-PCR using testes of prepubertal mice treated with androgen
(testosterone proprionate, TP) or anti-androgen (flutamide), and in untreated (control)
testes. The genes Rhox5, Eppin, Drd4, and Gpdl were significantly reduced after three
days anti-androgen treatment, the expression of these and the further five genes (Galgtl,
Tsx, Tubb3, PCI, and Tpd52Il) were significantly reduced after five days treatment. All
nine genes were predominantly expressed in the tubulular compartment in the testes.
The expression pattern of Eppin, Drd4, and Gpdl during prepubertal development in
both WT and SCARKO mice strongly paralleled that of the established androgen-
reponsive gene Rhox5 (see section 1.4.2), when assessed by gene array and RT-PCR.
Differential expression of the serine protease inhibitors (tPA in addition to Eppin and
PCI), cell adhesion molecules (Cldnll, Emb, and Dsc2), cytoskeletal components
(Actin3 and Scin, in addition to Tubb3), and members of the extracellular matrix
(Col4a6, Thbsl, and Bean), were also identified as differentially expressed by gene array
between SCARKO and WT mice during the prepubertal period. The expression of all
but Scin, Bean and Dsc2, were reduced in the SCARKO testes (Denolet et al., 2006a).
Comparison of gene expression in adult WT and SCARKO mouse SC in another study,
also reports significant reduction in expression of Rhox5, plus Aquaporin8, Tight
junction protein 1, Gatal, Espin, solute carrier 7a4 and solute carrier 38a5, all ofwhich
are therefore putative targets of androgen-regulation (Abel et al., 2008).
1.5 Studies using isolated Sertoli cells in vitro
1.5.1 Primary and immortalised Sertoli cell cultures
Studies of SC function have also been performed using both primary cell cultures and
immortalised cell lines. Generation of primary cultures of isolated SC is a complex
procedure which is typically carried out using mice or rats between days 18 and 21 (i.e.
before full spermatogenesis is established) and a protocol is described by Karl and
Griswold (Karl and Griswold, 1990). Although these cultures contain a purified
population of SC there are also contaminating cells, specifically peritubular myoid cells,
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which under certain culture conditions can overgrow the SC within a few days (Karl and
Griswold, 1990). AR expression is not maintained in the primary SC for more than a
few days in vitro (Denolet et al., 2006b). On day 3 AR protein is reported to exhibit
cytoplasmic and nuclear localisations expected in the absence or presence of testosterone
respectively (Nakhla et ah, 1984). Primary cultures of SC are only of limited use
because they do not maintain their specialised phenotype beyond six days and primary
adult SC do not divide (Skinner and Griswold, 1982; Steinberger and Jakubomaik,
1992).
Due to the limitations of primary cell cultures a number of immortalised SC-lines have
been prepared. These include the Tm4 (Mather, 1980), MSC-1 (Peschon et ah, 1992),
and SK11 (Walther et ah, 1996) cell lines. Both Tm4 cells and SK11 cells are derived
from immature mice at postnatal day 11-13 and day 10 respectively (Mather, 1980;
Walther et ah, 1996). Immortalised cell lines, including SC, can be derived from
transgenic animals expressing SV40 large T-antigen. Both the SK11 and MSC-1 lines
were derived from such animals (Jat et ah, 1991; Peschon et ah, 1992), but Tm4 cells
immortalised spontaneously in culture (Mather, 1980).
1.5.2 SK11 cell line
The SK11 immortalised cell line consists of SC derived from the H-2Kb-tsA58
transgenic mouse, which expresses the temperature-sensitive large T-antigen (tsA58)
under control of the H-2IC promoter in cells throughout its body (Jat et ah, 1991).
When cells derived from this mouse are cultured at 33°C, termed the pennissive
temperature, the large T-antigen remains active and immortalises the cells. When the
cells are cultured at the non-permissive temperature, 39.5°C, the large T-antigen is
inactivated and proliferation ceases (Jat et ah, 1991).
The SKI 1 cell line was one of several SC lines derived from the testes of prepubertal H-
2Kb-tsA58 mice ten days post-partum (Walther et ah, 1996). In SK11 cells cultured at
39.5°C senescence and altered cell morphology occurred within two days, in addition
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gene expression becomes similar to that of differentiated SC in vivo (Walther et al.,
1996; Walther et ah, 1997). SKI 1 cells at both temperatures expressed a-inhibin, /?-
actin, SGP-1, SGP-2, AMH, Steel factor (kit ligand), transferrin, SF-1, GATA-1,
aromatase, AR, ERf and FSH receptor mRNAs (Sneddon et ah, 2005; Walther et ah,
1996; Walther et ah, 1997). The changes in gene expression between permissive and
non-permissive temperatures include increased SGP-2 and transferrin expression, and
decreased expression of Steel factor (kit ligand) (Sneddon et ah, 2005; Walther et ah,
1996; Walther et ah, 1997). SKI 1 cells are also reported to be responsive to testosterone
and forskolin, with expression of transferrin, Dax-1, and aromatase increased by
treatment with one or both (Walther et ah, 1997). A previous study demonstrated the
presence of functional AR and ERfi that were able to stimulate androgen and oestrogen
response elements respectively in the prescence of DHT and E2 and to up-regulate
expression of their own mRNAs. AR and ERB proteins were localised to the nuclei of
SKI 1 cells cultured at 33°C and 39°C, and expression of AR, but not ER(3, appeared
greater at 39°C (Sneddon et ah, 2005).
1.6 Adenovirus
Human Adenoviruses are non-enveloped icosahedral DNA viruses that are separated
into six species (A-F), some serotypes are commonly used as vectors for introduction of
genetic material into cells in vivo and in vitro (Goncalves and de Vries, 2006). The use
of adenoviruses as vectors requires genetic modification to optimise their use (Bett et ah,
1994).
1.6.1 Wild-type virus
The wild-type adenovirus consists of the viral genome encapsulated with the capsid
head, attached to the surface of the capsid fibre proteins. The structure of an adenoviral
particle is shown in Figure 1-12. Together pll (hexon) and pill (penton) proteins
constitute the key constituents of the viral capsid shell. The fibres attached to the capsid
consist of pIV protein trimers, whose C-terminal globular 'knob' domain interacts with
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the adenoviral, CAR, receptor (Henry et ah, 1994; Maizel et al., 1968). Inside the capsid
the viral genome is bound to polypeptide pVII (Brown et al., 1975) and terminal protein
(Rekosh et al., 1977), this nucleoprotein complex is bound to the inside of the capsid by
polypeptide pV (Goncalves and de Vries, 2006; Matthews and Russell, 1998).
Figure 1-12: Structure and protein constituents of adenoviral particle. Roman numerals
indicate location of each polypeptide within the particle structure. Key components are pll and
pill of the capsid, pIV fibres bound to the capsid, and pV and pVII enclosed in the capsid
associated with the viral genome (taken from Brown et al., 1975).
During infection of host cells the viral genome is expressed in two phases, that occur
before (early phase) and after (late phase) viral genome replication. In the early phase
transcription units El-4 are expressed, expression of unit ElA is absolutely required for
subsequent expression of other early gene units (Berk et al., 1979; Jones and Shenk,
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1979; Nevins, 1981). The E1B and E4 repress synthesis of host cell proteins (Babiss and
Ginsberg, 1984; Halbert et al., 1985); E2 induces DNA synthesis by contributing DNA-
binding protein, terminal protein and DNA polymerase to a pre-initiation complex (de
Jong and van der Vliet, 1999). Unit E3 disturbs the host cell immune response, for
example by interfering with viral antigen presentation by MHC I at the host cell surface
(Andersson et al., 1985; Goncalves and de Vries, 2006). During the late phase, genes
under control of the E2 late promoter and major late promoter (MLP) are expressed.
MLP genes (Ll-5) primarily encode the proteins of the capsid, fibres and nucleoprotein
complex. The products of the early and late phase combine in the host cell nucleus
yielding new viral particles (Goncalves and de Vries, 2006).
1.6.2 Modifications for laboratory use
Species C adenoviruses of serotype 2 or 5 are the most commonly used as vectors for
introduction of transgenes into cells in vivo and in vitro, they are modified from wild-
type adenoviruses to enable them to carry significant quantities of foreign DNA and to
prevent lysis of the infected cells (Goncalves and de Vries, 2006; Volpers and
Kochanek, 2004)). Removal of the El domain increases the vector's capacity for
transgenes, and also prevents expression of the other early viral units (El-4), which in
turn prevents productive viral cycles and cell lysis (Goncalves and de Vries, 2006; Jones
and Shenk, 1979)). The removal of El from the viral genome means that the vectors
have to be propagated in a cell expressing the El genes, to provide the essential El-
encoded products required for a productive viral cycle. HEK293 cells are a frequently
used helper-cell line that expresses 12% of the left and 10% of the right hand
components of the human adenovirus group 5 genome, and support the proliferation of
£7-deficient adenoviruses (Goncalves and de Vries, 2006; Graham et al., 1977).
Substitution of the El domain for the transgene provides the vector with a capacity of
nearly five kilobases, and an additional substitution within the E3 domain can raise the
capacity to at least 7.5 kilobases (Bett et al., 1994; Haj-Ahmad and Graham, 1986). The
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absence of E3 does not impact on the function of the virus in vitro (Bett et al., 1994)
(Haj-Ahmad and Graham, 1986), however a role is reported for E3 in limiting immune
response to infection of cells in vivo (Andersson et al., 1985; Goncalves and de Vries,
2006)).
Second-generation adenoviral vectors have been developed in which El and E2 or E4
domains have been ablated or deleted. These vectors require different culture conditions
or helper-cell lines, expressing more viral products than HEK293 cells, to compensate
for the loss of additional early genes during amplification of the vector (Engelhardt et
al., 1994; Gao et al., 1996; Wang et al., 1997). The second-generation vectors were
developed to improve the duration of transgene expression in target tissues and to reduce
immune responses, ^/-deleted vectors are associated with cytotoxicity, virus-specific
immune responses and inflammation, that are less severe when E1-E214 deleted vectors
are used (Engelhardt et al., 1994; Gao et al., 1996; Wang et al., 1997). As a
consequence, the transgenes carried by these vectors are expressed up to three months
after infection, compared to around three weeks with El-deletion alone (Engelhardt et
al., 1994; Wang et al., 1997).
A final form of adenoviral vectors are called helper-dependent or 'gutted' because they
contain none of the adenoviral genome and require co-transfection with a helper-virus
when amplifying the gene in vitro. The helper virus expresses all the viral genes
required to package the genetically modified viral genome of the vector, but is modified
so the competent genome is not incorporated into the viral particles (Parks et al., 1996).
The gutted vectors have a capacity for much larger transgenes than first or second-
generation adenoviral vectors, and eliminate expression of adenoviral proteins reducing
the immune response to infection. The duration of transgene expression in a gutted
compared to a first-generation vector is much greater with expression associated with
gutted vectors remaining two months after infection (Morsy et al., 1998).
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1.6.3 Coxsachie B virus and adenovirus receptor (CAR)
Type 2 and 5 adenoviruses, of species C, both bind to the same receptor which is
embedded in the plasma membrane of cells (Philipson et al., 1968). The receptor (CAR)
has been shown to be a common binding site for both type C adenoviruses and coxsackie
B virus and is a 46 kDa glycoprotein expressed in mice and humans. Comparison of the
human CAR protein's amino acid sequence with that of the mouse CAR receptor
revealed between eighty and ninety percent homology; two extracellular
immunoglobulin-like domains were also identified (Bergelson et al., 1997; Bergelson et
ah, 1998; Tomko et al., 1997).
Expression of human CAR mRNA was detected in pancreas, brain, heart, small
intestines, testis, and prostate, plus small amounts in liver and lungs. In mouse
concentrations ofmRNA were highest in liver, with weaker expression in kidney, heart,
lungs, and brain (Tomko et al., 1997). Within the testes of rats, CAR was identified at
the BTB and ES, at sites of SC-SC and SC-GC interaction, and CAR mRNA and protein
are detected in both SC and GC (Wang et al., 2007). In mice SC and LC were
immunopositive for CAR and strong immunostaining was associated with elongate
spermatids, weaker staining was observed with less mature GC (Mirza et al., 2006;
Peters et al., 2001). The expression of CAR in ectoplasmic specialisations is strongest
when associated with elongated spermatids prior to release into the lumen at stage VIII,
weaker staining is associated with round spermatids and less well developed elongating
spermatids (Wang et al., 2007). Expression of CAR can be detected in SC and
spermatogonia as early as fifteen days post partum, prior to the development of BTB.
Expression of CAR has been detected in spermatocytes as well (Wang et al., 2007).
1.6.4 Adenoviral Infection
1.6.4.1 Mechanism
Adenoviral particles interact with their target cell at two sites in the plasma membrane,
the CAR receptor and integrins. Binding to the CAR receptor is via the trimeric pIV
Chapter 1 Literature Review 51
protein fibres attached to the viral capsid as described above (Philipson et al., 1968).
There are a number of different integrin heterodimers consisting of combinations of a
and p subunits, including aV|33, aV|35, aV|31, a3|31, and a5pi, which have been
implicated in internalisation of adenoviral particles (Davison et al., 1997; Davison et al.,
2001; Salone et al., 2003; Wickham et al., 1994; Wickham et al., 1993). The cell surface
integrins frequently interact with Arg-Gly-Asp amino acid sequence (RGB domain) in
the capsid's penton protein (Wickham et al., 1993), although some, such as integrin
a3|31, can interact with other targets in the penton protein (Salone et al., 2003). Viral
particles enter target cells very rapidly by receptor-mediated endocytosis via clatherin-
coated pits and the vesicles (Chardonnet and Dales, 1970; Svensson, 1985; Varga et al.,
1991). The process of endocytosis is mediated by integrins including aVp3 and aVp5
(Wickham et al., 1993). Once endocytosis has been induced the viral particles must
escape from the vesicles into the cell cytoplasm by disrupting the endosome (FitzGerald
et al., 1983). The increased endosome permeability associated with its disruption is
dependent upon presence of aVp5 in the cell membrane for interaction with the penton
base (FitzGerald et al., 1983; Wang et al., 2000). The reduction in endosomal stability is
due to signals from the cell surface induced by viral attachment (Meier et al., 2002)and
is due to reduced pH (~5) within the vesicle (Blumenthal et al., 1986; Prchla et al., 1995;
Seth et al., 1984; Wickham et al., 1994).
Following release from the endosome pathway viral particles are transported through the
cell cytoplasm towards the nucleus and towards the cell periphery. Transport is along
the cells microtubules and in untreated cells in predominantly towards the nucleus
resulting in viral particles accumulating at the nuclear membrane. The movement
towards the nucleus is termed 'minus-end-directed' and requires the dynein/dynactin
motor for progress along the microtubules and directly attaches the adenoviral particle to
the tubules (Kelkar et al., 2004; Suomalainen et al., 2001; Suomalainen et al., 1999).
The final process in adenoviral infection is entry into the nucleus to undergo expression
of the adenoviral genome as described in section 1.6.1. As the viral particles progress
through the cell from the cell surface and eventually into the nucleus the virus
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progressively losses constituent proteins until finally before the viral genome enters the
nucleus it dissociates from protein pV (Greber et ah, 1993). Import of adenovirus type 2
DNA begins with the virus binding to CAN/Nup214 in the nuclear pore complex via its
fibrils. The capsids of the bound viral particles breakdown but protein fragments remain
bound to the genome these DNA-protein units associated with histone HI, ImpP and
Imp7 and are imported into the nucleus (Trotman et ah, 2001).
1.7 Conclusions
Interference with androgen and/or oestrogen signalling by loss of steroids or functional
receptors disrupts fertility in rodent models and human patients, however the
mechanisms for these effects are not clear. Sertoli cell specific knockout of AR in mice,
and other studies, emphatically show the SC's involvement in support of
spermatogenesis, so further investigation of this cells' responses to steroids is merited.
To date very few steroid-regulated genes have been identified in SC. SC are the only
somatic cell within the seminiferous epithelium the bulk of which is made up by germ
cells. Studies on this cell type therefore remain challenging. An in vitro model, such as
the SKI 1 cell line, isolates the SC from the complex environment of the testis, allowing
the study of steroid response in the absence of other confounding factors, such as
interactions with GC and indirect effects due to the responses of other testicular cells to
the experimental manipulations. Whilst the in vitro approach seeks to avoid the
complexities of the testis, an isolated SC is not physiologically normal as it lacks the
cyclic changes and interactions that it would undergo in vivo. Current methods for
specific knockout of receptors in SC (e.g. SCARKO mice) result in development of SC
in the absence of hormone action with potential consequences for their prepubertal
development. The potential for a method of knockdown of AR (or ER(3), after pubertal
development is complete, using RNAi delivered by adenoviral vector is therefore an
attractive option. A technique already employed to disrupt intra-testicular testosterone
by administration of EDS to rats, also allows 'normal' development of testes before
androgen signalling is disrupted by LC depletion. Although the impact of EDS
treatment is broader than simply depleting testosterone, the ease with which testosterone
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can be reintroduced makes this a favourable in vivo model for study of testosterone
function within testes.
1.8 Aims
Use the SKI 1 in vitro cell model, to extend the investigation of androgen and oestrogen
responsiveness of SC, and to identify genes which are differentially regulated under
control of these steroids. Validate androgen-responsiveness of genes identified in
published studies using the SKI 1 cells. It was hoped that genes identified as androgen
or oestrogen responsive in the SK11 cells may be associated with control of
spermatogenesis by SC, revealing mechanisms for regulation of spermatogenesis by
steroids.
To develop a method for introduction of RNAi constructs specifically into SC in vivo
and in vitro, using adenoviral constructs, with the intension of knocking out AR and
ERp expression separately in SC. Undertake a pilot study to determine efficiency of
construct expression, cell-specificity of infection, and impact of infection on cell and
tissue function.
To investigate mRNA and proteins expression of genes identified as androgen-
responsive in previously published studies, using the EDS-treated rat model to confirm
and validate these results. Genes associated with ectoplasmic specialisations, gap
junctions and cytoskeleton will be examined.
The overall aim of the these studies was to deverlop and extend the methods for
examining Sertoli cell function in regulation of spermatogenesis by androgens and
oestrogens, and to further validate impact of steroids on expression of genes and proteins
identified previously as androgen-responsive.
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2 Materials and Methods
2.1 Animals
2.1.1 Animal experimentation
Animal experimentation was performed under project licence PPL 60/3544 in adherence
to the UK Home Office Animals (Scientific Procedures) Act 1986. Animals were housed
in 12hour:12hour (light: dark) conditions, 22/23°C, 50% humidity with access to food
and water ad libitum.
2.1.2 Control tissues
Tissues (testis, prostate, epididymis, and kidney) of wild-type mice from mating of
Z)az/Tmlhgu/mlhgu heterozygous mice were used as a source of control protein and RNA in
studies of cultured Sertoli cell differentiation and response to steroid treatment (Chapters
3). Adult wild-type mice on a C57 BL/6 background were used for in vivo infection of
Sertoli cells by intra-testicular injection with the contralateral testis as the paired control
(chapter 4).
Adult Wistar rat testes injected with dimethylsulphoxide/water (1:3; v/v) and arachis oil
were collected for use in PCR, Western blots and immunohistochemistry as control
tissue in studies on EDS-treated rats (Chapter 5).
2.1.3 Tissue Recovery
Animals used in these studies were killed by schedule 1 methods (inhalation of CCE and
cervical dislocation) and tissues were immediately dissected out of the animals and onto
dry ice for RNA or protein extraction (sections 2.3.1 and 2.4.1), or into fixative (section
2.5.1) for immunohistochemistry. The tissues collected from treated animals were
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limited to the testes, efferent ducts and epididymis. Testes, prostate, epididymis and
kidney were collected from wild type mice.
2.2 Sertoli cell cultures
An immortalised Sertoli cell line (SK11) was used throughout the studies. The SK11
cell line was derived by Walther et al. at Institute of Hamburg (Walther et al., 1997)
from Sertoli cells isolated from the testes of 10 day old transgenic mice, H-2Kb-tsA58,
expressing the temperature sensitive SV40 T antigen (Jat et al., 1991). Incubation at
temperatures permissive of T antigen activity (34°C) results in proliferation of the cells,
at the non-permissive temperature (39°C) the T-antigen is inactivated and proliferation
stops, this is associated with changes in gene expression which parallel those of
differentiated Sertoli cells in vivo (Sneddon et al., 2005).
2.2.1 Culture conditions
SK11 cells were incubated in 'complete' medium (section 2.8.1) in humidified
conditions at either 34°C or 39°C with 5% carbon dioxide. Cells were routinely cultured
in T75 flasks at 34°C to maintain sufficient numbers of cells for experimental
treatments. To differentiate the cells they were incubated for 48 hours at 39°C. Prior to
experimental treatments, including treatment with steroids and culture at permissive and
non-permissive temperatures, cells were cultured in media free of phenol-red and
containing 10% charcoal-stripped fetal bovine serum plus additional supplements for 48
hours (see section 2.8.1).
2.2.2 Passaging of cells
Cells grown in T75 flasks were passaged at 2-3 day intervals, or when cell density
within culture vessels reached —70%. 'Complete' medium was removed and cells were
washed with 5 ml PBS (phosphate buffered saline) without CaCl2 or MgCB (Gibco,
Paisley, UK) to remove any remaining medium. The PBS was replaced with 2 ml of lx
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0.05% (w/v) Trypsin-EDTA (Gibco) and cells were incubated for 2-4 minutes at 37°C
until the cells detached from the flask's surface. Trypsin digestion was inactivated by
addition of 8ml of 'Complete' media containing 10% FBS and the cell suspensions were
centrifuged for 5 minutes at 115 x g to pellet the cells. For passaging of the cells, the
pellet was re-suspended in a volume of 'complete' media, 1/6 of that volume was
transferred to each fresh T75 flask and the total volume of media per flask was made up
to 10 ml. Cells for use in studies were counted using a haemocytometer, diluted in
phenol-red free 'complete' medium, and plated into culture vessels at the densities
shown in Table 2-1
Table 2-1; Density of cells seeded to culture vessels.





SKI 1 cells were treated with various ligands including androgens, oestrogens and a
steroid receptor antagonist. Testosterone (Sigma-Aldrich, Poole, Dorset, UK) was
dissolved in 100% ethanol and serially diluted to between lxlO"6 and lxlO"3 M. DFTT
(Sigma-Aldrich) and the natural oestrogen 17(3-oestradiol (E2, Sidma-Aldrich) were
diluted in filter-sterilised DMSO to lxlO"2 M and further diluted to lxlO"4 M in sterile
PBS then serially diluted from lxlO"8 M to lxlO"4 M in DMSO diluted 1/100 in PBS to
maintain the concentration of DMSO present. Diethylstibestrol (DES, Sigma), a
synthetic oestrogen, was serially diluted to between lxlO"9 and lxlO"4 M in DMSO
diluted 1/100 in PBS as above, 5 alpha-androstane-3-beta, 17 beta-diol (3[3Adiol, Sigma)
was diluted in ethanol diluted 1/100 in PBS, to lxlO"4 M, and then serially diluted with
8 4
the same ethanol/PBS solution to concentration between 1x10" M and 1x10" M. ICI
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182,780 (Tocris Cookson), is an oestrogen receptor antagonist, and was diluted in neat
DMSO, to a concentration of lxlO"3 M. All ligands and antagonist were used at a
further 1/1000 dilution in culture media for treatment of the SK11 cells, to give
concentrations in the range of lxl0"12 M to lxl0~6 M.
2.3 Polymerase Chain Reaction
2.3.1 RNA extraction and quantification
The lysis and homogenisation of both cells and tissue was by centrifugation through
QiaShredders (Qiagen, Crawley, West Sussex, UK) in the presence of denaturing
guanidine-thiocyanate buffer to prevent degradation by RNases that were released when
cells were lysed. Cells were removed from culture vessels suspended in guanine-
thiocyanate buffer using cell scrapers and were immediately homogenised in
Qiashredders. Tissue was snap frozen and ground under liquid nitrogen in an ice-cold
mortar and pestle and up to 30 mg of the powdered tissue was suspended in guanidine-
thiocyanate buffer to be lysed and homogenised in the QiaShredders according to the
manufacturer's instructions.
RNA was extracted from both tissue and cells using RNeasy extraction kits (Qiagen).
During extraction, RNA present in lysed and homogenised samples, was bound to a
silica membrane in the presence of a high-salt buffer and ethanol. Contaminants within
the samples are removed by a series of three washes, and the purified RNA sample is
finally eluted from the membrane in RNase-free water, achieved through centrifugation.
During the procedure samples bound to the silica membrane were treated with DNase
(Qiagen) to degrade any DNA within in the sample.
All tubes and pipette tips used in the processing of the cells and tissue were RNase-free
and pipettes, spatulas and bench surfaces were treated with RNase Zap (Ambion,
Huntingdon, UK) to eliminate RNase activity.
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RNA concentrations were determined using either the Nanodrop ND-1000
spectrophotometer (LabTech International, Ringmer, East Sussex, UK) or 2100
Bioanalyzer and RNA nanochip system (Agilent Technologies, South Queensferry, West
Lothian, UK). Briefly, the 2100 Bioanalyzer and nanochip were used to quantify RNA
concentration and sample quality in a 1 pi sample, fluorescently labelled samples were
forced electrophoretically through separate microchannels and detected to provide gel¬
like images and electropherograms displaying bands and peaks representing the 18S and
28S ribosomal RNA from which total RNA quantity and quality were assessed
according to the manufacturer's instructions. The Nanodrop ND-1000 also assesses
nucleic acid concentration and quality from a 1 pi sample. The sample was pipetted
onto the lower pedestal of the machine and light absorbance by the sample (OD) was
measured for wavelengths of 260 nm and 280 nm. The absorbance at 260 nm is
proportional to the RNA concentration, the absorbance at 280 nm detects the amount of
protein contamination and therefore the 260:280 absorbance ratio gives an estimate of
the quality of the sample. A sample with an RNA concentration of 40 ng/'pl has an
OD260 of 1, and a pure sample of RNA has a 260:280 ratio of 2. A 260:280 ratio lower
than 2 indicates contamination of the sample by proteins or phenol (Sambrook et al.,
1989). The samples analysed on the ND-1000 were compared against a blank standard
consisting of RNase free water, which was used to set zero for the OD measurements.
All RNA samples were diluted in RNase-free water to a concentration of 100 ng/pl prior
to use in RT-PCR and TaqMan Quantitative RT-PCR.
2.3.2 Semi-quantitative RT-PCR
Reverse transcriptase PCR was perfonned on RNA extracted from both cultured cells
and animal tissues (section 2.3.1). cDNA was synthesised from 1 pg of total RNA
diluted in 10 pi of water plus 1 pi of oligo dT (50 pM). The oligo (dT) and RNA were
incubated together at 70°C for 5 minutes and then held on ice to allow binding of the
thymine nucleotides to the poly-A tails of the mRNAs, until the following reagents were
added:
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RNase-free H2O (Promega, Southampton, UK) 3.85 |il
20 U/|il RNase inhibitors 0.5 pi
(Applied Biosystems, Warrington, UK)
5x reaction buffer (Bioline, London, UK) 4 pi
10 mM dNTPs (Promega) 0.4 pi
200 U/pl Bioscript Reverse transcriptase 0.25 pi
(Bioline)
Total Volume 20 u.1
The reaction mixture was incubated for 60 minutes at 42°C, then heated at 72°C for 10
minutes to inactivate the reverse transcriptase. The PCR reaction using cDNA prepared
with oligo dT was performed by two methods. The first method used separate Taq
polymerase (Bioline) and associated reagents and buffers as shown below:
cDNA 2 pi
Taq Polymerase (Bioline) 0.25 pi
5 pM Forward primer (MWG, 1 pi
Ebersberg, Germany)
5 pM Reverse primers(MWG) 1 pi
50 mM MgCl2 (Bioline) 0.3 pi
2 mM dNTPs 1 pi
lOx Reaction Buffer (Bioline) 1 pi
RNase-free H20 3.45 pi
Total Volume 10 pi
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In the second method the Taq polymerase, reaction buffer, MgCb and dNTPs were
supplied together as Biomix™ Red (2x). The reaction mixture was as follows:
cDNA 2 pi
Biomix™ Red (Bioline) 5 pi
Forward Primers 1 jitl
Reverse Primers 1 pi
RNase-free water 1 pi
Total Volume 10 ill












Although 30 cycles were used most frequently, between 25 and 35 cycles were used in
instances where the gene of interest had high or low levels of mRNA expression. The
annealing temperature (Labelled A°C) was dependent upon guanine and cytosine content
of the primers in use, the annealing temperature for each primer pair is shown in Table
2-2, together with the primer sequences and the expected PCR product size.
ERP mRNA expression was assessed by nested-PCR, the cDNA and PCR were prepared
as described above. However, 2 pi of the products from the PCR were used as template
for a second round of PCR using another pair of primers designed to amplify the product
from the first reaction (Nested ER(3, Table 2-2).
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Table 2-2: RT-PCR Primer sequences, with product size and annealing temperature.


















































Products of the reaction were run on 2% agarose gels containing either 0.5 pg/ml
ethidium bromide (Sigma) or Biotium GelRed™ (Cambridge Bioscience, Cambridge,
UK) diluted 1:10,000, gels were made up with and run in lx TAE buffer (Section 2.8.3)
at 80 V. Hyperladder IV (Bioline) that produces bands at 100 bp intervals from 100 to
1000 bp was run in parallel to samples to identify the size of the products. Hyperladder
1 (Bioline) and O'GeneRuler (Fermentas, York, UK) were used less frequently. The
PCR product was visualised on the gels using a GeneFlash transluminator (GRI
Syngene, Braintree, Essex, UK), digital images of the band patterns were acquired and
stored for analysis.
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2.3.3 TaqMan Quantitative PCR
2.3.3.1 cDNA Synthesis
To quantify expression and in order to detect low abundance transcripts TaqMan
Quantitative RT-PCR was employed. In contrast to the previous method cDNA was
prepared in a random hexamer primed reaction and required only 200 ng of RNA per
reaction:
RNA (100 ng/|il)
lOx RT buffer (Applied Biosystems)
25 mM Magnesium Chloride
(Applied Biosystems)





50 |iM Random Hexamers (Applied Biosystems) 0.5 |il
20 U/|ll RNase inhibitors (Applied Biosystems) 0.2 jil
50 U/|ll Multiscript Reverse Transcriptase 0.25 |ll
(Applied Biosystems)
Total Volume 10 ill




Quantitative PCR was conducted on the cDNA using 2 methods: the first used Assay-
On-Demand™ primer-probe mixtures (Applied Biosystems) specifically designed and
optimised for detection of the genes of interest in the mouse. The second system
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involved Roche's Universal Probe library™ (Roche, Burgess Hill, UK) and an
oligonucleotide pair specific to the gene of interest.
2.3.3.2 Principles of TaqMan™ Quantitative PCR
TaqMan™, whether by the Assay-On-Demand™ or Universal Probe Library™ (UPL)
method, works by the same principle. The primers function in the same manner as in
conventional PCR, binding within the gene's cDNA sequence providing the site for
initiation of DNA replication catalysed by DNA (Taq) polymerase. However, the
forward and reverse primers are designed to bind close together within the sequence
producing a product of less than 100 bp, within which there is a binding site for a
sequence-specific probe. These probes are labelled with a 5' fluorescent reporter dye
and a 3' quencher in close proximity. In the Assay-On-Demand™ kits the fluorescent
dye is Fluorescein (FAM™) and the quencher is 6-carboxy-tetramethyl-rhodamine
(TAMRA™), in the UPL the fluorescent dye is also FAM™ and the quencher is a dark
quencher dye. The probes used to detect endogenous loading controls (18S and
GAPDH) are labelled with VIC fluorescent dye and the quencher TAMRA™. When the
fluorescent dye and quencher are in close proximity, as they are when bound to opposite
ends of the probe, the reporter dye's fluorescence is inhibited. In the process of
amplifying the PCR products the nuclease activity of Taq DNA polymerase
progressively cleaves nucleotides from the 5' end of the probe which releases the
fluorescent marker and frees it from inhibition by the quencher and the reporter
fluoresces. A summary of the process is shown in Figure 2-1. The amount of
fluorescence emitted is a measure of the number of PCR products present during each
cycle of PCR. By recording the time, and thus the number of PCR cycles, required to
reach a threshold fluorescence level, the concentration of the original transcript relative
to other samples in the same run can be calculated (Section 2.3.3.5).
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1. Polymerization: A fluorescent reporter IR) d'ye and a quencher
IQ) are attached to the 5' and 3' ends of a TaqMan* probe,
respectively.
FORWARD PflltiCR n PROBE O





2. Strand displacement When the probe is intact, the report!
dye emission is quenched.




3. Cleavage: During each extension cycle, the DNA polymerase
cleaves the reporter dye from the pete.
4 Polymerization completed: Once separated Irom











Primer-probe combinations specific to Rhox5 (Cat no Mm00476718_ml), AR (Cat no
Mm00442688_ml), and SGP-2 (Cat no Mm00442771jml) were purchased from
Applied Biosystems (Warrington, UK). Primer-probe mix to detect either the 18S
ribosomal subunit or expression of GAPDH (Applied Biosystems) was included as an
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internal control for the amount the cDNA added in each sample. Each PCR reaction
consisted of:
cDNA 7.5 pi
Primer-probe (gene of interest) 3.75 pi
(Applied Biosystems)
Primer-probe (loading control) 1.125 pi
(Applied Biosystems)
Mastermix (Applied Biosystems) 37.5 pi
RNase-free Water 25.125 pi
Total volume 75 pi
As mentioned above an internal control, of primers/probes for 18S or GAPDH, was
included in the reaction mixture. The primers and probes for both internal loading
controls were supplied and used at the same concentrations. The stock primer/probe mix
consisted of:
20 pM Probe (Applied Biosystems) 106 pi
10 pM Forward Primer (Applied Biosystems) 53 pi
10 pM Reverse Primer (Applied Biosystems) 53 pi
Nuclease-free water 188 pi
Total Volume 400 ul
Reaction mixtures were loaded in triplicate with 25 pi per well into a 96-well MicroAmp
fast optical reaction plate (Applied Biosystems) for analysis on an ABI 7500 or ABI
7900 HT Fast Real-Time PCR machine (Applied Biosystems), reactions were sealed on
the plate with ABI prism optical adhesive cover (Applied Biosystems). The system was
further optimised in later studies allowing the total volume per triplicate to be reduced to
45 pi, all constituents remained in the same proportions.
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2.3.3.4 Roche Univeral Human Probe Library™
The Roche Univeral Probe Library™ consists of 165 probes, 8-9 nucleotides long, each
with several thousand binding sites distributed across the human genome and genomes
of other related organisms, including the mouse. Primers specific for a particular gene
are incubated with a probe that binds to the sequence between the forward and reverse
primers and is transcribed during the PCR reaction. Transcription of the sequence
between the primers results in fluorescence of the 5' FAM-label (section 2.3.3.2) that is
detected as a measure of gene expression.
Using the on-line Roche assay design centre, primers were designed against the genes
shown in Table 2-3. The design centre provides the sequence of both the forward and
reverse primers and indicates the appropriate probe to use. Primers were ordered from
MWG Biotech (Ebersberg, Germany) and were diluted in nuclease-free water to a
concentration of 20 pM. PCR was performed on cDNA prepared with random hexamers
(section 2.3.3.1) with an internal 18S control as in the Assay-On-Demand. The PCR
reaction mixture consisted of:
cDNA
20pM Forward primer (MWG)




2x Faststart mastermix (Roche)
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The reaction was run in triplicate with 20 pi per well in a 96-well MicroAmp fast optical
reaction plate and run as with Assay-On-Demand™.
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2.3.3.5 Analysis of Taqman Quantitative PCR
The ABI HT Fast Real-Time PCR machines measure the fluorescence produced by the
probes' Fam and Vic dyes over the course of the PCR reaction as the products are
amplified. The fluorescence is displayed as an exponential curve against number of
PCR cycles (an example is shown in Figure 2-2), with fluorescence directly representing
the number of copies of the product present. For the gene of interest, a threshold was set
within the exponential region of the fluorescence curves and the cycle number at which
the plot for each sample reached the threshold was designated the Ct value for that well.
The same process was repeated for the internal controls, 18S or GAPDH. Ct values were
collected for each of the triplicates and the Ct values for the gene of interest were
standardised against the internal control Ct (gene of interest Ct minus internal control
Ct) to give ACt. The ACt value accounts for variation in amount of mRNA in cDNA
synthesis and differences in quantity of cDNA loaded between wells and samples. The
ACt triplicates were averaged to give a mean value for each sample. For comparison
between samples, the average ACt value of a designated control group was subtracted
from the average ACt value of each sample, which gave the AACt value. Performing the
transformation y = 2~AACt converts the AACt values to fold change (y) compared to the
control group, which has a value of 1.
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Amplification Plot
0 5 10 15 20 25 30 35 40
Cycle
Detector: juNKNQWN FAM Plot:|ARn vs. Cycle Threshold: | 0.1 59311 43
Figure 2-2: Example of TaqMan amplification plots for an unknown product labelled with
Fam™. Horizontal line shows value set as 'threshold', note that it is within the region of
exponential increase in fluorescence.
2.3.3.6 Validation of UPL primer/probe
Assay-on-demand primer/probe mixtures are validated by the supplier (Applied
Biosystems) and therefore can be used without validation. The primers used in UPL
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reactions are supplied independently of the probes and have not been validated for use in
the assay by the supplier, therefore they need to be validated prior to use. Validation
determines the efficiency of the PCR reaction using the primers and probe, and ensures
that the gene of interest and endogenous internal loading control (18s) are amplified with
the same efficiencies. Both these factors must be determined to allow calculation of
fold-change and use of the AACt method. Both are determined by conducting real-time
PCR in triplicate on 6 serially diluted aliquots (neat, 1/2, 1/4, 1/8, 1/16, 1/32) of a known
positive sample using the primers and probe to be validated. To determine reaction
efficiency average Ct on the Y-axis is plotted against log(sample concentration) on the
X-axis, and the gradient of the line of best fit is calculated. A gradient of -3.32 and
R2>0.98 indicates a totally efficient reaction in which a 2-fold change in initial template
concentration corresponds to a change in Ct value of 1. To determine that the templates
of the endogenous control and gene of interest are amplified with the same efficiency the
ACt value (gene of interest's Ct - endogenous control's Ct) on the Y-axis is plotted
against log(sample concentration). A line of best-fit with gradient of approximately 0
(<0.1) indicates both templates are amplified with similar efficiencies.
2.4 Western Blot Analysis
2.4.1 Protein extraction and quantification
2.4.1.1 Total protein.
Protein was extracted from mouse and rat tissues and cultured SKI 1 cells using lx RIPA
buffer (Section 2.8.3). Frozen tissues were ground to powder in an ice-cold pestle and
mortar under liquid nitrogen. Approximately 1 ml RIPA buffer was added per 0.3 g of
ground tissue in a 1.5 ml EppendorFM, and the tissue was homogenised with a handheld
homogeniser (Sigma). Cells cultured in multi-welled plates were lysed directly in their
wells using RIPA buffer and detached from the growth surface with cell scrappers, cells
were incubated in buffer for 5 minutes on ice and then transferred to 1.5 ml
Eppendorfs™. The volume ofRIPA used to lyse cultured cells depended on well size, 6-
well plates received 500 |ll/well and 100 |il/well was added to 12-well plates. Once
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samples from cells and tissue were lysed they were incubated on ice for 1 hour, and then
spun at 6000 g for 10 minutes at 4°C in an Eppendorf™ centrifuge 5415R, to separate
cell debris in the pellet from proteins in the supernatant. The extracted proteins were
stored at -80°C prior to quantification and use.
2.4.1.2 Quantification of proteins
The protein concentration in samples was determined using DC Protein Assay (BioRad,
Hemel Hempstead, Hertfordshire, UK) which is based upon the Folin-Lowry assay
(Lowry et al., 1951). The assay was performed as prescribed in the protocol provided.
Briefly, 5 pi of each sample were added in duplicate to a clear flat-bottomed 96-well
plate. A series of BSA protein standards made up in lx RIPA, with a range of
concentrations from 0.125 to 1.5 mg/ml, were included in duplicate on the plate to
provide a protein standard curve. To each well 25 pi of alkaline copper tartrate solution
was added followed by 200 pi dilute Folin reagent, the solutions were mixed and
incubated at room temperature for 15 minutes. Absorbance at 690 nm was measured in
each well to quantify the colorimetric change, using a Labsystems Multiskan EX (Fisher
Scientific UK Ltd, Loughborough, Leicestershire, UK). The absorbencies of the protein
standards were plotted to give a standard curve from which the protein concentrations of
the samples were determined.
2.4.2 Fluorescent LiCor Western blot
Pre-cast 4-12% graduated Bis-Tris mini NuPAGE gels (Invitrogen, Paisley, UK) were
used to separate samples. Protein samples were added to NuPAGE loading buffer
(section 2.8.3) and heated to 70°C for 10 minutes prior to being loaded. The NuPAGE
gel was immersed in lx MOPs NuPAGE SDS running buffer, which was prepared by
diluting 50 ml 20x MOPs NuPAGE SDS running buffer (Invitrogen) in 950 ml dH20,
plus 0.25% NuPAGE antioxidant (Invitrogen) for reduced samples. The gel was loaded
with 20 pg/well of sample proteins and a protein ladder (NuPAGE SeeBlue ladder,
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Invitrogen) and run at 200 V for 50 minutes. Following electrophoresis the gel was
loaded into a transfer cassette in direct contact with HybondC super nitrocellulose
(Amersham Life Sciences) or Immobilon-FL polyvinylidene fluoride (Millipore,
Watford, UK) membrane with sponge and 3 mm Whatman papers (Scientific Laboratory
Supplies Ltd., Nottingham) either side of the gel and membrane as shown in Figure 2-3.
Protein transfer was performed overnight at 20 V or at 45 V for 3.5 hours in 20x












Figure 2-3: Orientation of components for transfer of protein from Bis-Tris gel to
membrane in Western blotting.
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Membranes were incubated at room temperature for 1 hour in Odyssey Blocking Buffer
(LiCor Biosciences UK Ltd, Cambridge, UK), diluted 1:1 with PBS (phosphate buffered
saline, Section 2.8.2), plus 20% goat serum. The blocked membranes were
simultaneously exposed to two antibodies raised in different species and with specificity
to either the protein of interest or the protein loading control (eg. (3-actin), the antibodies
were added to the blocking buffer plus 0.1% TWEEN-20 (Sigma) and incubated with
the membrane for 1 hour at room temperature. The antibodies and dilutions used are
shown in Table 2-4.
Table 2-4; Primary antibodies used for fluorescent (LiCor) Western blotting.
Antigen Dilution Species Raised Source
AR 1:200 rabbit US Biological
p-Tubulin 1:200 mouse Sigma















Secondary antibodies, raised against the species from which the primary antibodies were
derived, were diluted 1: 10,000 in Odyssey Blocking Buffer (1:1 in PBS, plus 20% goat
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serum, 0.1% TWEEN-20 and 0.01% SDS). Both secondary antibodies were labelled
with fluorescent markers, the first emitting at a wavelength of 680 nm and the second at
a wavelength of 800 nm. The fluorescent secondary antibodies used are shown in
Table 2-5.
Table 2-5: Fluorescent secondary antibodies used to visualise protein bands in Western
blotting.
Target Organism Raised In Fluorescent label Source
mouse goat Alexa fluor 680 Molecular Probes
rabbit goat IR dye 800 Rockland
By ensuring that the primary antibodies were derived from different species, each
secondary antibody bound to only one primary antibody and therefore each protein was
specifically labelled with fluorescence of a different wavelength. The position and
intensity of binding for each secondary antibody and therefore the location and density
of the protein bands were detected by scanning the membrane on the Odyssey scanner
(LiCor Bioscience). Inclusion of the SeeBlue protein ladder indicated protein size. The
band intensity was measured for the target protein and loading control, and intensity of
the target protein was standardised to the loading control in each well. Comparisons of
standardised intensities between samples were performed to determine any change in
protein expression.
2.5 Immunohistochemistry
2.5.1 Tissue fixation, wax embedding, and sectioning
Tissues dissected from mice and rats for immunohistochemistry were immediately fixed
in Bouins solution (Triangle Biomedical Sciences, Lancashire, UK) for 6 hours and then
transferred to 70% ethanol until embedded in paraffin wax. Embedding was performed
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over 24 hours on a Leica TP 1050 processor by the MRC Human Reproductive Sciences
Unit histology support service. Tissue sections 5pm thick were cut from embedded
tissues on a Leica RM 2135 microtome (Leica Microsystems UK Ltd, Milton Keynes,
Buckinghamshire, UK) and floated in a warm (42°C) water bath. Individual sections
were mounted on charged glass slides (BDH Superfrost® Plus, VWR international),
dried at 65°C for several hours then at 50°C overnight. Sections to be immunostained
were dewaxed by washing twice in xylene (Fisher Scientific UK Ltd) for 5 minutes and
then rehydrated in alcohol baths of descending concentration
(100%—>100%—>95%—>70%) for 20 seconds in each bath, the sections were finally
hydrated in tap water.
2.5.2 Detection with diaminobenzidene
2.5.2.1 Antigen retrieval
Antigen retrieval was perfonned with 0.01 M citrate buffer pH6. Sections were boiled
in citrate buffer under full pressure for 5 minutes in a Tefal Clipso pressure cooker at the
highest pressure setting, and were then rested for a further 20 minutes at atmospheric
pressure without further heating. Sections were washed in an excess of cold tap water
before peroxidase blocking.
2.5.2.2 Hydrogen peroxide block
Sections were blocked for 30 minutes with 3% hydrogen peroxide (BDH) in methanol
and then washed once with tap water and three times with TBS, each TBS wash was 5
minutes.
2.5.2.3 Serum block
Sections were blocked in serum from the animal in which the secondary antibody to be
used was raised. The blocking solution consisted of 1 part blocking serum (Diagnostics
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Scotland)/4 parts TBS/5% BSA and was applied to each slide for 30 minutes at room
temperature. Sections were washed 3 times with TBS, for 5 minutes each, following
blocking with serum.
2.5.2.4 (Strep)Avidin-biotin block
For staining using antibodies and tissues where endogenous biotin caused non-specific
background staining a (Strep)Avidin-Biotin block (Vector Laboratories Ltd.,
Peterbourgh, UK) was used. Neat avidin or strepavidin was applied to each section for
15 minutes at room temperature followed by three, 5 minute, washes in TBS. Neat
biotin was added to each slide and incubated for 15 minutes at room temperature
followed by a further three, 5 minute, washes in TBS.
2.5.2.5 Primary antibodies
Primary antibodies to target proteins were diluted in serum/TBS/BSA at appropriate
dilutions (Table 2-6), and were incubated on sections overnight at 4°C. Thereafter
sections were washed three times with TBS, for 5 minutes each. Primary antibodies
were diluted in serum from the species in which the secondary antibody, intended for
detection of the primary, was raised. Negative controls for which sections were
incubated with serum/TBS/BSA, without primary antibodies, were included in each
immunohistochemistry run. Sections in the negative control group were incubated with
secondary antibodies in common with all other samples to reveal any non-specific
binding of the secondary antibody. However pre-absorption of the primary antibodies
with their peptide targets were not included as controls.
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Table 2-6: Primary antibodies used in DAB immunohistochemistry.
Antigen Dilution Species raised Source
AR 1:50 rabbit Sigma
(3-tubulin 1:1500 mouse Sigma





SGP-2 1:250 rabbit Santa Cruz
2.5.2.6 Secondary antibodies
Sections were incubated with biotinylated secondary antibodies raised against the
species from which the primary antibody was derived (Table 2-7). Secondary antibodies
were diluted 1:500 in serum/TBS/BSA and incubated on sections for 30 minutes at room
temperature. The serum in which the secondary antibody was diluted was from the same
species in which the antibody was derived. After incubation slides were washed in TBS,
3 times for 5 minutes.
Table 2-7: Biotinylated secondary antibodies used in DAB immunohistochemistry.





2.5.2.7 Labelling and visualising biotinylated secondary antibodies
The biotinylated label on the secondary antibody was further labelled either with ABC-
HRP (DAKO) diluted in TBS (containing no salt) or Strepavidin-HRP diluted 1:1000 in
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TBS (Figure 2-4), both were incubated with the sections for 30 minutes at room
temperature. Slides were washed in TBS three times for 5 minutes and exposed to
diaminobenzidene (DAB) to visualise the HRP label. DAB solution was prepared by







peroxidase streptavidin enzyme\ complex
'• /
A
Figure 2-4: DAB staining using (A) avidin-biotin and (B) strepavidin enzymic complexes.
Based upon figures published in Immunohistochemical Staining Methods, Fourth Edition, Editor
Marc Key (Key, 2006).
2.5.2.8 Counter staining and mounting
DAB stained sections were counter stained in haemoxylin for 5 minutes. Washing the
sections in acid-alcohol, for 5-20 seconds, removed the haemoxylin from the cytoplasm
of cells more rapidly than from the nucleus resulting in blue nuclear staining when
developed in Scott's tap water, for 30 seconds. Slides were dehydrated in graded
alcohol washes (70%-h>80%—>95%->100%—>100%) for 20 seconds each, and then 2
xylene washes of 5 minutes. The slides were coverslip mounted using Pertex mounting
media (CellPath, Hemel Hempstead, UK).
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2.5.2.9 Bond-X automated immunohistochemistry
Sections immunostained using the Bond-X machine (Leica, Newcastle Upon Tyne, UK)
were prepared as described above up to and including citrate retrieval. The sections
were loaded onto the machine and the automated immunostaining assay procedure was
performed. The appropriate primary antibodies (Table 2-8) were diluted in Bond™
primary antibody diluent (Leica) and incubated on the sections for 1 hour during the
course of the protocol. The automated process includes all steps up to and including
counter staining, so upon completion of the run sections were dehydrated and mounted
with Pertex (Section 2.5.2.8)
Table 2-8: Primary antibodies used for automated immunohistochemistry using Bond-X
machine.




HIF-loc 1:200 rabbit Abeam
2.5.3 Fluorescence
Sections for fluorescent staining were prepared for incubation with primary antibodies as
for DAB staining (Sections 2.5.1 to 2.5.2.4), except for the use of PBS in place of TBS.
The hydrogen peroxidase-blocking step was only included when a peroxidase tagged
secondary antibody was to be used. Primary antibodies used in fluorescent
immunohistochemistry are shown in Table 2-9 and were diluted in serum/PBS/BSA at
the dilutions shown, the serum used was from the species in which the secondary
antibody to be used was derived.
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Table 2-9: Primary antibodies used in fluorescent immunohistochemistry.
Antigen Dilution Raised in Source
CD 68 1:50 mouse DAKO




N-cadherin 1:7000 mouse Zymed
SMA 1:500 mouse Sigma
MPO Pre-diluted rabbit Abeam
ZO-1 1:100 rabbit Zymed
2.5.3.1 Fluorescent labelling of primary antibodies
The fundamental difference between DAB and fluorescent immunohistochemistry was
the use of secondary and/or tertiary antibodies tagged with fluorescent labels to detect
bound primary antibodies; the antibodies used are listed in Table 2-10. Often a
secondary antibody directly conjugated to the fluorescent tag was used (panel A, Figure
2-5). To achieve greater sensitivity for low abundance targets a biotin- or peroxidase-
tagged secondary antibody was used and then fluorescently labelled in a further step:
biotin-tagged secondary antibodies were detected with a tertiary antibody with a
fluorescent label (panel B, Figure 2-5), peroxidase labelled antibodies were fluorescently
tagged with fluorescyl-tyramide (panel C, Figure 2-5). In double fluorescent
immunohistochemistry 2 primary antibodies raised in different species and targeting
different antigens were used, and were detected with 2 combinations of secondary and/or
tertiary antibodies, labelling primary antibodies of each species with different
fluorescent markers.
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Detection using two primary antibodies raised in the same species (mouse) was achieved
using FAB secondary antibodies labelled with biotin, and two tertiary complexes (avidin
and strepavidin) labelled with different fluorescent labels (panel D, Figure 2-5). The
FAB antibodies are monovalent, meaning they lack one of the two antigen-binding
domains found on conventional secondary antibodies (dotted line, panel D, Figure 2-5).
Therefore when the FAB antibody binds to a primary antibody all its binding sites are
occupied. A second primary antibody raised in the same species as the first can be
added to the same section without the FAB antibody capturing the new primary antibody
and interfering with staining, as would bccur with a conventional secondary antibody
(Negoescu et al., 1994). Antibodies are added in the order described above: first
primary antibody followed by FAB secondary antibody, then the second primary
antibody followed by the FAB secondary antibody.















Figure 2-5: Methods for visualising primary antibody binding in fluorescent
immunohistochemistry. Fluorescent staining using: a secondary antibody directly conjugated
to fluorescent tag (A), a tagged secondary antibody and fluorescently labelled tertiary complex
(B), a secondary antibody tagged with peroxidase catalysing fluorescyl-tyramide deposition (C),
and FAB secondary antibodies and fluorescently labelled tertiary complexes (D).
For fluorescent immunostaining PBS was used in place of TBS to wash the slides and
dilute antibodies and reagents. In wash steps prior to use of a fluorescent secondary
antibody PBS alone was used, but in all washing steps following incubation with a
fluorescent secondary antibody PDS plus 0.05% TWEEN-20 was used for the first of the
3 washes. The sections were counterstained with the nuclear stain DAPI (Sigma),
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diluted 1:1000 in PBS for 10 minutes. Sections were mounted under coverslips using
Permafluor (Beckman Coulter, High Wycombe, UK).
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2.5.4 Imaging
2.5.4.1 Light microscopy
DAB immunostaining was visualised on an Olympus Provis microscope (Olympus
Optical Co.) and images were captured with a digital Canon EOS 30D camera (Canon
Europe, Amsterdam).
2.5.4.2 Meta-confocal microscopy
Tissues and cells stained in fluorescent immunohistochemistry were observed on a Zeiss
LSM 510 laser scanning meta confocal microscope (Carl Zeiss Ltd, Welwyn Garden
City, UK). Green fluorescence was excited with the Argon2 488 nm laser, red
fluorescence by the HeNel 543 nm laser, and blue (DAPI) fluorescence with the laser
Diode 405 nm. Fluorescence at each wavelength was recorded separately, and images
are a composite of all channels.
2.6 Adenoviral construct amplification
The following procedures were carried out by staff in the MRC Human Reproductive
Sciences Unit's Biomolecular Core Facility (managed by Dr. Pamela Brown), to whom I
am very grateful.
Four adenoviral constructs were used in the course of these studies, the construct used in
chapter 3 contained ERE-Tk-luc and the constructs used in chapter 4 expressed green-
fluorescent protein (GFP), LacZ, or contained no insert. The sources and methods of
preparation of the constructs are described in the appropriate chapters, however the high
titre virus stocks required were generated using the following method in common.
The adenoviral constructs were multiplied in vitro by infection of HEK293 (Graham et
al., 1977) cells at 5-7 viral particles per cell (known as the multiplicity of infection or
MOI). The HEK293 cells were maintained in MEM media plus 10% FBS and penicillin-
streptomycin at 37°C in 5% CO2 until the cells showed a cytopathic response; virus was
Chapter 2 General Materials and Methods 85
released from the cells by 3 cycles of freeze thawing. The viral particles were purified
by buffer exchange with 8 volumes of 2.5% glycerol, 20mM Tris.HCl pH8 using a
Vivascience AdenoPack column (Generon House, Eton Wick, UK) and then
concentrated. The viral titre, in plaque forming units (pfu)/ml, was quantified on
HEK293 cells using an Adeno-X rapid titre kit (BD Bioscience, Oxford, UK) and 1:500
rabbit anti-adenovirus serotype 5 hexon antisera (Autogen Bioclear UL Ltd, Calne, UK)
to label infected cells.
2.7 Statistical Analyses
All statistical analyses were conducted using GraphPad Prism 5, in all analyses a
confidence level of p^).05 was deemed significant. Two-way analysis of variance
(ANOVA) was used to determine statistical significance when samples underwent two
independent treatments, for example in studies where cells were cultured at 34°C or
39°C and treated with steroids at a range of concentrations. Although results were
presented standardised against a control sample and are based upon small numbers of
repeats (n=2 or 3) indicating use of a non-parametric test, no non-parametric test with
capacity to analyse the studies as designed exists so the two-way ANOVA was chosen.
In two-way ANOVAs where significant differences were reported, the treatments
between which statistical significances were found were identified using the Bonferoni
post-hoc test. A Mann-Whitney analysis was used for comparisons in studies where
samples underwent one of two treatments, i.e. cells cultured at 34°C or 39°C, and small
n-numbers (n=3 experiments) were present in each group making the parametric t-test
inappropriate. The third statistical analysis used was the non-parametric Kruskal-Wallis
test, this analysis was used to analyse data in which more than two treatments of the
same type were used, for example when analysing expression of mRNA or protein in
control, EDS and EDS plus TE treated rats. The non-parametric test was used when n-
numbers were small or expression data were presented standardised to a control, valued
as 1, because these conditions prohibit use of the parametric one-way ANOVA.
Significant results in the Kruskal Wallis test were investigated further using Dunn's
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multiple comparison post-hoc test to identify the treatments between which significant
differences lay.
2.8 Commonly used solutions
2.8.1 Tissue culture
'Complete' medium: Dulbecco's Modified Eagles Medium (DMEM, Sigma),
supplemented with:
10% (v/v) heat-inactivated foetal bovine serum (FBS,
Gibco, Paisley, UK)
100 U/ml Penicillin & lOOpg/ml Streptomycin (Gibco)
1% (v/v) Non-essential amino acids (Sigma) 125 ng/ml
Fungizone (Gibco)
1% (v/v) D(+) Glucose (45% solution, Sigma)
1% (v/v) 2 mM L-Glutamine (Gibco)
5 pg/ml Plasmocin (Autogen Bioclear, Wiltshire, UK)
Prior to experimental treatments; such as dosing with ligands, culture at altered
temperatures, and transfection/infection; the cells were cultured in 'complete' media in
phenol-red free DMEM (Sigma) with charcoal-stripped foetal bovine serum.
Transfection medium: Phenol-red free DMEM (Sigma), supplemented with:
1% (v/v) Non-essential amino acids (Sigma)
1% (v/v) D(+) Glucose (45% solution, Sigma)
1 % (v/v) 2 mM L-Glutamine (Gibco)
Freezing medium 90% 'Complete' medium
10% fdter sterilised DMSO
Chapter 2 General Materials and Methods 87
2.8.2 Immunohistochemistry
lxTBS Tris (Sigma) 60.5 g
Sodium Chloride (Sigma) 87.6 g
Hydrochloric acid (BDH) 300 ml
Adjust to pH 7.4 with Cone. Hydrochloric acid




Make up to 1 litre in dH20
2.8.3 Molecular Biology
50x TAE 242 g Tris (Sigma)
100 ml 0.5 M EDTA (Sigma)
57.1 ml acetic acid (BDH)
made up to 1 litre with dH20
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1 x RIPA buffer 1% Triton X-100 (Sigma)
15 mM HEPES-NaOH (pH 7.5) (Sigma)
0.15 mMNaCl
1% Sodium deoxycholate (Sigma)
0.1% Sodium dodecyl sulfate (SDS) (Sigma)
1 mM Sodium orthovanadate (Sigma)
10 mM EDTA (Sigma)
0.5% Protease inhibitors cocktail (Roche)
Protease inhibitors were added on the day of use.
NuPAGE Loading buffer 20 jig Protein
2.5 pi NuPAGE LDS Sample Buffer (4x)
1 pi NuPAGE Reducing Agent (lOx)
made up to 10 pi with dELO.
Chapter 3 Gene expression using an immortalised Sertoli cell line 89
3 Gene expression studies using an immortalised Sertoli
cell line
3.1 Introduction
Sertoli cells support development of the germ cells associated with them. This support is
provided in the form of factors secreted by the SC as well as physical interactions
between SC and GC. Physical interactions include junctions such as ectoplasmic
specialisations, gap junctions, tubulobulbar complexes, and desmosome-like junctions
(McGinley et ah, 1979; Russell, 1977a; Russell, 1977b; Russell and Clermont, 1976);
SC-secreted factors that influence GC development include activin, steel factor and
GDNF (Marziali et ah, 1993; Matsui et ah, 1991; Meehan et ah, 2000; Meng et ah,
2000)(as described in section 1.2.3). Recent studies in mice including those in which a
SC-specific knockout of AR expression has been achieved demonstrate the importance
of somatic cell function as these mice are infertile because germ cells fail to complete
meiosis efficiently (De Gendt et ah, 2004). Oestrogen signalling also plays a role in
maintaining male fertility. In mice lacking a functional aromatase (Cypl9) gene GC
apoptosis increases, abnormal acrosome development occurs, and spermatids detach
from the seminiferous tubules (Robertson et ah, 1999). ERB is expressed in both
somatic and genu cells in rodents and primates (Saunders et ah, 1997; Saunders et ah,
2001; van Pelt et ah, 1999; Zhou et ah, 2002) and ERa has been detected in murine LC
and PTM with highest levels of expression in the efferent ductules (Fisher et ah, 1997;
Hess et ah, 1997b; Pelletier et ah, 2000; Zhou et ah, 2002). Interference with oestrogen
signalling by knocking out ERP also causes male infertility, although the mechanism has
not been identified it may be behavioural as no abnormalities in testis and epididymis
histology or spermatozoa motility have been observed (Antal et ah, 2008).
As described in section 1.3.2.1 steroid hormone receptor activation results in
dimerisation of the receptor and recruitment of transcriptional cofactors to initiate
expression of responsive genes via hormone response elements (HRE) in their promoter
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regions (Beato et al., 1989; Doesburg et al., 1997; Ikonen et al., 1997; Wong et al.,
1993). As androgen-dependent signalling in SC is essential for complete
spermatogenesis, identification of androgen responsive genes in SC has been
undertaken. Notably the expression of AR itself is androgen responsive; AR expression
in SC is dependent on high intratesticular testicular testosterone (Bremner et al., 1994;
Turner et al., 2001). The homeobox gene, Rhox5, which is expressed in SC and the
epididymis is also androgen-responsive (Lindsey and Wilkinson, 1996a; Lindsey and
Wilkinson, 1996b). Two promoter regions (distal and proximal) have been identified for
Rhox5; the proximal promoter contains two androgen response elements and is
responsible for expression within the SC (Barbulescu et al., 2001; Sutton et al., 1998).
Further studies to investigate differential gene expression between SC with or without
androgen receptor expression have identified numerous putative androgen responsive
genes including (33-tubulin, claudin3, claudinl 1 and espin (Abel et al., 2008; Denolet et
al., 2006a; Meng et al., 2005).
Sertoli cells isolated from the testes of rodents between the ages of 18 and 21 days have
been used to investigate the functions of these cells in the relatively convenient setting
of in vitro cultures, and a method for isolation has been described by Karl and Griswold
(Karl and Griswold, 1990). However in addition to being rapidly outgrown by the
peritubular myoid cells that contaminate the SC cultures (Karl and Griswold, 1990;
Schlatt et al., 1996) the phenotype of the SC is unstable and there are reports of
dedifferentiation of the cells within only a few days. For example, expression of AR is
lost rapidly in cultured primary SC; after 3 days in culture AR expression is still detected
but soon declines (Denolet et al., 2006b; Nakhla et al., 1984). In SC-enriched cultures
derived from rat tissue and maintained over the course of 6 or 16 days, secretion of
androgen-binding protein (ABP) can be used as a marker of SC function. The secretion
of ABP declined dramatically in cells in the absence of hormones over the culture period
(reduced by 6-8 days), although treatment with hormones including testosterone, insulin
and FSH increased ABP secretion above that in control cells (Karl and Griswold, 1980;
Rommerts et al., 1978). In cultures of primary rat SC, proliferation can be maintained
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beyond 22 days in culture by FSH treatment. However by 26-32 days of culture the SC
develop an abnormal phenotype characterised by cytoplasmic vacuoles, increased
cytoplasmic area and multiple nuclei per cell (Buzzard et al., 2002).
As described in chapter 1, section 1.5.1, immortalised cells have been used in place of
primary SC in an attempt to study SC in an in vitro setting whilst avoiding the problems
described above, such as dedifferentiation and loss of steroid hormone receptor
expression. Section 1.5.1 describes three immortalised SC cell lines: Tm4 (Mather,
1980), MSC-1 (Peschon et ah, 1992), and SK11 (Walther et ah, 1996); it is the last of
these that was utilised for the studies presented in this chapter. The SK11 cell line is
derived from SC isolated from the testes of a ten-day-old H-2Kb-tsA58 mouse, these
mice express the tsA58 large T-antigen in cells throughout their body and therefore in all
cells derived into culture (Jat et ah, 1991), as described in section 1.5.2. The
temperature-sensitive tsA58 is expressed when SKI 1 cells are cultured at permissive
temperatures (i.e. those below 39 C), e.g. at 34 C used in this study permitting
proliferation in an undifferentiated state (Walther et al., 1996). When SK11 cells are
cultured above the permissive temperature for at least 48 hours the large T-antigen is
inactivated and proliferation ceases, the phenotype of the cells also changes towards that
of a differentiated SC (Jat et al., 1991). The expression of various genes at permissive
and non-permissive temperatures were described in section 1.5.2, it is relevant to this
chapter to repeat that whilst the expression of SGP-1 is similar at permissive and non-
permissive temperatures, expression of SGP-2 is raised in differentiated cells at non-
permissive temperatures (Sneddon et al., 2005; Walther et al., 1996; Walther et al.,
1997), which suggests differentiation at the higher temperature.
Androgen and oestrogen receptors, AR and ERp, are expressed by mouse SC in vivo
(Suarez-Quian et al., 1996; Zhou et al., 2002), and both have been detected in the SKI 1
cell line (Sneddon et al., 2005; Walther et al., 1996). ERa has not been detected in SC
in vivo (Zhou et al., 2002) and no mRNA was expressed in SKI 1 cells (Sneddon et al.,
2005). There was no detectable difference in expression of ERJ3 in SKI 1 cells cultured at
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34°C and 39 °C, however AR mRNA and protein expression were increased at 39 C
(Sneddon et al., 2005). Expression of steroid hormone receptors in SKI 1 cells strongly
suggests that these cells retain androgen and oestrogen responsiveness. In a previous
study from our laboratory treatment of SKI 1 cells with testosterone or DHT, but not
oestradiol or 3pAdiol, stimulated a reporter construct linked to the androgen-responsive
Rhox5 promoter demonstrating expression of a functional AR protein in the cells
(Sneddon et ah, 2005). Stimulation of a reporter construct under control of three tandem
EREs was achieved in SK11 cells by treatment with oestradiol or 3(3Adiol, proving the
presence of functional ERp (Sneddon et ah, 2005). The same study also reported that
expression ofmRNA for AR and ERp are increased by androgen and oestrogen treatment
respectively (Sneddon et ah, 2005).
3.1.1 Aims
The aims of the studies presented in the following chapter were to extend the
investigation of androgen and oestrogen response in SKI 1 cells, and to identify genes
differentially expressed in the cells under control of these steroids. By using SKI 1 cells
as a model of in vivo SC action it was hoped that genes involved in control of
spermatogenesis by action of androgens and oestrogens on SC would be identified and
their roles could be investigated.
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3.2 Materials and methods
3.2.1 Cell culture
SKI 1 cells were incubated at 34°C in 5% CO2 in 'complete' culture media and passaged
every 2-3 days to maintain a stock of proliferating (undifferentiated) cells (section
2.2.2). The cells were cultured in phenol red-free 'complete' media (section 2.8.1) for 48
hours prior to and during steroid treatment, and for 48 hours prior to RNA/protein
extraction in proliferative versus differentiated cell studies. To differentiate cells they
were cultured for 48 hours at 39°C and then incubated as described below if further
treatments were required. The cells were used to provide materials for RT-PCR and
Western blot analysis (sections 2.3.1 and 2.4.1).
3.2.1.1 Steroid treatments
Both proliferating and differentiated SK11 cells were treated with androgens
(testosterone, DHT) or oestrogens (oestradiol (E2). diethylstibestrol (DES), 3(3Adiol) at
doses between 1x10"12 and lxlO"6 M. Stocks of these steroids were prepared as
described in section 2.2.3. Control cells were incubated with appropriate vehicle of
ethanol or DMSO (1:100 in PBS) diluted 1:1000 in growth media. In studies with
oestrogens the oestrogen receptor antagonist ICI 182,780 (1 |lM) was added to control
groups 1 hour prior to oestrogen treatment and was also included with some steroid
treatments to demonstrate oestrogen receptor specificity of the effects.
3.2.2 Transient transfection
The plasmids used in transient transfections were mouse AR (mAR), the proximal Rhox5
promoter linked to the firefly (Photinus pyralis) luciferase (Rhox5-luc), and Renilla
reniformis luciferase. Expression of the mAR plasmid is under control of the cmv5Tb
promoter and the Rhox5 promoter contains 2 androgen response elements whose
sequences are: AGATCTcattcTGTTCC (ARE-1) and AGCACAtcgTGCTCA (ARE-2).
The mAR plasmid was a kind gift from Dr. Frank Claesans (Leuven, Belgium), the
Rhox5-luc plasmid was a gift of Professor G. Verhoeven (Leuven, Belgium), and the
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Renilla plasmid was supplied by the MRC Human Reproductive Sciences Unit's
Biomolecular Core Facility (managed by Dr. Pamela Brown).
SK11 cells were seeded onto 6-well plates at 4xl05 cells/well, in phenol-red free
'complete' medium, 48 hours prior to transfection and cultured at 34°C. The 'complete'
media was removed from the cells 1 hour before transfection and replaced with 500 pi
'transfection' medium (section 2.8.1). Plasmids (mouse AR, Rhox5-Luc, and Renilla)
were transfected into cells using JetPEI (Qbiogene, Cambridge, UK), as shown in Figure
3-1. Briefly, plasmids were diluted in 50 pi NaCl (50 mM) per well, and JetPEI was
diluted in a separate 50 pi NaCl per well. The JetPEI solution was added to the plasmid
solution, mixed gently by pipetting, and incubated at room temperature for 30 minutes.
JetPEI/DNA solution (100 pl/well) was added to the transfection medium in each well
drop wise and mixed by swirling gently. The cells were incubated with the transfection
reagent and DNA for 4 hours at 37°C in 5% CO2 after which the transfection reagents
was removed and replaced with 2 ml transfection medium plus 10% carbon-stripped
FBS, supplemented with DHT or DMSO when required. Cells were returned to 34°C in
5% CO2 for 6-48 hours and expression of mRNAs {AR, Rhox5, Cldn3, and Cldnll) or
proteins (AR or luciferase) were assessed (sections 3.2.4.2 and 3.2.2.1 respectively).
SKI 1 cells were either transfected with 300-1500 ng mAR per well or with 500 ng mAR,
plus 2.5 pg Rhox5-luc and 625 pg Renilla per well. Depending upon the plasmids being
introduced into the cells the quantity of DNA being transfected ranged from 300 ng to
3.625 pg/well. Transfection using JetPEI requires an optimal ratio between the nitrogen
in the JetPEI and the phosphates in the plasmids, called the N/P ratio, which is 5 for
SK11 cells. The following equation determines the volume of JetPEI used in the
transfection mixture for a N/P ratio of 5:
pi of JetPEI to be used = (pg DNA x 3) x N/P ratio
7.5










Figure 3-1: Scheme for transient transfection of SK11 cells using JetPEI.
3.2.2.1 Luciferase assay.
Expression of firefly and renilla luciferase by SKI 1 cells following transfection with the
Rhox5-luc and Renilla plasmids was quantified using the Promega Dual Luciferase
Reporter™ assay. The assay was performed in a 96-well plate as described in the
manufacturer's protocol, and luminescence was measured on a Fluostar optima
luminometer (BMG labtech, Aylesbury, UK). Briefly, the protocol involves lysis of the
cells with 150 pi lx passive lysis buffer for 15 minutes at room temperature. Twenty
microlitres of cell lysate/sample was pipetted onto a 96-well plate and the lysates were
assayed using an automated protocol on the luminometer. The luminometer introduces
100 pi of luciferase assay reagent II (LARII) into a well and measures the luminescence
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due to the presence of firefly luciferase. After 8 seconds the luminometer introduces
100 |al of Stop & Glo® reagent to quench firefly luciferase luminescence and activate
renilla luciferase luminescence, which is measure for 7 seconds. The process is repeated
for each well in turn. The average luminescence due to firefly luciferase is standardised
to average renilla luminescence, to normalise for differences in transfection efficiency
and number of cells present.
3.2.3 Adenoviral ERE-Tk-luc construct
The ERE-Tk-Luc construct was a kind gift of S.C. Nagel and D.P. McDonnell (Duke
University, USA). The constmct consists of 3 copies of the vitellogenin ERE linked to
the TATA-Luc reporter (Hall and McDonnell, 1999). The construct was introduced into
an adenoviral construct as described below. The sequence of the promoter region of the
reporter construct is shown below, the locations of the 3 ERE repeats are underlined:
TAGGTCAcagTGACCTGCGGATCCGCAGGTCActgTGACCTAGATCCGCAGGTC
ActgTGACCT
3.2.3.1 Preparation of construct
The following procedures were carried out by staff in the MRC Human Reproductive
Sciences Unit's Biomolecular Core Facility (managed by Dr. Pamela Brown), to whom I
am very grateful.
The ERE-Tk-Luc plasmid was subcloned into the pDC316 shuttle plasmid, which
contains a loxP recombination site. The shuttle plasmid, bearing the ERE-Tk-Luc, was
co-transfected with the adenoviral genomic plasmid pBHGloxAEl,3Cre in HEK293
cells. The adenoviral genomic plasmid lacked both the El and E3 regions rendering the
genome replication incompetent in the absence of a helper cell line such as HEK293,
and a Cre and loxP site for incorporation of the shuttle. Co-transfection in the HEK293
cells yielded a recombinant viral vector containing the ERE-Tk-Luc in place of the El
domain and also lacking the E3 region. The plasmids and reagents were supplied by
Microbix Biosystems Inc. (Toronto, Ontario, Canada), and the procedure was as
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described in their protocol. High titre stocks of the ERE-Tk-luc construct were
generated by amplification in HEK293 cells as described in Section 2.6.
3.2.3.2 Viral infection
Prior to infection with the adenoviral ERE, SKI 1 cells were cultured in 96-well plates at
7.5 xlO3 cell/well for 48 hours at 39°C in phenol red-free 'complete' media. Media was
removed from each well and replaced with 400 pl/well of fresh media. The ERE-luc
viral stock was diluted in phenol red-free 'complete' media to a concentration of 50
pfu/cell (50 MOI) in 50 pi/well. Each well was infected with 50 pi of diluted viral
solution and incubated for 4 hours at 37°C in 5% CO2. The media and virus were
removed and replaced with phenol red-free media and cells were returned to culture at
39°C. The cells infected with ERE-luc were incubated with oestrogen ligands (section
3.2.1.1) for between 12 and 48 hours, in 5% CO2, at 39°C.
3.2.3.3 ERE-luciferase assay
SKI 1 cells infected with the ERE-Luc adenovirus were treated with E2, DES, or
3pAdiol at concentrations from 10"12 to 10"7 M, plus or minus 1 jlM ICI 182,780. Cells
in control wells were treated with 1 p.M ICI 182,780 (section 3.2.1.1).
Two distinct studies were undertaken. The first was a time course study in which ERE-
Luc infected cells were treated with E2 (10"8 or 10"7 M) plus and minus ICI 182,780 or
DES (10~8 M) for 12, 24, 36 and 48 hours. At each time point luciferase protein was
extracted from the cells for quantification (section 3.2.3.4).
In the second study SKI 1 cells were exposed to E2 (10"" - 10~7 M), DES (10"'2 - 10"7
M), and 3(3Adiol (10"" - 10"7 M). A duplicate of each treatment was also performed
with ICI 182,780 (1 p.M) added 1 hour prior to and throughout ligand treatment. Cells
were exposed to the treatment for 24 hours before the luciferase was extracted and
analysed. The luciferase assay was performed as described in section 3.2.3.4.
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3.2.3.4 Bright-glo Luciferase assay
Luciferase expression was quantified using the BrightGlo luciferase assay (Promega) in
accordance with the provided protocol. SKI 1 cells were lysed in 100 jil of glo lysis
buffer per well for 5 minutes at room temperature, and 90 |il/wcll of the lysed solution
was transferred to a white polystyrene 96-well assay plate (Fisher Scientific). An equal
amount (90 pi) of BrightGlo reagent was added to each well and the solutions were




RNA extracted from SKI 1 cells and adult mouse testis was used to synthesis cDNA in
an oligo-dT primed reaction as described in section 2.3.1. A standard PCR reaction
catalysed by Taq polymerase (Bioline) was prepared using primers to AR, Rhox5, SGP-
1, and SGP-2. Primer sequences, predicted product size and annealing temperatures for
each reaction are shown in Table 3-1.
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Table 3-1: RT-PCR primer sequences, product size, and annealing temperatures
















































3.2.4.2 TaqMan Quantitative RT-PCR
Samples of RNA extracted from mouse tissues (testis, prostate, epididymis and kidney)
and SKI 1 cells were incubated in a random hexamer primed reverse transcriptase
reaction to produce cDNA (section 2.3.3.1). The cDNA was used for TaqMan in both
Assay-On-Demand™ (section 2.3.3.3) and the Universal Human Probe Library™
reactions (section 2.3.3.4) undertaken on an ABI 7900 HT Real-Time PCR Machine.
Details of the Assay-On-Demand reagents are shown in Table 3-2, the sequences of the
primers and probes in the UPL TaqMan are shown in Table 3-3.
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Table 3-2: Taqman Assay-On-Demand™ primer/probe assays for TaqMan.










































Western blots were performed on proteins extracted from SKI 1 cells and adult mouse
tissues (testis and prostate) using lx RIPA (section 2.4.1). SKI 1 cell samples were from
untreated cells cultured at 34°C and 39°C, and those incubated with media alone DMSO
(vehicle) or DHT (sections 2.2.1 and 2.2.3). Western blots were performed as described
in section 2.4.2, protein bands were visualised by fluorescent staining using the LiCor
Chapter 3 Gene expression using an immortalised Sertoli cell line 101
system. SKI 1 cell extracts were incubated with antibodies directed against AR, Rhox5,
and Sdmg-1 plus P-Actin as a loading control. The primary antibodies used are listed in
Table 3-4. The fluorescent secondary antibodies are those listed in
Table 2-5.






AR 1:200 rabbit US Biological









Immunohistochemistry was perfonned on sections from wild-type mouse testes prepared
as described in section 2.5. The expression of AR, Sdmg-1, and SGP-2 was determined
in testes from adult and post-natal day 10 mice, and visualised by DAB staining using
the methods, reagents and biotinylated secondary antibodies described in Table 2-7 and
Table 3-5.
Chapter 3 Gene expression using an immortalised Sertoli cell line 102











SGP-2 1:250 rabbit Santa Cruz
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3.3 Results
3.3.1 Immunolocalisation of Sertoli cell proteins
Immunoexpression of AR, SGP-2 and Sdmg-1 in adult and day 10 mouse testes was
assessed using fixed tissue sections (Figure 3-2, Figure 3-3, and Figure 3-4 respectively).
Analysis of day 10 testes was important because SK11 cells were originally derived
from mouse testes of this age, and it was essential to demonstrate expression in the
equivalent cells in vivo before investigating in vitro expression.
The testes of day 10 mice were dramatically different from those of adults. The tubules
of day 10 mice were much smaller and many had not developed a lumen. The immature
tubules had a homogeneous structure with little variation in structure or cell complement
between tubules. In adult testes spermatogenesis was apparent with GC at each step of
development present, therefore tubules at different stages of the spermatogenesis cycle
were identified. The tubules of the adult testes all possessed a lumen, and its size varied
with tubule's stage in spermatogenesis.
Expression ofAR (Figure 3-2) was detected in testes at both ages within the tubules and
in the interstitium, staining was present in the nuclei of Leydig cells (LC), peritubular
myoid cells (PTM) and SC, but GC in the adult sections were not stained. In adult testes
(panels B and D) the SC nuclei, which stained for AR, were found at the basement of the
tubules in contrast to SC of day 10 mice (A and C) where the nuclei were localised
towards the centre of the tubules within the epithelium. In the day 10 testes staining for
AR was present in SC nuclei in all tubules, AR immunostaining in adult testes was
dependent upon the stage of spermatogenesis of the tubules. Tubules at stages VII and
VIII in adult mouse testes contained SC with the most intense immunopositive staining
for AR in their nuclei.






















Figure 3-2: Immunostaining of AR in day 10 (A and C) and adult (B and D) mouse testes.
Panels A and B are 20x magnification, and panels C and D are 40x magnification. The scale
bars represents 100 pm (A and B) and 50 pm (C and D). Arrows indicate positive
immunostaining in peritubular myoid cells (PTM), Leydig cells (LC), and Sertoli cell nuclei (SC).
SGP-2 (Figure 3-3) was detected at both ages but was restricted to the SC, and again the
distribution differed between ages. Staining in day 10 testes (panel A and B) was
concentrated in SC cytoplasm near the centre of the tubule, and lacked the extended
cytoplasmic distribution seen in adult testes. In the adult testes (panels C and D) the
cytoplasmic location resulted in narrow bands of staining from the base of the tubule in
towards its centre, and there was limited stage-dependent variation in intensity of
expression.
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Figure 3-3: Immunostaining of SGP-2 in day 10 (A and C) and adult (B and D) mouse
testes. Panels A and B are 20x magnification, and panels C and D are 40x magnification. The
scale bars represents 100 pm (A and B) and 50 pm (C and D).
Sdmg-1 staining (Figure 3-4) was present in the tubules of both day 10 and adult testes.
In day 10 testes SC cytoplasm was stained strongly from the base to the centre of the
tubules surrounding the GC and SC nuclei present. In adult testes Sdmg-1 was also
immunolocalised to SC cytoplasm, the staining was in narrow bands from the basement
of the tubule inwards towards the lumen in a similar pattern to that of SGP-2.
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Figure 3-4: Immunostaining of Sdmg-1 in day 10 (A and C) and adult (B and D) mouse
testes. Panels A and B are 20x magnification, and panels C and D are 40x magnification. The
scale bars represents 100 pm and 50 gm respectively.
3.3.2 Gene expression in SK11 cells at permissive and non-permissive
temperatures
3.3.2.1 SGP-1 and -2 mRNA
3.3.2.1.1 RT-PCR
SGP-1 (484 bp) and SGP-2 (460 bp) PCR products were detected in SKI 1 cells
incubated at 34°C, or 39°C for 48 hours, and compared to expression in day 8 and adult
mouse testes, plus adult mouse epididymis. Expression of SGP-1 mRNA (Figure 3-5)
appeared higher in cells after incubation at 39°C (lane 3) compared with those at 34°C
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(lane 2). SGP-1 was also expressed in the adult testis and epididymis, and day 8 testis
(lanes 1, 4, and 5 respectively), consistent with SC specific expression the amount of
mRNA compared to the total testicular RNA was higher at day 8 than in adulthood. In
SKI 1 cells cultured at the 34°C (lane 2, Figure 3-5) expression of SGP-2 was not
detected however mRNA was induced in cells cultured at 39°C (lane 3) and was present
in day 8 and adult testes, and epididymis. Expression of SGP-2 was detected in adult
and day 8 testes (lanes 1 and 5), and to a greater extent in adult mouse epididymis (lane
4).
SGP-1
L 1 2 3 4 6 5 7
484 bp ►
460 bp ►
L 1 2 3 4 5 6 7
SGP-2
288 bp^
1 2 3 4 5 6 7
GAPDH
Figure 3-5: Detection of SGP-1 (484 bp) and SGP-2 (460 bp) mRNAs. Lane 1 is adult
mouse testis (positive control), lane 2 is SK11 cells cultured at 34°C, lane 3 is SK11 cells
cultured at 39°C, lane 4 is epididymis, and lane 5 shows immature day 8 mouse testis. Lanes 6
and 7 are negative controls, lane 6 is a reverse transcriptase negative sample, and lane 7 is a
water control. L is Hyperladder IV DNA marker and band sizes are marked on the left side of the
figure. Expression of GAPDH (288 bp) mRNA in the same samples is include as a control for
comparison with SGP-1 and -2 mRNA expression.
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3.3.2.1.2 Q-RT-PCR for SGP-2 in SK11 cells incubated with
testosterone
The mRNA expression ofSGP-2 in SKI 1 cells cultured at 34°C, or for 48 hours at 39°C,
was also measured by TaqMan Q-RT-PCR (Figure 3-6) to quantify the difference in
expression detected by RT-PCR (shown in Figure 3-5). The impact of testosterone
(lxlO"9 - lxlO"6 M) was also quantified. Expression of SGP-2 mRNA was increased by
3 - 4.5-fold when cells were cultured at 39°C, compared to untreated cells cultured at
34°C. Treatment of cells, cultured at 34°C or 39°C, with testosterone did not induce a
statistically significant change in SGP-2 mRNA expression at any concentration.
Statistical analysis by 2-way ANOVA confirmed these observations and reported that
culture temperature had a highly significant effect on SGP-2 expression (p<0.0001), but
that testosterone treatment had no significant effect (p=0.55). A Post-hoc test showed
that the difference in SGP-2 mRNA expression between cells cultured at 34°C and 39°C
was only (p<0.01) highly significant in cells cultured with 1 x 10"6 M testosterone
(indicated by ** in Figure 3-6).
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Figure 3-6: TaqMan for SGP-2 mRNA in SK11 cells grown at 34°C (blue) and 39°C (red)
and treated with testosterone (1x109 - 1x10"6 M) for 48 hours. The control (0) cells were
incubated in phenol-red free media alone, and DMSO is the vehicle control. Expression is
presented relative to that of control SK11 cells cultured at 34°C. Bars represent average
expression ± SEM, for n=3 experiments. 2-way ANOVA reported that culture temperature had a
significant effect (p<0.0001) on SGP-2 expression. Treatment with media, DMSO or
testosterone did not affect expression significantly (p=0.55). ** = p<0.01.
3.3.2.1.3 Western
SGP-2 protein was detected in samples extracted from SKI 1 cells incubated at 34°C and
39°C (Figure 3-7). Panel A shows the fluorescently labelled proteins bands of SGP-2
(70 kDa) and P-actin (42 kDa), extracts from cells incubated at 34°C (lanes 1) were
associated with less total SGP-2 than extracts from cells at 39°C (lanes 2). Panel B
shows quantification of SGP-2 expression in cell extracts, standardised to P-actin;
approximately 80% more SGP-2 was detected in cells incubated at 39°C, than at 34°C.
Statistical analysis of these data was performed using A Mann Whitney analysis, and
revealed no significant difference (p=1.00) in expression between culture temperatures.





Figure 3-7: Expression of SGP-2 protein in SK11 cells cultured at 34°C or 39°C. Panel A
shows fluorescently labelled bands associated with SGP-2 (70 kDa, green) and p-actin (42 kDa,
red). Proteins were extracted from SK11 cells incubated at 34°C (lanes 1) or 39°C (lanes 2),
lane L contained SeeBlue protein ladder. Panel B is quantification of SGP-2, standardised to p-
actin, detected in n=3 sets of cell extracts. No significant difference (p=1.00) in expression
between cells cultured at 34°C and 39°C was detected by the Mann Whitney test.
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3.3.2.2 Sdmg-1
3.3.2.2.1 Western
Sdmg-1 protein was detected in protein extracts from SK11 cells incubated at 34°C
(lanes 1) or 39°C (lanes 2), the fluorescently labelled bands associated with Sdmg-1 (80
kDa, green) and p-actin (42 kDa, red) are shown in panel A (Figure 3-8). The size of
Sdmg-1 protein was predicted from its nucleotide sequence to be 49 kDa (Best et al.,
2008), however shift in the gel is reduced by N-glycosylation. Sdmg-1 shift can be
reduced to equivalent to that of a 110-120 kDa protein, shift of the protein has not been
reduced this dramatically in the SKI 1 cell samples but fluorescence of the putative
Sdmg-1 bands is strong indicating specific-binding. The Sdmg-1 expression appeared
similar at both temperatures, to be certain Sdmg-1 was quantified and standardised to |3-
actin in each extract. Panel B shows standardised Sdmg-1 protein expression,
approximately 30% more Sdmg-1 was detected in extracts from cells incubated at 39°C,
compared to 34°C. A Mann Whitney statistical analysis revealed no significant
difference (p=0.40) in expression between cells cultured at each temperature.




Figure 3-8: Sdmg-1 protein in extracts from SK11 cells incubated at 34°C (lanes 1) or 39°C
(lanes 2). Sdmg-1 was detected using fluorescent western blotting, panel A shows the
fluorescent bands associated with Sdmg-1 (80 kDa, green) and (3-actin (42 kDa, red), and in
lane L the SeeBlue protein ladder. Panel B shows quantification of Sdmg-1 standardised to (3-
actin in 3 sets of cell extracts, a Mann Whitney detected no significant difference (p=0.40)
between cells cultured at 34°C and 39°C.
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3.3.2.3 Androgen receptor
3.3.2.3.1 RT-PCR for AR in SK11 cells incubated with DHT
Weak expression of AR mRNA (171 bp) was detected by RT-PCR in SKI 1 cells
cultured at 34°C (top panel) or 39°C (bottom panel), and the level of expression
appeared similar at both temperatures (Figure 3-9). Incubation of cells with DMSO
(vehicle, lanes marked 3) or lxl(F7M DHT (lanes marked 2) for 48 hours did not alter
expression ofAR compared to cells cultured in media alone (lanes marked 1).
L 1 2 3 4 5
Figure 3-9: Detection of AR mRNAs in SK11 cells incubation at 34°C or 39°C with media,
DHT or DMSO for 48 hours. AR (171 bp) expression was detected in control SK11 cells (1,
cultured in media) and those incubated with, 10"7 M DHT (2) and DMSO (3). Lane 4 shows a
RT-negative control, and lane 5 is a water control. L is Hyperladder IV DNA marker and band
sizes are marked on the left side of the figure. Expression of GAPDH mRNA (288 bp) in the
same samples is included as a control.
3.3.2.3.2 Q-RT-PCR for Ar in SK11 cells incubated with testosterone
Expression ofAR mRNA in SKI 1 cells was quantified by TaqMan Q-RT-PCR to assess
whether culture temperature or incubation with androgens had an impact on AR
expression, which had not been detected by semi-quantitative RT-PCR. The
quantification from the TaqMan is shown in Figure 3-10, SK11 cells cultured at 34°C
(blue bars) and the differentiated cells at 39°C (red bars). However overall AR mRNA
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expression was increased by culture at 34°C compared to 39°C (p=0.01). In addition,
Bonferoni post-hoc test found no statistically significant difference in AR expression
between cells cultured at 34°C or 39°C undergoing the same treatment. Incubation with
media, DMSO or testosterone did not affect AR expression significantly (p=0.56).
1.75n
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Figure 3-10: TaqMan quantification of AR mRNA in SK11 cells incubated for 48 hours with
testosterone (109 to 10"6 M), media (control, 0), or DMSO. Cells were cultured at 34°C (blue)
or 39°C (red). AR expression was standardised to SK11 cells incubated in media at 34°C. Bars
represent average expression ± SEM, for n=3 experiments. Expression of AR was significantly
affected by culture temperature (p=0.01), but incubation with media, DMSO or testosterone did
not have a significant effect (p=0.56), when analysed by 2-way ANOVA.
3.3.2.3.3 Western
Androgen receptor protein was detected in SKI 1 cells incubated at 34°C or 39°C (Figure
3-11). Fluorescently labelled AR (110 kDa, green) and [3-actin (42 kDa, red) protein
bands detected using a Western blot are shown in panel A, a modest reduction in total
AR was seen in cells incubated at 39°C. The amount of AR detected in extracts from
three experimental runs was quantified and standardised to (3-actin. The average
standardised AR detected in cells at each temperature is presented, statistical analysis by
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Mann Whitney test detected no significant difference (p=0.20) in AR protein expression
between cells cultured at 34°C and 39°C.
A
L 1 2 3
Temperature
Figure 3-11: Androgen receptor protein expression in SK11 cells cultured at 34°C (lanes
1) or 39°C (Lanes 2). Panel A shows fluorescently labelled AR (110 kDa, top green band only)
and (3-actin (42 kDa, red) protein bands detected by western blotting in the cell extracts. Lane 3
contained protein extracted from adult mouse testis and lane L was SeeBlue protein ladder.
Panel B shows quantification of AR protein detected in cell incubated at 34°C and 39°C. AR
level was standardised to p-actin, and is the average of 3 runs. Statistical analysis by Mann
Whitney test reported no significant difference (p=0.20).
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3.3.2.4 Rhox5
3.3.2.4.1 RT-PCR for Rhox5 in SK11 cells incubated with DHT
Expression of Rhox5 was detected by RT-PCR in adult mouse testis (positive control)
and samples extracted from cells cultured at 34°C or 39°C in the absence or presence of
DHT (Figure 3-12). Although mRNA was readily detected in all samples it was not
possible to determine whether culture temperature or incubation with DHT had a
significant impact on expression ofRhox5 mRNA.
Figure 3-12: Rhox5 (635 bp) mRNA detected using RT-PCR in SK11 cells cultured at 34°C
(lanes 1-3) and 39°C (lanes 4-6). Cells were incubated with media (lanes 1 and 4), 10"7M DHT
(lanes 2 and 5), or DMSO (lanes 2 and 6) for 48 hours. Lane 7 is a positive control (adult mouse
testis), lane 8 is a reverse transcriptase negative adult mouse testis sample, and lane 9 is a
water control. L is Hyperladder IV DNA marker and the band size is marked on the left side of
the figure. Expression of GAPDH mRNA (288 bp) in the same samples is included as a control.
3.3.2.4.2 Q-RT-PCR for Rhox5 in SK11 cells incubated with
testosterone
The expression of Rhox5 by SKI 1 cells was also quantified by TaqMan RT-PCR (Figure
3-13). Culturing SKI 1 cells at 39°C resulted in a significantly greater expression of
Rhox5 mRNA than in cells cultured at 34°C (p<0.0001), expression in SKI 1 cells
cultured at 39°C ranged from 2-3 fold greater than in cells cultured at 34°C. Changes in
Rhox5 mRNA expression between cells in different culture conditions were analysed by
Bonferoni post-hoc test. When cells were cultured in media, or in the presence of
Chapter 3 Gene expression using an immortalised Sertoli cell line 1T7
testosterone at lxlO"7 M, lxl0"6 M or lxlO"9 M there was a significant increase in Rhox5
mRNA expression when cultured at 39°C, compared to 34°C. Treatment with DMSO
(vehicle control) or doses of testosterone between lxl 0"9 M and lxl 0"6 M did not change
Rhox5 expression significantly from that in cells cultured in media (p=0.91).
0 DMSO 10-9 10-8 10-7 10-6
Figure 3-13: Quantification of Rhox5 mRNA by SK11 cells by Taqman Q-RT-PCR. SK11
cells were incubated with testosterone (10~9 - 10"6 M), media (control), or DMSO (vehicle control)
for 48 hours at 34°C (blue) and 39°C (red). Expression was standardised to that of SK11 cells
incubated with media at 34°C. Bars represent average expression ± SEM, for n=3 experiments.
A 2-way ANOVA demonstrates a significant difference (p<0.0001) in expression between culture
temperatures, but no difference due to testosterone treatment (p=0.91). ** = p<0.01 and *** =
p<0.001.
3.3.2.4.3 Western
Expression of Rhox5 protein was detected in SKI 1 cells by fluorescent Western blotting
(top panel, Figure 3-14). Included on the Western blots is the positive control tissue,
adult mouse testis (lane 7). Expression of Rhox5 (30 kDa, bottom green band on
Western blot) and p-actin (42 kDa, top green band) were quantified, and Rhox5
expression was normalised to the [Tactin in each sample. Expression in each sample
was expressed relative to SKI 1 cells incubated with media at 34°C, and the average
expressions in cells cultured at 34°C (blue) or 39°C (red) and mouse tissues (purple bars)
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are shown below in Figure 3-14 (bottom panel). Expression of Rhox5 protein was
significantly increased by culture at 39°C (p<0.002), although expression only reached a
maximum of around 1.6-fold the level detected in SK11 cells incubated with media at
34°C. Bonferoni post-hoc test detected a significant difference in expression specifically
between cells cultured at 34°C and 39°C incubated in media alone (p<0.05). Treatment
with DHT or DMSO had no significant impact on expression of Rhox5 protein (p=0.61).





Control DMSO DHT Testis
Figure 3-14: Western blot analysis of Rhox5 protein detected in SK11 cells cultured at
34°C or 39°C, and treated with DHT. The top panel shows fluorescently labelled (3-actin (42
kDa, top green bands) and Rhox5 (23 kDa, bottom green bands) following Western blotting.
Cells were incubated with media (lanes 1 and 4), DMSO (lanes 2 and 5), or 10~7M DHT (lanes 3
and 6) for 48 hours. Lane 7 is protein from adult mouse testis, and L is SeeBlue protein marker
and protein band sizes (30 kDa). The lower panel shows quantified Rhox5 expression
(standardised to (3-actin) in cells cultured at 34°C (blue) or 39°C (red). Rhox5 expression was
plotted relative to expression in SK11 cells incubated in media at 34°C. The purple bars show
expression of Rhox5 in testis (positive control tissue). Bars represent mean expression ± SEM,
for n=4 samples (Control and DHT), n=2 sample (DMSO), or n=1 (testis). Analysis by 2-way
ANOVA demonstrated a significant difference between culture at 34°C and 39°C (p<0.002), but
no significant difference between control, DMSO or DHT treatments (p=0.61). * = p<0.05.
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3.3.3 Gene expression in SK11 cells following transfection with AR cDNA
As levels of AR mRNA in SKI l cells appeared to be low and there was no detectable
androgen response, cells were transfected with between 300ng and 1.5|ig of mouse AR
(mAR) cDNA. It was hoped that expression of the transfected mAR plasmid would result
in a detectable androgen-dependent response.
3.3.3.1 Androgen receptor
3.3.3.1.1 Q-RT-PCR
Expression ofmAR was quantified by TaqMan in SKI 1 cells transiently transfected with
a mAR cDNA and cultured ± 1x10"7M DHT at 34°C for 48 hours (Figure 3-15).
Transfection successfully increased the amount of AR mRNA detected. In cells
transfected with 500 ng mAR cDNA was significantly greater than in untransfected cells
(p<0.01), and this significance rose when >750 ng were introduced (p<0.0001). The
fold increases in expression detected following transfection were in the tens to hundreds
of thousands compared to untransfected cells. Treatment of the cells with DHT did not
affect expression of AR significantly in transfected or untransfected cells, even when
large quantities ofAR cDNA were introduced (p=0.12).
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Figure 3-15: AR mRNA quantification in SK11 cells transfected with 0 - 1500 ng mAR
cDNA per well. Cells were cultured for 48 hours with DMSO (blue) or 10"7 M DHT (red) at 34°C.
Expression was assessed by Taqman Q-RT-PCR, and expression levels were standardised to
mAR expression in untransfected SK11 cells incubated with DMSO (valued at 1). Adult mouse
testis cDNA (purple) was included for comparison. The graph shows mean ± SEM, based on
n=2 samples. Statistical analysis by 2-way ANOVA demonstrated that expression of AR was
affected significantly (p<0.0001) by the quantity of mAR plasmid transfected into the cells,
however expression level was not affected by DHT treatment (P=0.12). ** = p<0.01 and *** =
p<0.001.
3.3.3.1.2 Western
The expression of Ail protein (110 kDa) detected in SK11 cells transfected with mAR
cDNA (300 - 1500 ng/well) was quantified by fluorescent Western blotting in cells
incubated with DHT (lxlO7 M) or media alone for 48hours at 34°C (Figure 3-16). AR
protein expression was normalised to (3-actin in each well, and in panel B is presented
relative to expression in untransfected cells incubated in media. AR protein was not
detected in untransfected cells, but all transfected cells incubated with DHT expressed
detectable amounts of AR. Cells transfected with 300 ng mAR and incubated with DHT
did not give a visible fluorescence band in panel A, but were sufficiently labelled for
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detection with the Odyssey scanner and quantification for panel B. AR protein detected
in cells not incubated with DHT ranged from equal to that found in untransfected cells to
-25-fold more. In cells incubated with DHT fold increases ranged from -5-250 fold
compared to untransfected cells incubated with media. Expression of AR protein was
only detected in the absence of DHT in cells transfected with >500 ng/well cDNA, and
AR protein expression was significantly greater than in untransfected cells when >500ng
cDNA were introduced (p<0.0001). The amount of AR protein detected was
significantly greater in cells incubated in DHT than those incubated in media
(p<0.0001), specifically in cells transfected with 500 ng/well (p<0.01) and 750-1500
ng/well (p=0.0001). There was a positive association between the quantity of cDNA
introduced into the cells and the amount of AR protein detected (p<0.0001), but the
increase was more dramatic in DHT-treated cells (significant interaction between cDNA
quantity and DHT treatment, p<0.0001). The amount of AR protein detected in SKI 1
cells transfected with 500 or 750 ng/well cDNA and incubated with DHT was similar to
expression detected in adult mouse prostate.
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Figure 3-16: Detection of AR protein (110 kDa) in SK11 cells transfected with 0 - 1500ng
mAR cDNA per well. Cells were incubated with 10"7 M DHT or media alone at 34°C. Top panel
shows mAR (green) and (3-actin (42 kDa loading control, red) expression following transfection
of each quantity of plasmid into cells incubated with (+) or without (-) 10"7M DHT. On the left of
the image is See-blue protein ladder and protein band sizes (kDa) and on the far right is prostate
(P, positive control tissue). The bottom panel shows standardised mAR expression (mAR/p-
actin) in cells incubated in media alone (blue) or 1x1CT7M DHT (red), and adult mouse prostate
(purple) relative to expression in untransfected cells incubated in media. The graph shows
mean ± SEM, based on n=3 samples. A 2-way ANOVA reported a significant differences
between cells transfected with different quantities of mAR plasmid and between cells treated
DHT and media, the analysis also indicated interaction between these factors resulting in a
greater than cumulative effect (p<0.0001, all three comparisons). ** = p<0.01 and *** = p<0.001.
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3.3.3.2 Rhox5-luc reporter assay
The functionality of AR protein was investigated by co-transfection of 500 ng mAR
together with the Rhox5(ARE)-luc and Renilla plasmids into SK11 cells cultured at
34°C. If the transfected cells express functional mAR protein then incubation with DHT
should induce luciferase expression following binding of AR to the ARE. Transfected
SKI 1 cells were incubated with transfection media plus FBS alone, DMSO or lxlO"10 -
lxl0"7 M DHT for 48 hours, expression of firefly luciferase was standardised to renilla
expression in each sample, and standardised firefly luciferase expression relative to
expression in cells cultured in media alone is shown in Figure 3-17. Treatment of cells
with DHT had a significant impact on the amount of luciferase (p=0.01, Kruskal-Wallis
test), raising expression more than 5-fold over cells cultured in media alone. Post-hoc
Dunn's multiple comparison test, revealed that there was a significant difference in
expression between cells treated with 1 x 10"9 M DHT and the control cells treated with
media alone and DMSO (p<0.05).
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Figure 3-17: Expression of luciferase protein in response to activation of Rhox5-luc, in
SK11 cells transfected with mouse AR plasmid. SK11 cells transfected with mAR, Rhox5-luc
and Renilla were treated with media alone, DMSO or DHT (1x10"10 - 1x10"7 M) at 34°C for 48
hours. Expression is shown relative to luciferase in cells cultured in media. Bars represent
mean luciferase expression ± SEM for n=3 experiments. Analysis using the non-parametric
Kruskal-Wallis test demonstrated a significant difference between treatments (p=0.01). * =
p<0.05.
3.3.3.3 Expression Rhox5 mRNA
Expression of Rhox5 mRNA was quantified by TaqMan in SK11 cells transfected with
300-1500 ng mAR cDNA/well and treated with 1x10"7M DHT for 48 hours at 34°C
(Figure 3-18). Expression of Rhox5 mRNA in the untransfected and transfected SKI 1
cells was high in comparison to the adult mouse testis sample. Rhox5 expression was
significantly altered by transfection with mAR cDNA (p<0.01, 2-way ANOVA), the
highest expression was seen in cells transfected with 500 ng/well and the lowest in
control cells (untransfected cells incubated with DMSO). Rhox5 mRNA expression was
raised compared to control cells following transfection with 500 ng (p< 0.01), or 750 ng
and 1000 ng (p<0.05), although the greatest fold-changes were <2. Rhox5 mRNA
expression was not altered significantly by incubation with DHT (p<0.62), even in cells
transfected with 500 ng/well mAR, which resulted in significant Rhox5 promoter
activation as described in section 3.3.3.2.
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Figure 3-18: Quantification of Rhox5 mRNA in SK11 cells transfected with between 0 -
1500 ng mAR plasmid per well. Cells were cultured for 48 hours with DMSO (blue) or 10"7 M
DHT (red) at 34°C. Expression was detected by Taqman Q-RT-PCR, and standardised to
Rhox5 expression in untransfected (0) SK11 cells incubated with DMSO. A sample of adult
mouse testis cDNA (purple) was included in the analysis. The graph shows standardised mean
± SEM, based on n=2 samples. The quantity of mAR cDNA significantly affected Rhox5
expression (p<0.01), but DHT treatment did not have a significant effect (p=0.62). * = p<0.05,
and ** = pO.01.
In order to determine whether there was a time-dependent change in Rhox5 mRNA in
cells transfected with 500 ng/well mAR cDNA cells were incubated for 6 to 48 hours
with lxlO"9 M DHT, DMSO, or transfection media plus FBS. These conditions should
ensure substantial AR protein expression and the optimal DHT concentration to
stimulate the Rhox5 proximal promoter and cover a time period in which Rhox5 mRNA
expression can be expected to change. Rhox5 mRNA expression relative to control cells
cultured for 6 hours in media alone is shown in Figure 3-19. Expression rose from 16
hours to 24 hours and declined by 48 hours, all changes were within 2-fold of control.
Statistical analysis by 2-way ANOVA reported that the differences in expression
between time points were not significant (p=0.11), nor did treatment with DHT have a
significant effect (p=0.81).
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Figure 3-19: Time course of Rhox5 mRNA detected in SK11 cells transfected with mouse
AR. Expression of Rhox5 mRNA was quantified by Q-RT-PCR in samples from cells incubated
at 34°C for between 6 and 48 hours with transfection media plus FBS (blue), DMSO (red), or 1
x10"9 M DHT (purple). Expression in each sample was standardised to that of cells incubated for
6 hours with FBS. Bars represent mean expression ± SEM from 3 independent experiments.
Statistical analysis by 2-way ANOVA revealed no significant differences between time points (p
= 0.11) or treatment with media, DMSO or DFIT (p= 0.81).
3.3.3.4 Expression of junctional mRNAs
SK11 cells were transfected with 500 ng/well of mAR cDNA and incubated with 1x10"
9M DHT, DMSO or transfection media plus FBS for 6-48 hours at 34°C. Claudin3
(<Cldn3) and claudinll (Cldnll) mRNA expression were quantified by TaqMan Q-RT-
PCR.
3.3.3.4.1 Claudin3 Q-RT-PCR
Expression of Cldn3 in cells from 3 independent experiments was standardised to
expression in cells incubated for 6 hours in media within the same experiment; the
results were highly variable and are shown separately in Figure 3-20. The amounts of
mRNA detected were highly variable between experiments. Fold changes ranging from
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less than 1 to close to 50 were detected and no common pattern of expression was seen
between graphs. None of the time points or treatments were consistently associated with
changes in expression.
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Figure 3-20 (previous page): Quantification of claudin3 (Cldn3) mRNA in SK11 cells
transfected with mouse AR. Expression of Cldn3 in SK11 cells, cultured at 34°C and
incubated with transfection media plus FBS (blue), DMSO (red), and 1 x 10"9 M DHT (purple),
was detected by Q-RT-PCR. Expression was quantified at 6, 16, 24 and 48 hours. Three
independent experiments were undertaken and the results of each are shown separately above.
Bars show the average expression, from 2 wells per treatment per time point, standardised to
expression in SK11 cells incubated with transfection media plus FBS for 6 hours.
3.3.3.4.2 Claudin11 Q-RT-PCR
SKI l cells were transfected as described above and incubated with DMSO; lxlO9 M
DHT; or transfection media plus FBS for between 6 and 48 hours. Quantification of
Cldnl 1 expression is shown in Figure 3-21. Expression at 48 hours was greater than at
the other timepoints; however the fold change was less than 1.5 for all 3 treatments.
Analysis by 2-way AVOVA showed that expression was significantly different between
time points (p=0.0005). Using the Bonferoni post-hoc test, specific differences were
found between cells incubated in DHT at 24 and 48 hours (p=0.05), and cells incubated
in DMSO at 48 hours compared to those at 16 or 24 hours (p= 0.05 and 0.01,
respectively). Treatment of cells with DMSO or DHT at 48 hours or any of the 3 other
time points did not result in expression of Cldnl 1 that was significantly different from
cells incubated with media (p=0.98).
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Figure 3-21: Expression of claudinU (Cldn11) mRNA in SK11 cells transfected with mAR
quantified by Q-RT-PCR. Cells were incubated with media plus FBS (blue), DMSO (red) and
1x10"9 M DHT (purple). Expression was determined after incubation for 6, 16, 24 and 48 hours
at 34°C. Expression is relative to that in cells incubated with media plus FBS for 6 hours; bars
represent average expression ± SEM from 3 independent experiments. A 2-way ANOVA
showed a statistically significant overall effect of time (p= 0.0005 ) but treatment with DMSO or
DHT does not have a significant effect compared to media (p= 0.98). * = p<0.05 and ** =
p<0.01.
3.3.4 Oestrogen responsiveness of SK11 cell line
3.3.4.1 ERp mRNA expression assessed by RT-PCR
The expression of mouse ER/3 in SK11 cells cultured at 34°C (lanes 1) and in cells
differentiated by culture at 39°C for 48 hours (lanes 2) was detected by nested RT-PCR
(Figure 3-22). Expression of ER/3 was detected in cells incubated at both temperatures
and did not appear to change when cells were cultured at 39°C; ER/3 mRNA was also
detected in adult mouse prostate, testis and kidney (lanes 3, 4, and 5 respectively).
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Figure 3-22: Detection of ERJ3 mRNA (348 bp) with RT-PCR in SK11 cells cultured at 34°C
(lanes 1) or 39°C for 48 hours (lanes 2). Positive tissues: adult mouse prostate (lane 3), testis
(lane 4), and kidney (lane 5) and negative controls: RT- testis sample (lane 6) and water (lane 7)
were included. L1 is O'GeneRuler 1 kb ladder and L2 is Bioline Hyperladder I, band sizes (bp)
are shown on the left of the figure. Expression of GAPDH mRNA (288 bp) in the same samples
is included as a control.
3.3.4.2 ERE-luciferase reporter assay
SKI 1 cells were infected with an adenovirus containing an ERE-Tk-luc construct to
determine whether they expressed a functional ER|3 protein.
3.3.4.2.1 Time course
Luciferase protein expression was quantified (Figure 3-23) in SKI 1 cells infected with
the viral ERE and incubated with media ± the antioestrogen ICI 182,780 (ICI), DMSO,
E2 (lxlO"8 or lxlO"7 M) ± ICI or DES (10"8 M) for 12 to 48 hours. Luciferase
expression was standardised to expression in cells incubated in media plus ICI for 12
hours and all changes were within 3-fold of this expression. Statistical analysis, by 2-
way AVOVA, reveals that there was a significant difference in expression between time
points (p=0.005) and that oestrogen treatment altered luciferase expression significantly
(p=0.01). The increase in expression observed after incubation of cells with E2 was less
dramatic than in response to DES, and similar to that of cells treated with the DMSO
vehicle control. The impact of E2 on receptor gene expression was inhibited by
inclusion of ICI with the oestrogen, reducing expression to a level similar to that in cells
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incubated with media plus ICI. Luciferase expression was highest at 24 hours and effect






Figure 3-23: Luciferase expression in SK11 cells infected with ERE-Tk-Luc viral construct
and treated with oestrogenic ligands in the presence or absence of ICI 182,780 (ICI). Cells
were incubated for 12 (blue), 24 (red), 36 (purple) or 48 hours (green). Cells were cultured at
39°C for 48 hours prior to and for the duration of the experiment. All values are relative to Luc
expression in SK11 cells cultured for 12 hours in media + ICI. Bars represent the mean Luc
expression ± SEM based on n=3 experiments. A 2-way ANOVA demonstrated that both steroid
treatments and duration of treatment significantly alter oestrogen response element activation
(p= 0.01 and p= 0.005, respectively).
3.3.4.2.2 Ligands ± ICI
The cell treatments described in section 3.3.4.2.1 demonstrated that SKI 1 cells were
capable of responding to oestrogens (E2 and DES), that this response was inhibited by
ICI 182,780, and that 24 hours is a suitable time point at which to investigate oestrogen
response in SKI 1 cells. The range of oestrogens and the concentrations at which they
were used was broadened to identify the optimum oestrogen treatment. Figure 3-24
shows expression of luciferase protein in SKI 1 cells incubated for 24 hours with media,
DMSO, ethanol, E2, Adiol and DES, all treatments were also duplicated with the
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addition of 1 (J,M ICI. Expression was standardised to expression in cells incubated with
media plus ICI, and over 2-fold expression was seen in some samples. Reporter gene
activation was highest in cells treated with E2 at concentrations between lxlO9 and
lxlCT7 M, but all these ligands were able to increase the amount of luciferase.
Expression of luciferase was inhibited by inclusion of ICI. Statistical analysis of the
data by 2-way ANOVA shows that overall oestrogen treatment and ICI treatment
significantly affected luciferase expression (both p<0.0001) and that these 2 factors had
a significant interaction (p=0.003). Specifically the Bonferoni post-hoc analysis showed
that luciferase expression was significantly greater in cells incubated with E2 at lxlO9
M (p<0.001), lxlO"8 M (p<0.01) and lxlO"7 M (p<0.05) compared to cells incubated in
media ± ICI. The inhibition of luciferase expression by ICI was significant in cells
cultured with E2 at lxlO"9 M (p<0.001), lxlCT8 M (p<0.01) and lxlO7 M (p<0.05) and
Adiol at lxlO"7 M (p<0.05).



















Figure 3-24: Luciferase expression in SK11 cells infected with ERE-Tk-Luc viral construct
and treated with oestrogenic ligands in the absence (blue) or presence (red) of ICI 182,780
for 24 hours. Cells were cultured at 39°C for 48 hours prior to and for the duration of the
experiment. All values are relative to Luc expression in SK11 cells cultured in media + ICI. Bars
represent the mean Luc expression ± SEM, based on n=3 runs. Analysis by 2-way ANOVA
shows that steroid and ICI treatment significantly affect activation of the oestrogen response
element (p=0.0009 and p<0.0001 respectively). Steroid and ICI treatment interacted
significantly to alter ERE activation (p=0.003). * = p<0.05, ** = p<0.01, *** = p<0.001.
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3.4 Discussion
The SKI 1 cells are an immortalised SC line derived from 10 day old mouse testes, these
cells have been assessed in terms of their gene and protein expression in a limited
number of papers (Sneddon et al., 2005; Walther et al., 1996; Walther et al., 1997). In
these papers it was reported that they expressed mRNA and protein for both AR and
ER(3, and are able to stimulate expression of reporter gene constructs in response to
androgens and oestrogens (Sneddon et al., 2005; Walther et al., 1996). To further our
understanding of the SKI 1 cells' properties and to investigate expression of SC products
with potential roles in control of spermatogenesis in response to steroid signals the
studies discussed below were undertaken. The studies include further characterisation
and comparison of gene and protein expression with that of immature and adult mouse
SC, and assessment of androgen and oestrogen responsiveness of the SKI 1 cells.
3.4.1 Characterisation
Immunohistochemistry was performed on testes of day 10 and adult mice to assess the
expression ofAR, SGP-2 and Sdmg-1. These three proteins are expressed by mature SC
and it was important to assess their expression in these and day 10 SC for comparison
with the SKI 1 cells, which are derived from day 10 mice. The structure of the tubules
within the day 10 testes was different to that of the adults, as described in the results
section, briefly the tubules at day 10 lacked a distinct lumen and the nuclei of the SC
were located away from the periphery of the tubules, approximately half way to the
centre. This is in contrast to adult testes in which a distinct lumen is present and SC
nuclei are located closer to the basement membrane of each tubule although the absolute
shape and position of adult SC is stage-dependent. Sertoli cells express AR, SGP-2 and
Sdmg-1 in both adult and day 10 mice, and whilst expression of Sdmg-1 is uniformly
expressed in all tubules at both ages, the pattern of expression of AR and SGP-2 exhibit
subtle differences between ages. In adult testes AR and SGP-2 expression in SC varies
between tubules at different stages of the spermatogenic cycle, in day 10 tubules a full
germ cell complement is not present, and SC in all tubules express AR and SGP-2 with
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equal intensities. Expression of AR was also detected in nuclei of LC and PTM in the
interstitium of testes at both ages. The stage specific AR expression observed in the
adult SC, in addition to expression in LC and PTM cells, is consistent with the pattern of
AR expression reported in previous rodent studies (Bremner et ah, 1994; Tan et al.,
2005; Zhou et al., 2002). The detection of AR expression in the dlO testis is in
agreement with previous investigations in which AR expression was first detected in SC
at 8 days post-partum (Tan et al., 2005). The expression of SGP-2 at both day 10 and in
adult testes is in agreement with previous in vivo studies, as is the stage-dependent
variation in expression in adult tubules (Tan et al., 2005).
To investigate the phenotype of the SKI 1 cells, the expression of mRNA and proteins
characteristic of SC were assessed in SKI 1 cells cultured at permissive and non-
permissive temperatures and compared to expression in mouse testes. Using semi¬
quantitative RT-PCR expression of SGP-1 mRNA appeared to be higher in SKI 1 cells
cultured at the non-permissive temperature over that in SK11 cells in permissive
conditions. The expression ofSGP-2 mRNA exhibited a similar pattern with very weak
expression in SK11 cells at the permissive temperature and strong expression in cells
cultured at the non-permissive temperature. These results were extended by Taqman
quantitative-PCR for SGP-2. Expression of SGP-1 and -2 were increased in mature
testes compared to immature, although total SC mRNA was diluted by that of GCs
expression of SGP-1 and -2 change in a similar manner when SC mature in vivo and
when SKI 1 cells change from their proliferative to senescent 'differentiated' state. The
increase in SGP-2 mRNA in non-proliferative SKI 1 cells appeared to be paralleled by
an increase in total protein detected by Western, however the change was not significant.
In contrast expression of Sdmg-1 protein appeared similar in SK11 cells at 34°C and
39°C suggesting this protein is not affected by the differentiated states of the SC.
In the current experiments, assessment of AR mRNA and protein expression between
cells cultured under permissive and non-permissive conditions did not detect any
significant change in AR expression. The low AR mRNA in SKI 1 cells at both
Chapter 3 Gene expression using an immortalised Sertoli cell line 138
permissive and non-permissive temperatures and low intensity of protein detected in
Western analysis suggest the SK11 cells used in these studies expressed AR poorly.
Immunohistochemistry did not detect any obvious difference in androgen receptor
expression in SC nuclei of testes from day 10 and adult mice, with the only apparent
difference being stage-specific expression in adults that was absent in the immature
testes. Absence of changes in the amount of AR mRNA in SKI 1 cells between culture
temperatures are in contrast to previous findings using SKI 1 cells where AR expression
was increased in cell cultured under non-permissive conditions (Sneddon et al., 2005)
and whilst it is difficult to compare experiments undertaken many years apart it is
possible that extended use of this cell line and repeated passage may have resulted in
selective loss ofAR.
However the SKI 1 cells had clearly retained a number of characteristics associated with
SC function. For example, compared to those at permissive temperatures, SKI 1 cells
cultured under non-permissive conditions express higher SGP-1, SGP-2, and Rhox5
mRNA levels, and have significantly increased protein expression of Rhox5. Previous
studies have already investigated the expression of mRNAs including SGP-1 and -2 in
SK11 cells. An increase in SGP-2 mRNA expression under non-permissive conditions
was first reported by Walther et al. (1996) and in the present study these results have
been extended by Taqman quantitative RT-PCR and Western blotting. A previous study
reported that SGP-1 mRNA expression was similar at permissive and non-permissive
temperatures (Sneddon et ah, 2005) and although a marginal increase in SGP-1 mRNA
was detected using semi-quantitative PCR reactions, this was not confirmed using any
other method so not too much emphasis should be placed on this result.
Data in this chapter demonstrate that SK11 cells express Sdmg-1, a gene first identified
in fetal SC (Best et ah, 2008), Rhox5, an androgen responsive gene expressed in SC and
epididymis in the male reproductive tract (Lindsey and Wilkinson, 1996a; Lindsey and
Wilkinson, 1996b), and mRNAs for claudin3 and 11 whose proteins localise to the tight
junctions between adjacent SC (Meng et ah, 2005; Morita et ah, 1999). Sdmg-1 protein
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has been implicated in protein secretory pathways in fetal SC (Best et al., 2008), and
interestingly a similar level of protein expression is maintained whether SKI 1 cells are
cultured at 34°C or 39°C. Recent in vitro studies of Sdmg-1 used SKI 1 cells and
reported that the protein localised to the endosomal compartment and demonstrated its
role in secretory pathways (Best et al., 2008). Expression of Rhox5 mRNA was
significantly greater in SKI 1 cells incubated at 39°C compared to those at 34°C, and is
in line with Rhox5 mRNA first being detected in SC of mice 9 days post-partum. In
adult mice Rhox5 expression is most intense in SC of stage VII and VIII tubules (Rao et
al., 2003).
3.4.2 Androgen responsiveness of SK11 cells
Previous studies have demonstrated that SKI 1 cells at 34°C contain low levels of
functional AR using a luciferase reporter gene driven by the proximal Rhox5 promoter
(Sneddon et al., 2005). However endogenous gene expression has not been explored
previously. The impact of androgen (testosterone or DHT) treatment on SGP-2, AR and
Rhox5 mRNAs and on Rhox5 protein expression was assessed, in SKI 1 cells at both
permissive and non-permissive conditions. Based on studies using in vivo models the
expression of SGP-2 mRNA was not expected to be androgen-responsive (McKinnell
and Sharpe, 1995; Turner et al., 2001), and no change in expression in the cells was
detected. SK11 cells at both permissive and non-permissive temperatures showed
erratic expression of AR mRNA which was not increased by androgen treatment at any
dose. From the evidence of previous studies, expression of AR protein appears to be
androgen responsive, for example treatment of immature SC in vitro with testosterone or
DHT results in increased androgen-binding (Verhoeven and Caillaeu, 1988). In rat
testes subjected to androgen-depletion by EDS-treatment AR protein expression detected
by immunohistochemistry is rapidly restored by testosterone ester treatment (Atanassova
et al., 2006; Bremner et al., 1994; Turner et al., 2001). Rhox5 has also been studied
extensively as an androgen responsive gene expressed within SC in vivo and in vitro
(Lindsey and Wilkinson, 1996b; Maclean et al., 2005), differential expression of Rhox5
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between SCARKO and control mouse testes has been identified in recent studies (De
Gendt et ah, 2004; Denolet et al., 2006a). In this study treatment of SK11 cells with
androgens in permissive and non-permissive conditions unexpectedly did not increase
Rhox5 mRNA or protein expression significantly. Lack of androgen response in SK11
cells may be due to the very low expression of AR mRNA discussed above, and as a
consequence low functional AR protein levels that prevent AR mediated responses.
Due to the absence of androgen response in two well defined androgen-responsive
genes, AR and Rhox5, the cause/s of the poor responsiveness of the SKI 1 cells was
further investigated. SKI 1 cells were transfected with mouse AR plasmid to determine
whether the SK11 cells were unable to support expression of functional AR protein.
Transfected cells expressed significant quantities of AR mRNA and showed a dose-
response between quantity of plasmid DNA introduced and amount of mRNA
transcribed. The introduction of AR plasmid also resulted in translation of AR protein
with dose-response seen between plasmid DNA introduced and amount of AR protein
generated. These results show that the SKI 1 cells maintained the capacity to express the
AR transgene and to generate AR protein. The AR protein also maintains a property of
AR identified in previous studies, its structure is stabilised following androgen binding
and is therefore more readily detected in techniques where it is identified using
antibodies, such as Western blots and immunohistochemistry (Saunders et al., 1996;
Zhou et al., 1995). Stabilisation of AR by androgens suggests that the protein expressed
by SKI 1 cells is functional and this was further investigated using a reporter gene assay.
If a loss of AR expression was the only deficiency to androgen signalling in SKI 1 cells
then transfection of cells with an appropriate quantity ofmouse AR plasmid would allow
increased expression of androgen-responsive genes in the presence of androgenic
ligands. The capacity of SKI 1 cells transfected with the exogenous AR plasmid, to
activate a well defined androgen-response element was tested by co-transfection of cells
with the proximal Rhox5 promoter linked to a luciferase reporter (Sneddon et al., 2005).
This experiment showed that transfection of SKI 1 cells with mouse AR plasmid alone
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was sufficient to enable the cells to stimulate the ARE containing promoter in the
presence of androgens, demonstrating that SKI 1 cells were capable of expressing
functional AR protein that can dimerise in the presence of androgens. The study also
identified 1x10"9M DHT as the most effective dose for activation of the Rhox5 response
element, inducing significantly greater levels of reporter expression than untreated cells
transfected with the same quantity of mAR plasmid. Stimulation of the same Rhox5-
luciferase construct was reported by Sneddon et al to be stimulated by DHT and
testosterone in SKI 1 cells, however the SKI 1 cells in that study did not require
transfection with AR plasmid prior to stimulation (Sneddon et al., 2005). In the previous
study, DHT concentrations of lxl0"7 and lxlO"6 M were required for maximum
stimulation of the promoter; however in the present study a much lower concentration of
lxlO9 M resulted in optimal stimulation. A lower androgen concentration may be
required as a consequence of higher concentrations ofAR following transfection.
Despite the observation that transfected cells were capable of stimulating expression of
luciferase linked directly to the Rhox5 proximal promoter in response to androgen-
treatment, they were unable to stimulate expression of endogenous Rhox5 mRNA whose
expression is reported to be controlled in SC through the same response elements
(Sutton et al., 1998). Even over expression ofAR protein using the highest quantities of
AR plasmid did not enable the cells to regulate expression of Rhox5 mRNA in response
to androgens. The mechanism for increased Rhox5 mRNA expression associated with
increased expression of AR following transfection regardless of androgen stimulation is
not clear. The amount of Rhox5 mRNA in SKI 1 cells was also investigated between 6
and 48 hours after androgen treatment but no significant increase over controls was
detected at any time point. Androgen treatment ofH/?-transfected SKI 1 cells also failed
to result in consistent stimulation of mRNA expression of previously identified
androgen-responsive tight junction proteins, claudin3 and claudinll (Denolet et al.,
2006a; Meng et al., 2005) compared with controls incubated without DHT.
-y
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The observation that SKI 1 cells incubated with DHT could stimulate an ARE-reporter
construct but not the expression of three endogenous androgen-responsive genes was
puzzling. The amount of AR detected in initial cultures of SKI 1 cells was expected to
be very low, but replacement of AR using a cDNA construct failed to result in altered
expression of Rhox5 in response to DHT. Secondly, in these cells derived from an
immature testis, there appears to be a deficiency in signalling capacity that does not
prevent expression from a promoter introduced by a plasmid vector, but is unable to
stimulate expression from the same promoter in a native conformation in the gene
promoter region. The loss of substantial AR expression and absence of endogenous
androgen-response when AR was re-introduced may both be due to phenotypic drift in
the SKI 1 cells due to the period of time over which the line has been maintained. They
might also provide insight into the differences in androgen-responsiveness of immature
versus adult SC.
3.4.3 Oestrogen responsiveness of SK11 cells
In addition to investigating androgen-response in SKI l cells, the capacity of these cells
to respond to oestrogens was also explored. Expression of ER/3 mRNA was detected in
SKI 1 cells cultured at permissive and non-permissive temperatures; expression was
modest - similar levels of expression were identified in mouse testes, prostate and
kidney; and did not appear to be altered by culture conditions. The detection of ER/3
mRNA in SKI 1 cells is in agreement with previous studies which have identified
expression in the same cell-line (Sneddon et al., 2005), and with in vivo studies which
detected ER/3 mRNA and protein in SC ofmice and rats (Saunders et al., 1997; van Pelt
et al., 1999; Zhou et al., 2002). Identification of modest ER/3 mRNA in the cells
suggested they might maintain the capacity to respond to oestrogen-treatment, as
described in a previous study (Sneddon et al., 2005).
The SKI 1 cells were able to induced expression of a luciferase reporter construct linked
to three EREs in tandem in response to oestradiol (E2), diethylstilbestrol (DES) and 3P-
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Adiol, at concentrations between 1 x 10~12 and 1 x 10~7 M, without the need for
transfection with an ERfl plasmid. The expression of the reporter was specific for the
action of oestrogens via ER(3 because expression of the reporter was prevented by pre-
treatment of cells with the oestrogen receptor antagonist, ICI 182,780 (Tremblay et al.,
1997). Studies showed that the greatest responses to oestrogen treatment occurred 24
hours after the start of incubation, and that E2 was the most active of the 3 ligands. A
dose of 1 xlO"9 M was the optimum E2 concentration to use. Reporter gene expression
was dose-responsive in the presence of all 3 ligands, and in all cases the responses were
blocked by pre-incubation with ICI 182,780. In previous studies on SK11 cells'
oestrogen response, maximal response to E2 treatment, at 1 x 10"7 M, caused reporter
expression to rise to ~4.5 times that in untreated control cells (Sneddon et ah, 2005),
however in this study maximum reporter expression reached less than 3-fold.
Unfortunately at this time no genes have been identified as candidates for oestrogen
responsiveness in SC, and therefore it has not been possible to study endogenous gene
expression in response to oestrogen treatment, as has been done for androgen responsive
genes.
3.4.4 Conclusions
The SK11 SC line used in this study has been characterised and used in previous
investigations, which have demonstrated changes in the cells phenotype when cultured
at permissive (~34°C) and non-permissive temperatures (>39°C) (Sneddon et al., 2005;
Walther et al., 1996; Walther et al., 1997). In the course of the studies presented in this
chapter the changes previously reported were confirmed (apart from the raised AR
expression at 39°C), and the gene and protein expression of SK11 cells in permissive
and non-permissive conditions were compared to the properties of immature day 10
mouse SC and adult mouse SC. The SKI 1 cells cultured in permissive conditions were
found to be an approximation of immature SC, whilst non-permissive conditions shifted
the SKI 1 cells towards a more differentiated, adult phenotype. SK11 cells have
previously been shown to express AR and ERfi mRNA and protein, plus be capable of
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responding to androgens and oestrogens (Sneddon et al., 2005). However in this study,
only the oestrogen response as measured by its ability to activate a reporter construct
could be demonstrated in unmanipulated SK11 cells. To achieve response to androgen
treatments the SKI 1 cells required transfection with mouse AR plasmid so that
substantial expression ofAR mRNA and protein occurred. Transfected SKI 1 cells were
able to stimulate expression of a luciferase reporter linked directly to the Rhox5
promoter, but were still unable to stimulate endogenous androgen-responsive genes
including Rhox5. As a consequence, it was not possible to use SKI 1 cells to confirm the
putative androgen-responsiveness of the genes identified in previous array analysis
(Denolet et al., 2006a). The causes of this deficient androgen response need to be
investigated. Alternative models for investigating androgen-dependent effects on
spermatogenesis via SC are required, examples include testis explants or in vivo
experimental models, such as those discussed in the following chapters. Alternatively
the loss of androgen-response may be indicative of a drift in cell phenotype caused by
the length of time the cell-line has been maintained in culture. If this is the case, SKI 1
cells from earlier passages or another source may have retained androgen-
responsiveness and could be used in future studies. The current SKI 1 cells still
maintained the capacity to respond to oestrogens and mean further studies might aid in
identification of oestrogen-responsive genes.
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4 Targeting of gene expression to Sertoli cells using
adenoviral constructs in vivo
4.1 Introduction
Each SC is associated with, and supports the development of, numerous germ cells so
the SC population is many times smaller than that of the GC. Although SC are in a
minority, they play an essential role in supporting the functional maturation of the GC
through spermatogenesis, as described in chapter 1. For example, the necessity for
androgen action, and therefore the expression of AR, in SC for successful
spermatogenesis has been elucidated by De Gendt et al and Chang et al. (Chang et al.,
2004; De Gendt et al., 2004) both of whom generated transgenic mice (SCARKO) with
SC-specific ablation of AR. In adult SCARKO mice germ cells failed to mature
normally and only 3% completed meiotic prophase to form round spermatids; the
androgen-dependent processes in SC that support GC development have not yet been
identified.
In chapter 3, an in vitro cell model, the SKI 1 line, was used to investigate the response
of SC to both androgen and oestrogen signalling. Treatment of cells with steroid ligands
was able to induce reporter expression regulated by androgen and oestrogen responsive
elements. However, in vitro expression of endogenous Rhox5, an androgen responsive
gene of SC, was not enhanced in response to androgens which was in contrast to what
happens in SC within the seminiferous epithelium in vivo (De Gendt et al., 2004;
Lindsey and Wilkinson, 1996b; Tan et al., 2005). This result, in addition to loss of
steroid response in primary cultures of SC after 3-4 days (Denolet et al., 2006b),
supports the view that SC require association with GC to maintain a fully differentiated
phenotype (Syed and Hecht, 1997).
Studies have confirmed the importance of AR and ER(3 in reproductive function, total
ablation of AR results in a female phenotype including failure of testes to descend
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(cryptochidism) (Lyon and Hawkes, 1970) and male mice lacking ER(3 display abnormal
mating behaviour (Temple et al., 2003). Cell specific knockouts of steroid receptors can
be very valuable, and a method for knocking out AR specifically in SC using CRE-
recombinase driven by the AMH promoter has been described (Chang et ah, 2004; De
Gendt et ah, 2004). However this method requires that mice with a floxed allele of the
gene of interest be available plus breeding and validation can be very time consuming
and expensive as two lines ofmice are required.
In place of establishing lines of transgenic mice using the Cre-lox method, due to the
drawbacks outlined above alternative strategies were considered for ablating gene
products specifically within SC. Introduction of constructs expressing short interfering
RNA (siRNAs) specifically into SC as a way of reducing expression of target mRNAs
was considered a viable option as a number of methods had been described that might
allow us to achieve this. For example, expression of a RNAi could be achieved by
introducing a construct containing a SC-specific promoter that regulated the expression
of a short hairpin (shRNA) or microRNA (miRNA), into mouse pronuclei to which were
then used to generate transgenic mice. Rao et ah (Rao et ah, 2006) succeeded in
reducing expression of WT-1 specifically in the SC of mice by this method using a
transgene consisting of a hairpin-loop targeting WT-1, under the control of the proximal
Rhox5 promoter. As an alternative to generating a transgenic line of mice expressing a
RNAi construct we considered the potential that it could be introduced directly into the
SC by infection of the cells with an adenoviral vector containing an appropriate
construct (e.g. Rhox5 promoter driven miRNA). Previous studies have reported the use
of adenoviral vectors to introduce transgenes, including those expressing CREB, LacZ or
Steel factor (kit ligand), into SC both in vitro and in vivo resulting in efficient expression
(Blanchard and Boekelheide, 1997; Kanatsu-Shinohara et ah, 2002; Scobey et ah, 2001).
In co-cultures of SC and GC, as well as in vivo studies in whole testes, GC have been
shown to be resistant to infection by adenoviruses even at high concentrations
(Blanchard and Boekelheide, 1997; Scobey et ah, 2001). In study outlined in this study
expression of the viral transgene was associated with specific stages at different time
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points after infection, suggesting that adenoviral vectors predominantly infect SC at
stages II-IV in rats (Blanchard and Boekelheide, 1997). It has been reported that SC-
specific expression of transgenes introduced using adenoviral vectors was achieved
without significant immune response when the vector was introduced by injection via
the efferent ductules/rete testis or by a direct intra-tubular route. Limited immune cell
(lymphocytes, plasma cells or myeloid cells) infiltration of injected tissues was
identified when routes via the rete testis were used (Blanchard and Boekelheide, 1997;
Kanatsu-Shinohara et al., 2002; Scobey et al., 2001). In the present study intra-tubular
injection of adenoviral vectors via the efferent ductules was used both because of reports
of only limit immune response and the presence of an established method of efferent
duct injection previously used for GC-transplantation studies within the laboratory.
4.1.1 Aims
To establish methods for infection of mouse SC with adenoviral vectors expressing
reporter constructs both in vitro and in vivo. In addition, to determine whether infection
with adenoviral constructs has any impact on testicular function and to use adenoviral
vectors to introduce RNAi constructs specifically into SC in vivo.
Chapter 4 Gene expression in Sertoli cells using adenoviral constructs 148
4.2 Materials and methods
4.2.1 Virus preparation
Three recombinant adenoviral constructs were used; these expressed /3-galactosidase,
green fluorescent protein (GFP), or had no insert. High titre stocks (1.3xl010 -
1.66x10'° plaque forming units (pfu)/ml) of viral particles were prepared for each
construct as described in section 2.6. Expression of [3-galactosidase was controlled by a
cytomegalovirus immediate early (CMV IE) promoter (RAD35) (Wilkinson and Akrigg,
1992) and the negative control contained a CMV IE promoter but no downstream
reporter (RAD60); both constructs were kind gifts from Professor AH Baker (British
Heart Foundation, Glasgow Cardiovascular Research Centre, Glasgow, UK). The GFP
construct was an Ad-CMV-GFP construct purchased from Vector Biolabs, (Philadelphia,
PA, USA).
4.2.2 In vitro infection
SKI 1 cells were cultured at 34°C and 39°C, 5% CO2, in 'complete' phenol-red free
media, as described in section 2.2. Cells were seeded at lxl05 cells/well in 12-well
plates for 48 hours prior to infection with the adenoviral /3-galactosidase, GFP or
RAD60 constructs. For the initial titration experiments expression of reporter constructs
and proportions of live and dead cells were determined using the Ad-p-galactosidase
construct at MOIs between 10 and 250. Thereafter the three viral constructs were used
at MOIs within the range 50-100. When infecting cells with any of the viral constructs
the procedure was identical. All media was removed from the wells and replaced with
400 |il of fresh phenol red-free media, which was just enough to cover the surface of the
well. The viral stocks were diluted in phenol red-free media to deliver the appropriate
number of plaque forming units for each MOI (multiplicity of infection; number of
infective viral particles / cell) in a volume of 50 (ll/well. The cells were cultured with
the virus for 4 hours at 37°C in 5% CO2. The media and virus were removed and
replaced with phenol red-free media and cells were cultured for a further 96 hours, in
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5% CO2, at 34°C or 39°C. After 96 hours incubation expression of GFP or [3-
galactosidase protein expression was determined and images collected as below.
4.2.2.1 Time Course of Infection
In addition to the studies above SK11 cells were also infected for 4, 6, 8, 12, 24 or 48
hours with the GFP adenoviral construct. After infection the cells were used in RNA
extractions (section 2.3.1), and Q-RT-PCR was carried out for interleukins -6 (section
4.2.6). RNA from SKI 1 cells not infected with viral particles was collected at each time
point in parallel with the samples from the infected cells, and were used as controls. The
media in which the cells were incubated was collected at each time point and used in
ELISAs for inteleukins -6 (section 4.2.9).
4.2.2.2 [3-galactosidase staining
Media was removed, cells were washed with PBS and 1ml LacZ fixation solution (2%
formaldehyde (VWR) and 0.2% glutaraldehyde (VWR) diluted in sterile PBS) was
added to each well for 5 minutes at room temperature. The fixed cells were stained with
1 ml/well of staining solution containing X-gal (Invitrogen, Paisley, UK) overnight at
37°C (see below for constituents). Expression of the LacZ gene by infected cells
produces the enzyme (3-galactosidase which catalyses the production of 4-chloro-3-
brom-indigo, a blue precipitate, from the X-gal present in the staining solution (Figure
4-1). Staining solution was replaced with PBS the following day to allow staining to be
viewed and photographed (section 4.2.8)
X-Gal
(colorless)




Figure 4-1: P-galactosidase reaction.
http://www.fermentas.com/catalog/ reagents/x-gal.htm.
Taken from
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X-gal staining solution 0.5 M NaH2PC>4 23 ml
0.5 M Na2HP04 77 ml
Potassium ferrocyanide 1.06 g
Potassium ferricyanide 0.82 g
1% deoxycholate 5 ml
2% nonidet P-400 5 ml
1 M MgCl2 1 ml
The solution was made up to final volume of 500 ml with distilled water. X-gal was
added to the stain solution immediately prior to use; 1 mg X-gal dissolved in
dimethylformamide (100 mg/ml, BDH) was added per millilitre of the solution above.
4.2.3 Intra-testicular injection
4.2.3.1 Preparation of viral solutions
The three viral constructs (section 4.2.1) were diluted in sterile saline and 20% (v/v)
Trypan blue (0.08% w/v, Sigma) to a concentration equivalent to between 4xl08 and
1x10s pfu per 50 pi of solution. Table 4-1 shows the various doses prepared for each
viral construct:
Table 4-1: Doses of each adenoviral construct injected into mouse testes.
Construct
pfu/50pl
4xl08 lxlO7 1x10" 1x10s
GFP X X X X
P-galactosidase - - X -
RAD60 - - - X
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4.2.3.2 Surgery
Animal experimentation was performed under the conditions described in chapter 2
(section 2.1.1.). Male mice on a C57 BL/6 background were used throughout the study.
The procedures for intra-testicular injection were essentially those of Ogawa et al.
(Ogawa et al., 1997), and the surgical exposure of the reproductive tract and canulation
of the efferent ducts were performed by Dr. M. Paterson. Surgery was performed under
aseptic conditions with anaesthesia and analgesia. Deep anaesthesia was induced with
ketamine/medetomidine (intraperitoneal injections), analgesia was ensured by
administration of buprenorphine (subcutaneous injection) at the time of surgery.
An area of the abdomen over the left testis was shaved and sterilised with
chlorohexidine (Sigma) before a small incision was made in the abdomen and muscle
wall. The left testis and epidermis were withdrawn through the incision and
manipulated on a sterile swab, the testis and swab were kept moist with sterile saline at
all times. The efferent ducts were identified under a dissecting microscope and isolated
from surrounding connective tissue. A small incision was made in the efferent duct
close to the rete testis with a hypodermic needle providing access to canulate the duct
with a glass needle and glass micro-needle syringe. The needles were produced in-
house and had a diameter of 5 pm at the tip and were ground to a tapered point to aid
insertion into the duct. The virus/dye solution (section 4.2.3.1) was gently injected into
the seminiferous tubules up to a total volume of 50 pi and penetration of the blue dye
through the tubules was monitored. The testis and epididymis were returned to the
abdominal cavity and the muscle and skin layers were closed with internal and external
vicryl (Ethicon, Livingston, UK) sutures. Following surgery the sedative effect of
medetomidine was reversed with atipamezole to quickly revive the mice and they were
kept warm and observed frequently in the post-operative period.
The right testis in each of the animal on which surgery was performed remained
undisturbed as a paired-control for the injected testis. Both testes were recovered from
each animal 2, 4 or 7 days after surgery; recovery, fixation, and preparation for
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immunohistochemistry were performed by the methods described in sections 2.1.3 and
2.5.
4.2.4 Tunel assay for detection of apoptotic cells
Sections were stained using the in situ apoptosis detection (Tunel) assay to detect single
stranded DNA consistent with DNA breaks (Gavrieli et al., 1992) as follows. Sections
were dewaxed and rehydrated by standard methods (section 2.5.1) and blocked in 3%
hydrogen peroxide in methanol (section 2.5.2.2) for 30 minutes. Sections were washed
twice, for 5 minutes each, in PBS then placed on ice-cold trays to cool before addition of
50 (ll/section of TdT/Dig-11-dUTP reaction mixture. The reaction mixture consists of
400 U/ml terminal d-transferase (TdT, Roche) and 5 pl/ml ImM digoxigenin-11-deoxy-
uridine-5'-triphosphate (Dig-11-dUTP, Roche) diluted in reaction buffer (30 mM
TRIS/HC1 pH7.2 (Sigma), 140 mM sodium cacodylate (VWR international) and 1.5 mM
C0CI2 (VWR international) made up in dEEO. Reaction buffer was sealed on the slide
under a GelBond (Cambrex, Rockland, ME, USA) coverslip with cow gum/hexane, and
heated to 37°C for 30 minutes on a Hybaid Omnislide to enable incorporation of dUTP
by the TdT enzyme. The slides were washed twice for 5 minutes in PBS to remove the
reaction mixture, and then blocked with normal rabbit serum (NRS, dissolved 1 in 5 in
PBS) for 10 minutes at room temperature in humidified conditions. Blocking buffer was
replaced with sheep anti-Dig primary antibody (Roche) diluted 1:100 in NRS/PBS,
which was incubated for 90 minutes at room temperature in humidified conditions.
Sections were washed twice with PBS, 5 minutes each, and then incubated for 30
minutes with rabbit anti-sheep biotinylated antibody (Vector, Peterbourgh, UK) diluted
in NRS/TBS (1 in 5) at room temperature. After incubation with the secondary antibody
slides were washed in TBS twice for 5 minutes. The Tunel staining was visualised with
ABC-HRP and DAB and sections were counterstained, dehydrated and mounted as
described sections 2.5.2.7 and 2.5.2.8.
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4.2.5 Haemoxylin and Eosin (H&E)
Sections from both testes (one control and the other infected) of mice that underwent
intra-testicular injection were stained with H&E to reveal the general histology of the
testes as follows. Sections were dewaxed and rehydrated in xylene and a descending
series of graded ethanol baths as for immunohistochemistry (section 2.5.2). Rehydrated
sections were washed in haematoxylin for 5 minutes, staining was differentiated by
washing in acid-alcohol for up to 20 seconds to preferentially withdraw haematoxylin
from the cytoplasm and the stain was precipitated in the nuclei with Scott's tap water for
20 seconds. The cytoplasm of the sections was visualised by staining with eosin for 20
seconds. Between each stage of staining sections were washed in tap water. Once
stained with haematoxylin and eosin the sections were dehydrated in graded ethanol
baths and xylene and were mounted under glass coverslips with pertex, as described in
section 2.5.2.8.
4.2.6 Q-RT-PCR
Synthesis of cDNA from RNA recovered from SKI 1 cells infected with virus (section
4.2.2.1) was performed with random hexamer primers (section 2.3.3.1), and the TaqMan
PCR reaction for IL-6 was undertaken using the Roche Universal Human Probe
Library™ method (section 2.3.3.4). Results were analysed using uninfected SKI 1 cells,
cultured in parallel with the infected cells, as the control groups. The expression level in
uninfected cells at the 4-hour time point was taken as equal to 1. The primers and probe
used are shown in Table 4-2.
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4.2.7 Immunohistochemistry
Immunohistochemistry was performed on testis sections from virally infected mice
using antibodies raised against GFP, Caspase-3, HIF-la, smooth muscle actin, SDMG-1
and junctional proteins. The procedures were as described in section 2.5. Caspase-3 and
SDMG-1 were visualised with DAB staining using the standard protocol (section 2.5.2),
GFP and HIF-la using the Bond-X protocol and junctional proteins MPO, CD68 and
SMA by double fluorescent staining as described in section 2.5.3. The antibodies and
conditions used are shown in Table 4-3.
Table 4-3: Primary antibodies for immunohistochemistry.
Antigen Dilution Species raised in Source
DAB
caspase-3 1:200 Rabbit Cell Signalling
GFP 1:1000 Rabbit Molecular probes






CD68 1:50 mouse DAKO




MPO pre-diluted rabbit Abeam
SMA 1:500 mouse Sigma
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4.2.8 Imaging
Sections stained with DAB using the Bond-X machine, stained in the Tunel assay or
after staining with H&E were all visualised on an Olympus Provis microscope
(Olympus, Optical Co., London, UK) and images were captured with a Canon EOS 30D
(Canon Europe, Amsterdam) (section 2.5.4.1).
The expression of proteins introduced via transient transfection or adenoviral infection
into cell lines was also examined. Expression of LacZ was determined by staining for |3-
galactosidase enzyme activity (section 4.2.2.2) which was visualised using an Olympus
CK2 inverted microscope (Olympus, Middlesex, UK) and Nikon D1 digital SLR camera
(Nikon, Kingston-upon-Thames, Surrey, UK). In vitro expression of GFP (section
4.2.2) was visualised on an Axiovert 200M microscope (Zeiss). The appearance and
numbers of the cells following infections was determined using an inverted Olympus
CK2 microscope and photographic images were taken with a Nikon D1 digital SLR.
4.2.9 Interleukin ELISA
Media from cultures of SKI 1 cells infected with 100 MOI of the GFP adenoviral
construct were used in an ELISA for IL-6 (R&D systems). The assay was performed as
described in the manufacturer's protocol unless stated otherwise. The procedure was as
follows. A series of eight interleukin standard solutions, with concentrations between 0
pg/ml and 500 pg/ml, were prepared by serial dilution and a control sample with a
concentration within a known range was diluted as instructed. The wells of the ELISA
plates are pre-coated with the appropriate anti-interleukin antibody, and 50 |ll of assay
diluent was added to each well. A volume of sample (100 |ll), control (50 ul) or
standard solution (50 jll) were added to the assay diluent in each well, with control and
standards added to the plate in duplicate. The solutions were gently mixed and
incubated at room temperature for 2 hours. The wells were thoroughly washed five
times with wash buffer before addition of 100 |il mouse IL-6 conjugate that binds the
interleukins attached to the coated wells. The conjugate was incubated on the plate for 2
hours at room temperature then the wells were washed five times. Each well was
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incubated with 100 |ll of Substrate solution for 30 minutes at room temperature whilst
protected from light, after which 100 jllI of Stop solution was added to the Substrate
solution. The optical density of the solutions in each well was measured at 450 nm on a
Labsystem Multiskan EX, with a second reading at 540 nm used to correct for
imperfections in the plate. A standard curve of interleukin concentration against optical
density was plotted and the accuracy of the ELISA confirmed by accurately predicting
the interleukin concentration in the control sample within the range stated. The
concentration of interleukin within each sample was calculated from its optical density.
Chapter 4 Gene expression in Sertoli cells using adenoviral constructs 157
4.3 Results
4.3.1 Impact of viral infection on Sertoli cells in vitro
4.3.1.1 Viral infection at different MOI
Viral infection of SK11 cells cultured at 34°C was performed at MOI between 10 and
250, with adenoviral particles containing a LacZ construct. The LacZ expression
detected by staining for (3-galactosidase activity is shown in Figure 4-2. No [3-
galactosidase was detected in uninfected cells, after infection with 10 MOI (3-
galactosidase expression was very weak. Intense uniform (3-galactosidase activity was
detected after infection with 25 and 50 MOI. The amount of cell detachment, associated
with disturbance of the cell and death, witnessed in these wells was negligible as
complete coverage of the wells' surfaces was still observed. At the highest MOIs used
(100 and 250) although intense reaction product was detected there was a dramatic loss
of cell from the surface of each well (Figure 4-2, panels E and F).
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Figure 4-2: Cell survival of SK11 cells infected with a LacZ adenoviral construct at MOIs
between 0 and 250. SK11 cells were cultured at 34°C for 96 hours following infection before
expression of [3-galactosidase was visualised by X-gal staining. SK11 cells were infected at the
following MOIs: 0 (A), 10 (B), 25 (C), 50 (D), 100 (E), and 250 (F).
4.3.1.2 Comparison of LacZ and GFP viral constructs
SKI 1 cells cultured at 34°C were infected with adenoviral GFP and LacZ constructs for
4 hours and incubated for a further 96 hours before protein expression was assessed by
fluorescent microscopy or X-gal staining, respectively (Figure 4-3). Cells were infected
with MOIs between 0 and 100, no endogenous expression was seen at 0 MOI.
Expression of reporter constructs was detected but low at 50 MOI for both constructs,
expression was greater for both constructs at higher MOI. The expression of GFP
peaked at 85-100 MOI with a large rise in expression seen between 75 and 85 MOI.
Staining for LacZ reporter expression was present in a greater proportion of cells at 60
and 75 MOI than at the same MOI in GFP infected cells, and the peak P-galactosidase
expression was observed following infection at 85 and 100 MOI. Cell density observed
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following infection with the LacZ construct at 100 MOI was reduced compared to 85




Figure 4-3: Expression of GFP (panels A-F) or p-galactosidase (panels G-L) reporter
constructs following incubation with adenovirus constructs. SK11 cells were incubated at
MOI 0 (panel A and G), 50 (panels B and H), 60 (panels C and I), 75 (panels D and J), 85
(panels E and K), and 100 (panels F and L) for 4 hours, and reporter expression was visualised
after 96 hours.
4.3.1.3 Impact on cell survival
Adenoviral particles containing LacZ or GFP constructs, or the RAD60 virus which had
no insert, each used to infect SKI 1 cells at between 50 and 100 MOI with each viral
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construct. Cell densities 96 hours after infection are shown in Figure 4-4. There was a
decline in the number of cells present with increasing MOI for all three viral constructs,
and there was not a significant difference in cell loss between constructs at each MOI.
In spite of the results in section 4.3.1.1 there was cell loss between the control (0 MOI)
and infection at 50 MOI, but the loss was less acute than at 75 and 100 MOI.
GFP LacZ Rad60
Figure 4-4: Densities of SK11 cells 96 hours after infection with GFP (A, D, G, and J), LacZ
(B, E, H, and K), or RAD60 (C, F, I, and L) adenoviral constructs at a range of MOIs. SK11
cells were infected at MOIs of 0 (A-C), 50 (D-F), 75 (G-l), and 100 (J-L). Images are at 20x
magnification.
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4.3.1.4 IL-6 production
The capacity of SKI 1 cells to produce interleukin-6 in response to infection by the GFP
adenoviral construct was assessed. SKI 1 cells were cultured at 34°C and 39°C for 4 to
48 hours with 100 MOI adenovirus; IL-6 protein secreted into the culture media was
measured by ELISA (Figure 4-6), and expression of IL-6 mRNA (Figure 4-5) was
assessed by Q-RT-PCR. The amount of IL-6 protein progressively accumulated in the
culture media over 48 hours and SKI 1 cells cultured at 39°C produced significantly
more IL-6 than cells cultured at 34°C. Despite the difference in IL-6 protein expression
between temperatures, infection by adenovirus was not associated with an increased
secretion of IL-6 at either temperature.
4 6 8 12 24 48
Figure 4-5: Expression of IL-6 mRNA following culture of SK11 cells in the absence (blue
and green bars) and presence (red and purple bars) of GFP-adenoviral constructs, at MOI
100. Cells were cultured for 4-48 hrs at 34°C (blue and purple bars) and 39°C (green and red
bars). Expression was standardised to that in SK11 cells cultured at 34°C for 4 hours in the
absence of adenovirus. Two-way ANOVA demonstrated that time and treatment both
significantly affected IL-6 expression (p=0.0003 and p=0.02 respectively), these two factors also
interact significantly (p=0.001).













4 6 8 12 24 48
Figure 4-6: Expression of IL-6 following culture of SK11 cells in the absence (blue and
green bars) and presence (red and purple bars) of GFP-adenoviral constructs, at MOI 100.
Cells were cultured for 4-48 hrs at 34°C (blue and purple bars) and 39°C (green and red bars).
IL-6 secretion was quantified through an ELISA performed on culture media. Two-way ANOVA
demonstrated that time and treatment (plus interaction between these 2 factors) both
significantly (p < 0.0001) affected IL-6 expression.
4.3.2 Impact of adenoviral infection on Sertoli cell function in vivo
4.3.2.1 Immunolocalisation of GFP demonstrates Sertoli cell specific
infection
Expression of the GFP following intra-testicular injection was detected by
immunohistochemistry Figure 4-7. Expression was Sertoli cell-specific and the intensity
of immunostaining was influenced by the quantity of plaque forming viral particles
o
introduced into the testis. Expression in testes injected with 4x10' pfu (panels A and B)
was the most intense, but cell-specific expression was hard to determine due to the
disrupted tubule structure. In testes infected with lxlO7 pfu per testis (panels B and C)
GFP staining was less intense than in panels A or B, but was more obviously SC-
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specific. In testes infected with lxlO6 pfu per testis GFP expression was SC-specific but
much weaker and the intensity of staining was reduced even further at lxlO5 pfu per
testis. Uninfected testes were immunonegative (panel I).
Within the injected testes only a limited number of tubules were immunopositive for
GFP expression, even at the two highest doses of virus. Expression of GFP was
associated with disturbance of tubule architecture, but many apparently damaged tubules
did not exhibit staining for GFP. Even when disrupted tubules were in close proximity
to a heavily stained tubule they did not necessarily express GFP (panels C and D); and at
lower viral doses despite damage to the tubules, infection was often not sufficient for
detectable GFP expression within the testis (panels G and H).
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Figure 4-7: Immunological staining of GFP expression in mouse testes infected with a
GFP adenoviral construct at a range of doses. Seminiferous tubules of the testes were
specifically infected by intra-testicular injection. Testes were collected 4 days after infection
except for those in panel A (3 days) and panel B (7 days). The doses of virus given per testis
were: 4x108 pfu (A and B), 1x107 pfu (C and D), 1x10® pfu (E and F), 1x105 pfu (G and H). The
untreated contralateral testis from the same animal as the testis in panel A is shown as a control
in panel I. Images are 40x magnification and the scale bar represents 50 pm.
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4.3.2.2 Impact of viral infection on testicular architecture
4.3.2.2.1 Haematoxylin and eosin
Sections from the testes infected with between lxlO4 and 4xl08 pfu per testis were
stained with H&E and are shown in Figure 4-8 (x20) and Figure 4-9 (xlOO). The
structure of the tubules in sections from testes infected with 4x10 pfu/testis was
severely disrupted at both 3 days (A) and 7 days (B) post infection notably, the lumen
was absent and GCs were displaced or absent. At both time points, elongated
spermatids were lost and cells were present in the interstial and seminiferous tubules that
resembled immune cells, specifically neutrophils and lymphocytes (marked with arrows
in panel B of both figures). Disruption of structures was significantly worse in the testis
collected 7 days (panel B) after infection and identification of GCs was impossible due
to the scale of disruption and invasion.
In sections from testes infected with lower viral concentrations (lxlO5 - lxlO7 pfu/testis)
overall tubular architecture was present, a lumen was visible and GCs could be
identified. However within the seminiferous epithelium 'vacuoles' appeared (indicated
by arrows in panels C-H in Figure 4-8 and Figure 4-9). Preliminary analysis suggests
that a significant proportion of the population of pachytene spermatocytes were missing
from the tubules and that the spaces created by this GC loss accounted for the
'vacuoles'.
At the three lowest doses of adenovirus not all seminiferous tubules were disrupted
within the infected testes. Both disrupted and normal tubules were found in close
proximity within sections, the normal tubules were indistinguishable from tubules of
uninfected testes.
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Figure 4-8: Haemoxylin and Eosin staining of adult mouse testes infected with a GFP
adenoviral construct at a range of doses. Seminiferous tubules of the testes were specifically
infected by intra-testicular injection. Testes were collected 4 days after infection except for those
in panels A and I (3 days) and panel B (7 days). The doses of virus given per testis were: 4x108
pfu (A and B), 1x107 pfu (C and D), 1x106 pfu (E and F), 1x105 pfu (G and H). Arrow in panel B
indicates a tubuie that has been invaded by an unidentified population of cells. The arrows in
panels C-H indicate sites of damage associated with infection with adenovirus. The untreated
contralateral testis from the same animal as the testis in panel A is shown as a control in panel I.
Images are 20x magnification and the scale bar represents 100 pm.
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Figure 4-9: Haemoxylin and Eosin staining of adult mouse testes infected with a GFP
adenoviral construct at a range of doses. Seminiferous tubules of the testes were specifically
infected by intra-testicular injection. Testes were collected 4 days after infection except for those
in panels A and I (3 days) and panel B (7 days). The doses of virus given per testis were: 4x108
pfu (A and B), 1x107 pfu (C and D), 1x10® pfu (E and F), 1x105 pfu (G and H). Arrows in panel B
indicate potential immune cells, neutrophil (top arrow) and lymphocyte (bottom arrow), that have
invaded the tubule. The arrows in panels C-H indicate sites of damage associated with infection
with adenovirus. The untreated contralateral testis from the same animal as the testis in panel A
is shown as a control in panel I. Images are 100x magnification and the scale bar represents 20
pm.
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4.3.2.2.2 Stage specific germ cell loss
Following the observation that pachytene spermatocytes were lost from infected tubules,
leaving vacuoles in the seminiferous epithelium, the stages of the spermatogenic cycle at
which these losses occur were determined using H&E stained sections. A survey of
tubules with GC loss and vacuoles was carried out on testes infected at lxlO6 and lxlO7
pfu per testis. Vacuoles and associated loss of GC were observed in tubules at stages II-
VI and IX-XI, examples of each stage are shown in Figure 4-10 (panels A-I). The stages
at which GC loss was most frequently observed were stages V and VI. Despite a
substantial number of tubules at stages VII and VIII in the sections from infected testes,
all appeared to have a full GC complement (panels M-O).
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Figure 4-10: Stages at which damage is observed in haemoxylin and eosin stained adult
mouse testes infected with a GFP adenoviral construct at 1x107 (A-F, & M) and 1x106 (G-L,
& N-O) pfu per testis. The stage of spermatogenesis in each tubule is shown in the top left
corner of every image. Images are 100x magnification and the scale bar represents 20 pm.
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4.3.2.2.3 Sdmg-1
Sdmg-1 is expressed in the cytoplasm of SC and was detected in tissue sections by
immunohistochemistry (Figure 4-11). Positive immunostaining for Sdmg-1 was seen in
the seminiferous tubules of all the testes infected with adenoviral particles irrespective
of the number of pfu injected. In those testes injected with 4xl08 pfu and recovered
after 7 days (panel A) the number of identifiable stained cells was reduced, and in testes
collected after 3 days (panel B) the amount of staining was similar to that of uninfected
testes (panel I). In testes injected with Ixl05-lxl07 pfu (panels C-H) immunopositive
SC cytoplasm extended from the basement of the tubules to the lumen. Within these
testes, the immunostaining was similar in damaged and undamaged tubules within the
same section.
In tubules from uninfected testes the Sdmg-1 staining was highly organised with dark
staining running from the basement membrane towards the lumen in narrow bands
around the full circumference of the tubule (panel I). In testes infected with 4xl08 pfu
the pattern was greatly disrupted. In testes collected 3 days after infection Sdmg-1
staining was seen throughout the tubule, including at the centre where the lumen had
collapsed. Staining was disorganised consistent with disruption of testicular architecture
(panel A). In the testes recovered 7 days after intra-testicular injection, what little
immunopositive staining was detected was disorganised (panel B). In the tubules
injected with lxl05 - lxlO7 pfu (panels C-H) the pattern of Sdmg-1 expression was
interrupted by the gaps in the seminiferous epithelium. Although Sdmg-1 was expressed
in the same narrow 'banded pattern' running from the basement towards the lumen it
followed the contours of the damage to the epithelium, in tubules lacking disruption to
their epithelium the Sdmg-1 distribution was unaltered.
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Figure 4-11: Immunological staining of Sdmg-1 (Sc-marker) expression in mouse testes
infected with GFP adenoviral construct at a range of doses. Seminiferous tubules of the
testes were specifically infected by intra-testicular injection. Testes were collected 4 days after
infection except for those in panel A (3 days) and panel B (7 days). The doses of virus given per
testis were: 4x108 pfu (A and B), 1x107 pfu (C and D), 1x106 pfu (E and F), 1x105 pfu (G and H).
The untreated contralateral testis from the same animal as the testis in panel A is shown as a
control in panel I. Images are 100x magnification and the scale bar represents 20 pm.
Chapter 4 Gene expression in Sertoli cells using adenoviral constructs 172
4.3.2.2.4 Junctional Complexes
4.3.2.2.4.1 Espin and connexin
Damage to seminiferous tubule structure and loss of GC, was associated with infection
5 8of testes by 1x10 -4x10 pfu/testis. In order to determine whether this was also
associated with disturbance in the physical/junctional interactions between SC and GC,
sections were stained for espin (ectoplasmic specialisation) and Cx43 (Gap junction).
The uninfected contra-lateral testes recovered from treated animals at the same time as
the infected testes served as controls (Figure 4-12 and Figure 4-13 panels C, F, I and L).
Expression of espin and Cx43 in infected and uninfected testes counterstained with
DAPI at x40 and x80 magnification is shown in Figure 4-12 and Figure 4-13
respectively.
No immunoexpression of Cx43 in tubules of testes infected with 4xl08 pfu/testis was
detected in testes recovered at 3 (panel A) and 7 days (panel B) after infection.
Expression of espin was detected at 3 days but was absent from testes collected at 7
days. In testes injected with 1x10s - lxlO7 pfu/testis and recovered 4 days later the
expression of Cx43, but not of espin, was reduced in tubules with vacuoles in their
epithelium (marked by * in panels). Expression of Cx43 in these tubules was either lost
or diminished significantly, but the loss of Cx43 expression was only seen in tubules
with vacuoles; the expression of Cx43 in adjacent undisrupted tubules was not affected.
The loss of Cx43 expression was greatest in tubules infected with lx 106 (panels G and
H) and lxlO7 (panels D and E) pfu/testis, in which only very limited expression of Cx43
was observed. In testes infected with lxlO5 pfu (panels J and K) expression of Cx43
was reduced compared to uninfected testes but some tubules which had some loss of GC
showed moderate Cx43 expression.
Although expression of espin was still detected in infected testes (except in testes
infected with 4xl08 pfu and recovered 7 days later) the distribution of espin
immunostaining was altered by the presence of vacuoles in the epithelium with positive
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staining apparent at the boundaries of the vacuoles (indicated by arrows). In the testes
infected with 4xl08 pfu/testis where espin was detected at the peripheries of the tubules
expression was maintained but appeared disorganised towards the centre of the tubule.
In control testes and those tubules with a normal GC complement in infected testes co-
expression of espin and Cx43 was detected at the peripheries of the tubule (yellow
fluorescence). Co-expression of espin and Cx43 was also observed in disrupted tubules
of testes infected with lxlO5 pfu/testis, when expression of Cx43 was only slightly
diminished.
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Figure 4-12: Fluorescent immunohistochemistry for espin (green) and Cx43 (red) in
mouse testes infected with GFP adenoviral construct at a range of doses. Seminiferous
tubules with disrupted epithelium are denoted by a *, arrows indicate the location of vacuoles.
Testes were collected 4 days after infection except for those in panels A and C (3 days) and
panel B (7 days). The doses of virus given per testis were: 4x108 pfu (A and B), 1x107 pfu (D
and E), 1x106 pfu (G and H), 1x10s pfu (J and K). An untreated contralateral testis taken from a
treated animal at each dose is shown in panels C, F, I and L. Each section was counterstained
with DAPI nuclear marker (blue). Images are at x40 magnification and the scale bar represents
50 pm.
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Figure 4-13: Fluorescent immunohistochemistry for espin (green) and Cx43 (red) in
mouse testes infected with GFP adenoviral construct at a range of doses. Seminiferous
tubules with disrupted epithelium are signified by a *, arrows indicate the location of vacuoles.
Testes were collected 4 days after infection except for those in panels A and C (3 days) and
panel B (7 days). The doses of virus given per testis were: 4x108 pfu (A and B), 1x107 pfu (D
and E), 1x106 pfu (G and H), 1x10G pfu (J and K). An untreated contralateral testis taken from a
treated animal at each dose is shown in panels C, F, I and L. Each section was counterstained
with DAPI nuclear marker (blue). Images are at x80 magnification and the scale bar represents
20 pm.
Chapter 4 Gene expression in Sertoli cells using adenoviral constructs 176
4.3.2.3 Evidence of hypoxia and cell death
4.3.2.3.1 HIF-1oc
Hypoxia induced factor la (Hif-la) is a marker of hypoxia and its expression was
visualised by immunohistochemistry (Figure 4-14). Hif-la was immunolocalised to GCs
of testes infected with 4xl08 pfu/testis and recovered 3 or 7 days after infection (panels
A and B respectively), as well as testes recovered 4 days after infection with lxlO5 pfu
(panels G and H). Testes infected for 4 days with lxlO5 pfu/testis had more intense
immunostaining than those infected with 4xl08 pfu. Testes infected with lxlO6 and
lxlO7 pfu and recovered 4 days later did not contain Hif-la positive staining within the
infected tubules (panels C-F) and neither did uninfected testes recovered 3 days after
injection of the contra-lateral testis (panel I).
Immunopositive Hif-la staining was observed in some LC within the interstitium of
tubules injected at the four viral doses/testis, and was also expected in LC of uninfected
control testes due to reports in previous literature.
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Figure 4-14: Immunohistochemical localisation of HIF-1a in mouse testes infected with
GFP adenoviral construct at a range of doses. Seminiferous tubules of the testes were
specifically infected by intra-testicular injection. Testes were collected 4 days after infection
except for those in panel A (3 days) and panel B (7 days). The doses of virus given per testis
were: 4x10s pfu (A and B), 1x107 pfu (C and D), 1x106 pfu (E and F), 1x105 pfu (G and H). The
untreated contralateral testis from the same animal as the testis in panel A is shown as a control
in panel I. Images are 40x magnification and the scale bar represents 50 pm.
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4.3.2.3.2 Cleaved-Caspase-3
Immunohistochemistry for cleaved-caspase 3, a marker of apoptotic cell death, was
performed on sections from mouse testes infected with 1x10s - 4xl08 pfu/testis (Figure
4-15). Weak immunopositive staining for cleaved-caspase 3 was only found within the
seminiferous tubules in sections of testes injected with 4xl08 pfu and recovered 3 or 7
days after infection (panels A and B respectively) or injected with lxlO5 pfu (panels G
and H). The location and number of stained cells within the seminiferous tubules
indicated that they were GC. The number of cleaved-caspase 3 positive cells present in
testes injected with 4xl08 pfu was greater in the testes recovered 7 days after injection
compared to those collected after 3 days. No positive staining was found in testes
infected with lxl06 - lxlO7 pfu/testis (panels C-F), or in the uninfected contra-lateral
testis associated with the testis infected with 4xl08 pfu and collected 7 days after
infection (panel I). The absence of any cleaved-caspase in these testes was unexpected
because a low incidence of cell death, marked by cleaved-caspase, would be expected
even within a healthy population of testicular cells.
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Figure 4-15: Immunological staining of cleaved-caspase 3 expression in mouse testes
infected with a GFP adenoviral construct at a range of doses. Seminiferous tubules of the
testes were specifically infected by intra-testicular injection. Testes were collected 4 days after
infection except for those in panel A (3 days) and panel B (7 days). The doses of virus given per
testis were: 4x108 pfu (A and B), 1x107 pfu (C and D), 1x106 pfu (E and F), 1x10s pfu (G and H).
The untreated contralateral testis from the same animal as the testis in panel A is shown as a
control in panel I. Images are 40x magnification and the scale bar represents 50 pm.
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4.3.2.3.3 Apoptag
Apoptag staining, also known as the Tunel assay, detects single-stranded DNA and
therefore the presence of DNA stand breaks associated with cells undergoing apoptosis
(Figure 4-16). Only mouse testes infected with adenovirus at 4xl08 pfu/testis and
collected 3 days or 7 days after infection contained Apotag positive cells (panels A and
B, Figure 4-16). The immunopositive cells were localised within the seminiferous
tubules and were assumed to be GC or immune cells. The uninfected contra-lateral
testis associated with the testis recovered after 3 days showed no positive cells (panel I).
Isolated cells with faint staining were found in sections from testes collected 4 days after
infection with 1x10s - lxlO7 pfu/testis, the positive cells are indicated by arrows in
panels C - H in Figure 4-16. The proportion of Tunel-positive cells in these section was
very low and no greater than would be expected in an uninfected healthy testis, only the
proportion of cells seen in testes infected with 4x10s pfii was significant.
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Figure 4-16: Immunological staining of DNA-strand breaks (Tunel assay) in mouse testes
infected with a GFP adenoviral construct at a range of doses. Seminiferous tubules of the
testes were specifically infected by intra-testicular injection. Testes were collected 4 days after
infection except for those in panel A (3 days) and panel B (7 days). The doses of virus given per
testis were: 4x108 pfu (A and B), 1x107 pfu (C and D), 1x106 pfu (panels E and F), 1x105 pfu (G
and H). The untreated contralateral testis from the same animal as the testis in panel A is
shown as a control in panel I. Isolated positively stained cells are indicated by arrows. Images
are 40x magnification and the scale bar represents 50 pm.
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4.3.2.4 Evidence of immune cell invasion
4.3.2.4.1 MPO
Testis sections were stained with an antibody to myeloperoxidase (MPO) to detect
neutrophils in testes infected with lxl05 - 4xl08 pfu (Figure 4-17 and Figure 4-18).
MPO-positive cells were observed in testes infected with 4xl08 and lxlO5 pfu (panels A,
B, G and H), and were absent from non-infected testes (panel I) and those infected with
lxlO6 and lxlO7 pfu (panels C - F). There was more invasion by MPO-positive cells in
testes infected with 4xl08 pfu than those infected with lxl05, but MPO positive cells
were found both within the interstitium and the tubules at both doses. The testes
infected with 4xl08 pfu and recovered 7-days after infection (panel B) were associated
with a greater degree of disruption and with greater invasion by the MPO-positive cells
than testes collected only 3 days after the same dose of virus (panel A).



















Figure 4-17: Fluorescent immunohistochemistry for myeloperoxidase (MPO) neutrophil
marker (red) and smooth muscle actin (green) in mouse testes infected with a GFP
adenoviral construct at a range of doses. Testes were collected 4 days after infection except
for those in panels A and C (3 days) and panel B (7 days). The doses of virus given per testis
were: 4x108 pfu (A and B), 1x107 pfu (D and E), 1x106 pfu (G and H), 1x105 pfu (panels J and K).
The arrow in panel A indicates MPO-positive cells in the testes' interstitium, those in panels B, J
and K denote MPO-positive cells within the tubule itself. An untreated contralateral testis taken
from a treated animal at each dose is shown in panels C, F, I and L. Each section was
counterstained with DAPI nuclear marker (blue). Images are at x40 magnification and the scale
bar represents 50 pm.



















Figure 4-18: Fluorescent immunohistochemistry for myeloperoxidase (MPO) neutrophil
marker (red) and smooth muscle actin (green) in mouse testes infected with a GFP
adenoviral construct at a range of doses. Testes were collected 4 days after infection except
for those in panels A and C (3 days) and panel B (7 days). The doses of virus given per testis
were: 4x10s pfu (A and B), 1x107 pfu (D and E), 1x10® pfu (G and H), 1x105 pfu (J and K). The
arrow in panel A indicates MPO-positive cells in the testes' interstitium, those in panels B, J and
K denote MPO-positive cells within the tubule itself. An untreated contralateral testis taken from
a treated animal at each dose is shown in panels C, F, I and L. Each section was
counterstained with DAPI nuclear marker (blue). Images are at x80 magnification and the scale
bar represents 20 pm.
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4.3.2.4.2 CD68
5 8
Macrophages in tissue sections from mouse testes infected with 1x10 - 4x10 pfu/testis
were detected by fluorescent immunohistochemistry for CD68 (Figure 4-19 and Figure
4-20). A small number of CD68-positive cells were observed in the interstitium of both
5 8infected and uninfected testes, however testes infected with 1x10 or 4x10 pfu
contained increased numbers of CD68-positive cells. Testes infected with lxlO5
pfu/testis had a greater number of CD68-positive cells present but they were restricted to
the interstitium, in testes injected with 4x108 pfu/testis CD68-positive cells also
infiltrated the seminiferous tubules in addition to increased numbers of cell in the
interstitium. Co-staining with SMA (PTM cell marker) at the base of the seminiferous
tubules revealed disruption to tubular architecture associated with increased numbers of
o
CD68-positive cells in testes collected 3 days after injection with 4x10 pfu. In contrast
to infiltration by MPO-positive cells (section 4.3.2.4.1), testes infected with 4xl08 pfu
appeared to contain a greater number of CD68-positive cells in their interstitium and
seminiferous tubules when testes were collected 3 days rather than 7 days after infection.

























Figure 4-19: Fluorescent immunohistochemistry for CD68 macrophage marker (red) and
smooth muscle actin (green) in mouse testes infected with a GFP adenoviral construct at
a range of doses. Testes were collected 4 days after infection except for those in panels A and
C (3 days) and panel B (7 days). The doses of virus given per testis were: 4x108 pfu (A and B),
1x107 pfu (D and E), 1x106 pfu (G and H), 1x105 pfu (J and K). Arrows indicate CD68-positive
cells, in the interstitium and seminiferous tubules of infected testes and in the interstitium of
untreated control testes. An untreated contralateral testis taken from a treated animal at each
dose is shown in panels C, F, I and L. Each section was counterstained with DAPI nuclear
marker (blue). Images are at x40 magnification and the scale bar represents 50 pm.




















Figure 4-20: Fluorescent immunohistochemistry for CD68 macrophage marker (red) and
smooth muscle actin (green) in mouse testes infected with a GFP adenoviral construct at
a range of doses. Testes were collected 4 days after infection except for those in panels A and
C (3 days) and panel B (7 days). The doses of virus given per testis were: 4x10s pfu (A and B),
1x107 pfu (D and E), 1x106 pfu (G and H), 1x105 pfu (J and K). Arrows indicate CD68-positive
cells found in the interstitium and seminiferous tubules of infected testes and only the interstitium
of control testes. An untreated contralateral testis taken from a treated animal at each dose is
shown in panels C, F, I and L. Each section was counterstained with DAPI nuclear marker
(blue). Images are at x80 magnification and the scale bar represents 20 jim.
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4.4 Discussion
In the course of investigating the feasibility of adenoviral constructs for introduction of
constructs specifically into SC in vivo it was found that in vitro SC, SK11 cells,
efficiently expressed reporter constructs introduced via adenoviral infection. The
moderate quantities of plaque-forming viral particles required for substantial expression
of LacZ or GFP reporter genes were not sufficient to cause cell death in vitro, however
infection with higher concentrations of virus did have a cytotoxic effect. In vivo use of
the same adenoviral GFP-construct resulted in SC-specific expression when the virus
was introduced by intra-testicular injection and no expression occurred in the GC. In
vivo infections resulted in highly variable expression of the reporter protein between
adjacent tubules. Infection at MOIs which had no impact on SC function in vitro were
associated with low levels of expression of GFP and were associated with detrimental
effects including germ cell loss, structural disruption and infiltration by macrophages
and neutrophils.
4.4.1 In Vitro
The present study demonstrates that an SC cell line maintained in vitro (SKI 1) can
readily be infected by adenoviral vectors and will efficiently express transgenes carried
by these constructs, a finding that has been reported previously in primary SC cultures
(Blanchard and Boekelheide, 1997; Scobey et al., 2001) and in the immortalised Tm4
SC line (Fleming et al., 2003b). Although we were able to show that the majority of
cells would express the transgene at MOIs of 50-75, the MOIs required for significant
transgene expression were many fold higher in the study by Blanchard and Boekelheide
(Blanchard and Boekelheide, 1997). For example they claimed that they did not
observe any morphological signs of cell disruption or cell detachment from the culture
surface using infections at 5000 MOI, whereas we found that infection of SKI 1 cells at
only 85 MOI caused cell detachment. Fleming et al, who also used immortalised cells
found 10 and 100 MOI resulted in efficient expression of the transgene (Fleming et al.,
2003b). These differences may reflect differences in the SC and viral constructs used as
the SKI 1 and Tm4 cells are immortalised, whilst Blanchard et al used purified primary
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SC cultures and immortalisation of the SK11 cells may have enhanced their sensitivity
to viral infection. There may also have been differences between the adenoviral
constructs in each study, their method ofpurification, and indeed their purity.
Differentiated SK11 cells, cultured at 39°C, secreted more IL-6 protein than did
proliferative cells cultured at 34°C. This result is in agreement with previous studies in
which IL-6 expression was greater in primary cultures of SC derived from pubertal rats,
compared to those from pre-pubertal animals (Syed et al., 1992). The SC of the pubertal
rats should be mature and are comparable to the differentiated SK11 cells, whilst the
proliferative SKI 1 cells should resemble the pre-pubertal cells. A similar pattern of low
pre-pubertal and higher pubertal expression has also been reported for IL-la, which as a
key factor in the regulation of IL-6, and could be investigated to complement the
increased IL-6 expression found in differentiated SKI 1 cells (Gerard et al., 1991).
Although the pattern of release of IL-6 by the SKI 1 cells paralleled expression in SC in
the immature and mature states, the SKI 1 cells did not respond to infection by
adenoviral constructs by raising expression of IL-6. This is in contrast to primary
cultures of SC which show an increase in expression of IL-6 in response to treatment
with LPS or residual bodies (Riccioli et al., 1995; Syed et al., 1993). Although this
experiment does not provide a direct comparison to adenoviral infection, it does show
that primary SC cultures maintain a capacity to respond to inflammatory stimulation that
SKI 1 cells appear to lack. In primary cells the increased expression of IL-6 expression
is in response to increased autocrine IL-la signalling (Syed et al., 1995). Further studies
are therefore required to determine whether viral infection of SKI 1 cells has any impact
on IL-la. The time course used in this study covered 48 hours and included time points
at 6 and 24 hours after viral infection, it was at these times that LPS and residual bodies,
respectively, induced maximal IL-6 expression in primary SC cultures (Syed et al.,
1993), so it is unlikely that a virally induced IL-6 surge was missed.
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4.4.2 In Vivo
Detection of the GFP reporter protein in SC, but not in GC, within the tubules of testes
injected with adenoviral constructs via the efferent ductules demonstrates the specificity
of adenoviral infection for SC, and the capacity of SC to express transgenes introduced
via adenoviral vectors. These findings were in agreement with the in vitro data
presented above and in vitro and in vivo data presented in previous studies on rats and
mice (Blanchard and Boekelheide, 1997; Fleming et al., 2003a; Fleming et al., 2003b;
Ikawa et al., 2002; Kanatsu-Shinohara et al., 2002; Scobey et al., 2001). Blanchard and
Boekelheide (Blanchard and Boekelheide, 1997) used in vitro co-cultures of SC and GC
and showed that at viral concentrations sufficient for efficient expression in SC, only a
very small minority (<1%) of GC showed expression of an adenoviral transgene. In
previous studies adenoviral constructs were introduced into seminiferous tubules in vivo
by similar methods to those used in the current study and included injection into the rete
testis, seminiferous tubule lumen or efferent ductile. In these studies SC-specific
expression was achieved (Blanchard and Boekelheide, 1997; Kanatsu-Shinohara et al.,
2002; Scobey et al., 2001), and the GC of the infected tubules did not express the viral
transgene (Scobey et al., 2001). In addition, systemic infection of mice with an
adenovirus bearing a GC-specific promoter and reporter protein construct resulted in no
germ line expression (Peters et al., 2001).
The efficiency of in vivo transgene expression in this study was not as high as in vitro, as
only a small proportion of tubules contained SC expressing the GFP transgene, and not
all SC within each immunopostitive tubule expressed GFP, especially at the lower viral
concentrations. Incomplete coverage of transgene expression was also reported in
previous studies with between 5 and 34 percent of tubules expressing adenoviral
transgenes (Blanchard and Boekelheide, 1997; Scobey et al., 2001). The reduced
efficiency of in vivo expression at lxl05 - lxlO7 pfu/testis, compared to in vitro, is
likely to be a consequence of the reduced MOI (pfu per cell to be infected) achieved in
vivo that are predicted to be between 0.05 and 5. These MOI assume the entire length of
the seminiferous tubules was bathed by the injected viral solution that is unlikely. Even
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if the virus reached only a fraction of the total length increasing the MOI several fold it
would still be below 50, which was required in vitro for substantial transgene
expression. Fleming et al suggest that introducing the virus via the rete testis results in
high exposure at sites near the rete but that the viral titre is decreased at more distal sites
due to dilution and uptake of the virus by proximal cells. In addition, the decline in viral
concentration they describe would directly impact expression of the transgene because
expression level is correlated with the number of copies of the transgene that enter each
cell (Fleming et al., 2003b). The original intention was to use vectors expressing both
target-specific miRNAs and GFP so that changes in cell expression/germ cell survival
could be linked to sites of specific knockdown so patchy expression would not
necessarily have been a drawback as it would have allowed direct comparison between
infected and non-infected cells.
Expression of the transgene in infected cells was detected as early as 72 hours after
infection, which was the earliest time point at which GFP transgene expression was
investigated in this study, in previous studies expression was detected as early as 48
hours after infection and could still be maintained after 3 months (Blanchard and
Boekelheide, 1997; Kanatsu-Shinohara et al., 2002). Adenoviral infection has not only
been used for expression of reporters to demonstrate the cell-specificity of the technique
as constructs expressing i) a cyclic adenosine 3',5'-monophosphate response element-
binding protein (CREB) mutant and ii) steel factor (kit ligand), have been used in intra-
testicular infections to either disrupt spermatogenesis in wild-type rats or to rescue
spermatogenesis in infertile mice respectively (Kanatsu-Shinohara et al., 2002; Scobey
et al., 2001).
In the present study dramatic responses to adenoviral infection were observed. The
responses were apparent in testes 3, 4 and 7 days after infection. The testes can be
separated into two groups based upon their responses to infection. The first group
o
contains testes infected at the greatest dose (4x10 pfu/testis) in which the internal
structure of the seminiferous tubule disintegrated, there was evidence of hypoxia and
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apoptosis and invasion of the interstitium and sometimes the tubules by macrophages
and neutrophils. The testes of the second group were infected at lower doses (lxlO5-
lxlO7 pfu/testis) and exhibited less severe effects that were similar at the 3 doses.
Instead of collapsing, the tubules maintained a distinct lumen and a distinguishable
seminiferous epithelium but with apparent GC loss and co-incident 'vacuole' formation
at the sites of cell loss. Infrequently, neutrophil and macrophage invasion was
associated with infected testes at these lower doses. The types of disturbances described
above were not reported in studies carried out prior to the start of the work presented
here. In previous studies low levels of immune response were reported when adenoviral
constructs were injected into seminiferous tubules, even when infection of the
interstitium was avoided. Blanchard and Boekelheide (1997) reported an inflammatory
response that began 10 days after adenoviral infection via the rete testis, and lasted
around 8 days. The inflammatory event was marked by lymphocyte and plasma cell
infdtration into the interstitium, and chromatin fragmentation in cells of the seminiferous
epithelium. The immune response following infection within tubules had a shorter
duration than that associated with injections into the interstitium, which lasted up to 30
days after infection but also included invasion by lymphocytes and plasma cells
(Blanchard and Boekelheide, 1997). Injection of adenovirus via the rete testis was
reported to result in limited necrosis and invasion by immune cells, which is in contrast
to injection directly into the lumen of seminiferous tubules that was apparently
associated with no tissue damage or immune cell invasion (Scobey et al., 2001).
Injection into the rete testis was sometimes associated with leakage of virus into the
interstitium (Blanchard and Boekelheide, 1997), which would explain the
immunological response associated with testicular injection by this method. A study
comparing the efficiency of numerous viral vectors for introduction of transgenes into
SC reported a significant reduction in testis weight compared to control testes when
adenovirus was used as the vector (Ikawa et al., 2002), but this result is in contrast to the
majority of the existing literature.
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The presence or absence of vacuoles in tubules at specific stages of the spermatogenic
cycle suggested that tubules vary in susceptibility to infection dependent upon their
germ cell complement. Differential susceptibility of SC to adenoviral infection has
already been reported in rat testes, with SC in tubules at stage II-VI predicted to be the
primary targets (Blanchard and Boekelheide, 1997). However in a later study from the
same group, 80% of infection was suggested to occur in stage V-XII tubules (Fleming et
al., 2003b). In the present study the testes were examined 4 days after infection, and it
was shown that the only stages of tubules that were identified as lacking vacuoles were
those in stages VII and VIII. Four days previously when the testes were initially
infected these tubules would have been in stages I-III. The worst affected stages 4 days
after infection were stages V and VI, which would have been stages XI and XII of the
previous cycle at the time of infection. The position of the gaps in the seminiferous
epithelium and the GC complement in affected tubules indicated that the GC lost
following infection are pachytene spermatocytes. The loss of pachytene spermatocyte
following viral infection suggests that development of zygotene spermatocytes was
compromised following viral infection of the SC. Although the previous studies of
Blanchard, Scobey and Kanatsu-Shinohara (Blanchard and Boekelheide, 1997; Kanatsu-
Shinohara et al., 2002; Scobey et al., 2001) reported immunological responses to
adenoviral infection, none of them showed any evidence of germ cell loss or the
appearance of vacuoles in the seminiferous epithelium when constructs expressing
reporter proteins were used. The sensitivity of zygotene spermatoctyes to disruption
during inflammatory events has been reported previously in a study using a systemic
injection of LPS and this study also reported significant losses of pachytene
spermatocytes 7 days after treatment (Liew et al., 2007). The zygotene spermatocytes in
the LPS study did not undergo apoptosis or premature release, instead their development
appears to be delayed, and the study links the disruption in development of the zygotene
spermatocytes to their loss when they reached the pachytene spermatocyte stage. In
contrast to the studies presented here, LPS-treatment also resulted in loss of round
spermatids, which were released prematurely into the tubule lumen together with the
spermatocytes (Liew et al., 2007).
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Evidence of apoptosis and hypoxia were detected in testes infected with 4xl08 pfu/testis,
associated with immunopositive staining for activated caspase-3, DNA-strand breakage
and Hif-la. The cells exhibiting positive staining were GC, which are not infected
directly by the adenoviral constructs suggesting that the effect was secondary to the
impact of viral infection on SC function. The expression of markers for hypoxia and
apoptosis in these testes could be a consequence of the disrupted structure of their
tubules. The distribution of the SC cytoplasm is dramatically altered in these tubules, as
visualised in Figure 4-11, resulting in reduced and often total loss of contact between
GC and their supporting SC. The compact structure of the disrupted tubules which
lacked a distinct lumen following viral infection could reduce the oxygen permeability
of the tubule as a whole and combined with loss of GC-SC contact could result in a
reduction in oxygen concentration, i.e. hypoxia, within the tubule and thereby
compromise the GC. Hypoxia results in stabilisation and build-up of the Hif-la protein
that may then bind hypoxic response elements in genes some of which are components
of the apoptotic pathway (Carmeliet et al., 1998). In light of the association between
apoptosis and hypoxia the presence of signs of apoptosis (activated caspase-3 and DNA-
strand breaks) in GC that also express hypoxia markers is logical. In the absence of
contact between GC and SC, the GC could also be deprived of essential factors supplied
by SC that could contribute to induction of apoptosis in these cells. The presence of
fragmented chromatin, indicating apoptosis, following adenoviral infection was
previously reported in cells of the seminiferous epithelium, but within these tubules no
evidence of apoptosis was reported in GC (Blanchard and Boekelheide, 1997), other
studies using the Tunel assay revealed only normal levels of GC apoptosis following
adenoviral infection (Scobey et ah, 2001). However apoptosis of GC has been reported
in inflamed rat testes induced by infection with LPS (Liew et ah, 2007). Germ cell death
also occurs in testes exhibiting experimental autoimmune orchitis (EAO) and includes
the activation of caspase-3 in these cells (Theas et ah, 2003). Further relevance in
relation to findings of the current study are limited because although both are examples
of orchitis the EAO is induced by priming the host immune system using host antigens
Chapter 4 Gene expression in Sertoli cells using adenoviral constructs 195
including those of haploid and meiotic GC meaning that the animal is specifically
sensitised to these cell types. In addition, autoimmune orchitis requires up to fifty days
after stimulation to induce apoptosis (Theas et al., 2003), whereas apoptosis was
observed within 72 hours in this study.
Hif-la expression was detected in tubules of testes injected with 1x10s pfu/testis, but in
the absence of detectable markers of apoptosis even 4 days after infection i.e. 1 day later
than apoptotic markers were detected in testes infected with 4x10X pfu/testis. Some of
the expression ofHif-la in the testes infected at both doses may be related to invasion
by immune cells, as described below. Macrophages and neutrophils both rely on
glycolysis to generate energy in the hypoxic conditions associated with inflamed and
damaged tissues and Hif-la also regulates components of the glycolytic pathway
(Semenza et al., 1994). Therefore some expression ofHIF-la in infected testes could be
associated with immune cells, as well as the GC.
The gap junctions, marked by Cx43, appear more sensitive to adenoviral infection than
ectoplasmic specialisations, assessed by espin expression. Connexin43 was not detected
# gin testes infected with 4x10 pfu/testis at 3 and 7 days post infection at a time when GC
were undergoing apoptosis. The onset of both GC apoptosis and breakdown of gap
junctions precede the first time point in the study so it is not possible to determine which
occurs first and whether one event causes the other. Spermatogenesis fails in the
absence of Cx43 expression as demonstrated in studies using SC-specific knockout of
Cx43 (Brehm et al., 2007) and transplantation of testes from Cx43 deficient mice into
wildtype mice (Roscoe et al., 2001). Development of the testes occurred in the absence
of Cx43 in these models which may account for the deficiencies in spermatogenesis.
Batias et al used mice with impaired spermatogenesis (ebo/ebo and jun-d ) to
demonstrate that absence of GC caused reduced expression of Cx43 in seminiferous
tubules compared to expression in wild-type animals (Batias et al., 1999). Connexin43
expression in these animals was modulated specifically by the elongated spermatids
(Batias et al., 1999), but in the virally infected seminiferous tubules with reduced Cx43
Chapter 4 Gene expression in Sertoli cells using adenoviral constructs 196
expression elongated spermatids had not been lost. In testes from humans with
klinefelter's syndrome and mice with mosaic mutation and partial deletion of the Y
chromosome similar losses of Cx43 expression were noted (Kotula-Balak et al., 2007).
The decline in Cx43 expression in testes infected with adenovirus at lxl05 - lxlO7
pfu/testis, was restricted to tubules in which GC cell loss and vacuole formation had
already occurred. That Cx43 expression is still present but begins to decline in the
absence of GC suggests that in these testes gap junctions begin to breakdown as a
consequence of GC loss and not the other way round. The reduced expression may also
be due to loss of Cx43 expressed by the GC that are missing as it is reported that Cx43
in the gap junctions is synthesised by both GC and SC (Risley et al., 1992). The reason
for complete loss of expression in testes just 3 days after injection with 4xl08 pfu/testis,
but not in testes infected with lower viral doses, may be a reflection of the more
significant damage to the function of the SC caused by the higher doses. Therefore it
appears that adenoviral infection may do more than adversely affect the secretion of
factors that support GC development by also having an impact on the maintenance of
junctional integrity and physical support to the GC.
The ectoplasmic specialisations appeared to be less sensitive to adenoviral infection,
because expression of espin was maintained under conditions where Cx43 expression
was either lost or diminished. Disturbances in the patterns of expression of espin
appeared to occur following altered distribution of SC cytoplasm following GC loss as
expression followed the contours of the vacuoles. The loss of espin expression at 7 days
following infection with 4xl08 pfu/testis may either be a consequence of 1) extensive
damage to SC due to the unusually high dose used, as described above, that took longer
to become apparent than Cx43 loss or 2) the loss of contact between SC and GC due to
the disrupted structure and apoptosis of GC. An in vitro study on immortalised SC
cultured in the presence or absence of GC detected increased expression of espin protein
in SC co-cultured with GC, increase espin expression was not associated with binding
between SC and GC (Wolski et al., 2007).
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Invasion of immune cells into the interstitium and tubules of testes that had a disrupted
architecture consisting of early infiltration by macrophages, at 3 days post-infection,
followed by neutrophils by 7 days post-infection. Earlier detection of macrophages than
neutrophils would be expected because testes contain resident macrophages in their
interstitium. However there is some evidence that the types of macrophages most
important for inducing inflammation are not resident in the testis prior to infection,
rather they are recruited from the circulating population outside the testis (Gerdprasert et
al., 2002). The macrophage marker used in this study does not differentiation between
these two populations of macrophages. The infiltration of tubules in these highly
damaged testes may occur as a result of disruption of the basement membranes of the
tubules as SMA staining at this location also appeared to be disturbed. The suggestion
that immune cells enter the testes sequentially is supported by data from EAO
experiments in which macrophages were first seen surrounding the perimeter of tubules
and then entering the lumen if the tubule were damaged, subsequently there was
invasion of the interstitium and lumen by neutrophils (Tung et al., 1970).
In a limited number of tubules in testes infected with 1x10s pfu/testis, neutrophils were
observed infiltrating the tubules, and the interstitial macrophage population was slightly
enlarged although they did not penetrate into the seminiferous tubules. The infiltration
of tubules by neutrophils was less pronounced in the testes injected with 1x10s pfu,
probably because the basement of the tubules was relatively intact based upon the
distribution of SMA staining. Infiltration of macrophages and neutrophils into
seminiferous tubules was not observed following LPS-induced immune response
(Gerdprasert et al., 2002), and in that respect the lack of macrophage invasion into
tubules in testes infected with 1x10s pfu/testis corresponds to the milder phenotype
shared by testes infected with LPS and low doses of adenovirus (lxl05 - lxl07
pfu/testis). The presence of neutrophils in seminiferous tubules and increased numbers
ofmacrophages in the interstitium of testes following infection with 1x10s pfu/testis, but
not following infection with lxl 06 or lxl07 pfu/testis, could be a consequence of
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variation in the viral stocks used or in the way the intra-testicular injections were carried
out.
The evidence presented above in relation to gap junctions and ectoplasmic
specialisations, suggests that the GC loss observed in adenoviral-infected testes is not a
consequence of disruption to Cx43 or espin expression at sites of SC-GC interaction.
Involvement of an immune response in the loss ofGC from testes injected with less than
lxl07 pfu/testis has also not been demonstrated. On this basis, other mechanisms for the
impact of adenoviral infection on GC survival should be investigated. Expression of
factors essential for support of spermatogenesis by SC, such as activin, steel factor and
GDNF, would be obvious first candidates for investigation in testes infected with
adenovirus.
Damage to seminiferous tubules associated with intra-testicular injection of adenovirus
could be due to another cause. Ogawa et al. reported increased internal testicular
pressure resulting in ischemia caused by injections into the efferent ducts during GC
transplantation (Ogawa et al., 1997). However the volumes used in that study were
between two- and three-fold higher than in my studies. The differences in amount of
damage observed when testes were injected with varying concentrations of viral
constructs in the same volume of vehicle (trypan blue and saline solution) suggest that
the viral concentration had a substantial impact on the damage caused to the tubules,
independent of injection of fluids. Other factors that may contribute to tubule damage in
addition to the effect of viruses could include the increased pressure in testes described
above or an effect of the components of the injection vehicle. The impact of the
injection process can not be determined from the present studies because sham
operations in which the testes of the mouse would be injected with saline or vehicle
(saline solution plus trypan blue) were not carried out. Such sham experiments would
determine whether injection of 50 pi of fluid or the presence of trypan blue cause tubule
disruption independent of introduction of the adenovirus.
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4.4.3 Conclusions
Although adenoviral particles specifically infect SC in vitro and in vivo we were not able
to develop an in vivo method for disruption of specific gene expression within SC using
this method of gene delivery under normal physiological conditions. This was because
although the viral infection resulted in SC-specific expression even modest levels of
expression of the reporter protein was associated with significant adverse effects on the
integrity of the seminiferous tubules. The adverse effects were present at all doses that
achieved substantial transgene expression, and therefore the use of adenoviruses to
introduce RNA interference into SC in vivo was shown to be unfeasible in this first
phase of the study. To achieve SC specific knockdown, methods such as the SC-specific
promoter linked to an RNAi construct, or the Cre-lox system described in the
introduction will need to be employed. In contrast, adenoviral constructs can be used in
vitro as vectors, free from the complications encountered in vivo.
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5 Gene expression in rat testes: studies using Leydig cell
depletion with ethane dimethane sulphonate
5.1 Introduction
Steroid action is essential for successful spermatogenesis, and of particular importance
in the testis are the actions of androgens. The requirement for SC to express functional
AR and respond to androgen signalling has been confirmed by transgenic approaches.
Studies on SC function have involved both in vitro and in vivo models. In vitro models
used include isolated primary cells and immortalised cell-lines (Denolet et al., 2006b;
Mather, 1980; Peschon et al., 1992; Sneddon et al., 2005; Steinberger and Jakubomaik,
1992), such as the SKI 1 line used in chapter 3. In vivo methods used in investigation of
androgen response throughout the reproductive tract include models with diminished AR
expression (ARKO, SCARKO, Tfm mice) or disruption to androgen secretion (steroid
implants, Hpg mouse, hypophysectomy, and EDS-treatment) (Bartlett et al., 1986; De
Gendt et al., 2004; Denolet et al., 2006a; El Shennawy et al., 1998; O'Donnell et al.,
1994; Singh and Handelsman, 1995). In chapter 4, a pilot study for a novel method
intended for disruption of AR expression was undertaken, however the results were
unsatisfactory. As a consequence of abandoning the in vivo model in chapter 4, an
alternative system employing the testicular toxin ethane dimethanesulphonate (EDS) to
induce withdrawal of testosterone in rats, was adopted.
Cycles of spermatogenesis in rat seminiferous tubules are divided into 14 stages
(Leblond and Clermont, 1952a). Androgen receptor expression in SC is highest during
stages VII and VIII, and expression in LC and PTM does not vary in relation to stages of
associated tubules (Bremner et al., 1994). In models in which intratesticular testosterone
(ITT) is depleted, including Hypogonadal {Hpg) mice and rodents treated with high
concentrations of testosterone and oestradiol (T+E) implants, two androgen dependent
stages in spermatogenesis have been identified, the first being completion ofmeiosis and
the second conversion of round to elongate spermatids in the process of spermiogenesis
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(Hill et ah, 2004; O'Donnell et ah, 1994; Singh and Handelsman, 1995). These steps are
associated with stage VII-VIII tubules, and so these stages have been characterised as
'androgen-dependent' (Sharpe, 1994). Spermatogenesis could be rescued in these
models by treatment with high doses of testosterone to restore ITT concentrations (El
Shennawy et al., 1998; Franca et ah, 1998; Hill et al., 2004; O'Donnell et al., 1994;
Singh and Handelsman, 1995).
In the Hpg mouse model described above, animals have developed in the absence of
testosterone and gonadotrophins, with impacts on testis size, proliferation of cells, and
size of cell populations within the testis (Singh and Handelsman, 1995). A single
injection of EDS diminishes testosterone within 6 hours of treatment and totally ablates
mature LC from the interstitium within 3 days in adult rats. Partial recovery of serum
testosterone levels occurred after 14 days, a graph of serum testosterone over a 10 week
period is shown in Figure 5-1 (Bartlett et al., 1986). Use of EDS to disrupt LCs and
cause depletion of ITT can be applied to rats, guinea pigs, and Syrian hamsters but not to
mice. In mice spermatogenesis is disrupted, but not by disruption of LC which are
resistant to effects of EDS (Kerr et al., 1987).
Chapter 5 Gene expression in rat testes: studies using LC depletion with EDS 202
Figure 5-1: Serum testosterone detected in an adult rat between 4 hours and 70 days
after a single injection of EDS. Plotted values show mean ± standard error, * p<0.025, **
p<0.01, *** p<0.001 compared to control. Adapted from (Bartlett et al., 1986).
Disruption to spermatogenesis and the seminiferous tubule in response to a single EDS
injection occurs 3 days after EDS-treatment with degeneration of a minority of
pachytene spermatocytes at stages VII and VIII, indicating high androgen-sensitivity
during these stages of the epithelial cycle and for the development of these cells (Bartlett
et al., 1986; Kerr et al., 1993a). Analysis of gene and protein expression within 6 days
of EDS-treatment can be performed on whole testes because the majority of the GC
complement is maintained so results are not skewed by altered cell composition within
the testis (Turner et al., 2001), although absence of testosterone's impact may alter GC
gene expression influencing expression in whole testis. A week after EDS-treatment,
abnormal development of spermatocytes and spermatids in stage VII-XI tubules,
particularly stage 7 and 8 spermatids, plus retention of stage 19 spermatids was observed
(Bartlett et al., 1986; Kerr et al., 1993a). Sertoli cells are also affected and develop
vacuoles in the basal region 7 days after EDS-treatment which are thought to be caused
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by interference with tight junctions due to androgen-deficiency (Bartlett et al., 1986).
Disruption to GC from stage VII tubules and appearance of vacuoles can be prevented
by testosterone replacement (Kerr et al., 1993a). Expression of AR protein, and its
nuclear localisation has been shown to be dependent upon androgen signalling in
numerous androgen depletion models including in EDS-treated rats (Bremner et al.,
1994; Hill et al., 2004). In the testes of rats treated with EDS for 6 days,
immunodetection of AR protein expression is completely lost from SC, PTM, and any
remaining or newly formed LC, following depletion of intra-testicular testosterone
(Atanassova et al., 2006; Bremner et al., 1994). Immunopositive staining for AR was
reinstated by treatment with exogenous testosterone, the pattern of differential
expression between tubules at different stages was indistinguishable from that of
untreated rats (Bremner et al., 1994; Turner et al., 2001).
The EDS model has been used to demonstrate that secretion of seminiferous tubule fluid
is stage dependent; secretion in tubules at stages VI-VIII is 2-fold greater than in tubules
at other stages. Differential secretion is absent in tubules of rat testes between 3 and 6
days after treatment with EDS, secretion in stage VI-VIII tubules is equal to that at
stages II-V and IX-XII. Increased secretion in stage VI-VIII tubules can be reinstated by
treatment with testosterone (Sharpe et al., 1994; Sharpe et al., 1992). Androgens
regulate the secretion but not synthesis of tubule fluid proteins. Secretion of
constitutively expressed SC proteins such as SGP-1 and -2 is not regulated by
androgens, but secretion of cyclic protein 2 (CP-2) and proteins secreted by GC and SC
via regulated pathways are affected (McKinnell and Sharpe, 1995).
In recent experiments androgen responsive genes have been identified whose mRNA
expression has been assessed through arrays and quantitative RT-PCR on testes of
SCARKO and anti-androgen-treated mice. Androgen responsive genes identified in
addition to AR, include Rhox5 (a reproductive homeobox gene), -tubulin, espin, and
tight junction protein 1 (Abel et al., 2008; Denolet et al., 2006a). Array data supported
by immunohistochemistry and Western blotting on tissues derived from another SC-
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specific AR knockout mouse model (J4.^loxlexl~neo)', Amh-cre) demonstrated androgen-
dependent expression of the tight junction component claudin3 in SC (Meng et al.,
2005).
There is extensive intimate contact between SC and GC in seminiferous tubules through
ectoplasmic specialisations, gap-junctions, tubulobulbar complexes and, desmosome-
like junctions (McGinley et al., 1979; Russell, 1977a; Russell, 1977b; Russell and
Clermont, 1976) Holdcraft et al. reported androgen-sensitivity of spermiation and
adhesion of round spermatids prior to elongation, suggesting that the primary role of
androgen signalling is to influence adhesion between SC and GC (Holdcraft and Braun,
2004). Therefore expression of other genes in response to androgens has also been
examined, with particular attention on expression of junctional proteins within
seminiferous tubules. In rats treated with high doses of testosterone and oestrogens to
induce chronic reduction in intra-testicular testosterone, stage 8 round spermatids detach
from the seminiferous epithelium, however the integrity of ectoplasmic specialisations at
the sites of spermatid loss, determined by espin expression, is maintained (O'Donnell et
al., 1994). A/m(exl~neo/y-T Amh-Cre mice share a similar pattern of GC loss, and the
permeability of the BTB in these mice is increased in association with a loss of claudin3
expression, however tight junctions and expression of their components, such as
claudinl 1 and occludin, are maintained (Holdcraft and Braun, 2004; Meng et al., 2005).
Staining for espin at basal ES and N-cadherin are also reported to be unchanged
following suppression of testosterone and FSH (Beardsley and O'Donnell, 2003). In
contrast to Beardsley et als findings, subsequent studies report increased expression and
a wider distribution of N-cadherin within tubules of testosterone-depleted animals.
Increased N-cadherin distribution was attributed to dissociation from [3-catenin and
disruption to adherens junctions (Xia et al., 2005). Testosterone depletion also induces
increased expression of the tight junction adaptor protein, zona occludins-1 (ZO-1), but
its distribution within the TJ was maintained as was BTB integrity (Xia et al., 2005).
Connexin43 (Cx43) is a component of gap junctions identified in tissues including the
testis. Within the testis Cx43 is expressed injunctions between adjacent SC (Risley et
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al., 1992; Tan et al., 1996) and in the adluminal compartment between SC and GC
(Batias et al., 1999; Tan et al., 1996). Expression of Cx43 is stage-specific in rat and
mouse testes. In rat testes, little or no positive staining for Cx43 was seen in stages IX-
XIV whilst strong staining was present in tubules at stages I-VIII. In mice, strong
staining was restricted to stages VI-VIII, stages I-V and IX-XII exhibited low expression
(Risley et al., 1992).
5.1.1 Aims
To use the established EDS-treated rat model to validate androgen-responsive
expression of target genes identified in vitro and in vivo, using models including
SCARKO mice and rodents with depleted intra-testicular testosterone. Also, extend
studies in previous array-based publications by investigating protein expression.
Investigations focus on the established androgen responsive genes, AR and Rhox5, and
on components of junctions or the cytoskeleton. These have either been described as
androgen-responsive in previous studies or are related targets with potentially for novel
androgen-responsive expression.
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5.2 Materials and Methods
5.2.1 Animal treatments
Treatment of rats with EDS and testosterone esters was undertaken as described by
Turner et al. (Turner, Morley et al. 2001). Briefly, adult male Wistar rats were treated
with 75 mg/kg ethane dimethane sulphonate (EDS, synthesised in house) in
dimethylsulphoxide/water (1:3; v/v) by intra-peritoneal injection 6 days prior to testes
being collected. A second group received the same EDS injection plus a simultaneous
subcutaneous injection with 25 mg/kg testosterone esters (TE; Organon Laboratories,
Cambridge, UK) in arachis oil and a second TE injection 3 days later, testes were
collected 6 days after the initial EDS treatment. A third (vehicle control) group of adult
rats were injected with dimethylsulphoxide/water (1:3; v/v) by intra-peritoneal injection
6 days prior to testes being collected. EDS treatment depletes serum and testicular
testosterone to undetectable levels (by RIA) by destroying Leydig cells, this treatment
also depletes oestrogens for which testosterone is a precursor. TE injections compensate
for the reduced testosterone levels caused by Leydig cell ablation. All treatments were
carried out by Prof Richard Sharpe, of the Human Reproductive Sciences Unit
Edinburgh, under his project licence. I am most grateful to Prof Sharpe for allowing me
to use these tissues. Effectiveness of the EDS-treatment was confirmed at the time of
testicular tissue collection by checking for reduced prostate size, and efficiency of rescue
by testosterone esters was established by the prostates returning to a similar size to that
of control animals (Turner et al., 2001).
5.2.2 TaqMan Q-RT-PCR
Samples of RNA extracted from the testes of EDS-treated and control adult rats were
incubated in a random hexamer primed reverse transcriptase reaction to produce cDNA
(section 2.3.3.1). The cDNA was used in Universal Human Probe Library™ (section
2.3.3.4.) TaqMan reactions that were undertaken on an ABI 7900 HT Real-Time PCR
Machine.
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The UPL TaqMan primer and probe sequences designed to quantify rat mRNA
transcripts are shown in Table 5-1.
Table 5-1: Universal Human Probe Library™ primer and probe sequences for TaqMan Q-






































Western blots were performed on proteins extracted from rat testis tissue using lx RIPA
(section 2.4.1). The rat testes were from animals treated with EDS, EDS plus TE, or
injected with vehicle (control) (section 5.2.1). Western blots were performed as
described in section 2.4.2, and protein bands were visualised on membranes using
fluorescence (LiCor). Blotting was carried out on rat tissues for (3-tubulin and (33-
tubulin, junctional proteins, and Rhox5. The primary antibodies used are listed in Table
5-2. The secondary antibodies used are described in
Table 2-5 (section 2.4.2).
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Table 5-2: Primary antibodies for Western blots.
Antigen Dilution Species Raised Source
AR 1:200 rabbit US Biological
P-Tubulin 1:200 mouse Sigma












Immunohistochemistry was performed using both DAB and fluorescent staining
methods (sections 2.5.2 and 2.5.3). The rat testis sections were stained for junctional
proteins, Sertoli cell markers (Sdmg-1, GATA-1), androgen responsive product (Rhox5)
and PTM cell marker (SMA). The primary antibodies used are shown in Table 5-3.
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Table 5-3: Primary antibodies for immunohistochemistry.
Antigen Dilution Species raised Source
AR 1:50 rabbit Santa Cruz
P-tubulin 1:1500 Mouse Sigma









SMA 1:500 mouse Sigma
ZO-1 1:100 Rabbit Zymed




Expression of AR mRNA was quantified by Taqman quantitative PCR in samples
extracted from rat testes treated with EDS or EDS plus testosterone esters (Figure 5-2).
Treatment with EDS to ablate LC and reduce intra testicular testosterone reduced
expression of AR to less than 30% of control expression, and testosterone replacement
with testosterone esters in parallel with EDS-treatment increased expression to over
double that seen in controls. Although the differences in AR expression were large, the
small number of animals in each treatment group (n=3 in control, and n=4 in EDS and
EDS plus T) meant that the effects of treatments were not significant when analysed by
Kruskal-Wallis test, p=0.49. Wide variation in expression between animals within each
group compounded the effect of small sample size.
Figure 5-2: Quantification of androgen receptor mRNA in rat testes by Taqman Q-RT-PCR.
Testes were collected 6 days after treatment with EDS or EDS plus TE. Expression was
standardised to that of control rat testes. Bars represent average expression ± SEM, for n=4
animals per treatment (except for control group with n=3 animals). A Kruskal-Wallis test
demonstrates no significant difference (p=0.49) in expression between treatments.
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5.3.1.2 Rhox5
Expression of Rhox5 mRNA was also quantified by Taqman RT-PCR (Figure 5-3).
Treatment of rats with EDS caused almost total depletion of Rhox5 mRNA to less than
1.5% of control levels. Expression of Rhox5 was maintained in rats treated with EDS
and testosterone esters. Although Rhox5 mRNA was almost undetectable in the EDS-
treated group the small numbers of repeats in each treatment group (n=2 in control
group, and n=4 in EDS and EDS plus T) means that the effect of treatments on Rhox5
expression are not significant when assessed by Kruskal-Wallis test, p=0.42. High
variability of expression within treatment groups, particularly control animals,














Figure 5-3: Quantification of Rhox5 expression in testes of rats treated with EDS or EDS
plus TE by Taqman. Testes were collected 6 days after treatment, and expression
standardised to that of untreated control testes. Bars represent average expression ± SEM, for
n=4 animals per treatment (except for control group with n=2 animals). A Kruskal-Wallis test
demonstrates no significant difference (p=0.42) in expression between treatments.
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5.3.1.3 p3-tubulin
Expression of (33-tubulin mRNA in the testes of rats treated with EDS was depleted to
less than 3% of expression detected in untreated (control) rats' testes. Expression was
increased to 140% of control level when intra testicular testosterone loss was
compensated for with testosterone ester treatment. Expression was quantified by
Taqman quantitative RT-PCR, and is presented standardised to expression in control
testes (Figure 5-4). Depletion of p3-tubulin mRNA in testes of EDS-treated rats is
almost absolute, but the small number of animals in each treatment group (n=2 control
animals, and n=4 in EDS and EDS plus T groups) resulted in the Kruskal-Wallis test
finding no statistically significant effect of the treatments given, p=0.44. The impact on
statistical significance of high variability of (33-tubulin expression within the EDS plus
testosterone treatment and control groups was enhanced by the small numbers of





Figure 5-4: Taqman quantification of (33-tubulin expression in rat testes treated with EDS
or EDS plus TE. Testes were collected 6 days after treatment, and expression standardised to
that of untreated control testes. Bars represent average expression ± SEM, for n=4 animals per
treatment (except for control group with n=2 animals). A Kruskal-Wallis test demonstrates no
significant difference (p=0.44) in expression between treatments.
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5.3.1.4 Espin
Expression of espin mRNA in testes of rats treated with EDS is reduced to less than 20%
of expression detected in testes of untreated (control) animals. Treatment with
testosterone esters in addition to EDS causes expression of espin mRNA to increase by
50% compared to control rat testes. A graph of average expression and associated error
bars is shown in Figure 5-5. Although the changes in mRNA expression are dramatic in
response to EDS or EDS plus testosterone ester treatments, the analysis of expression in
small group sizes (n=3 in control group, and n=4 EDS and EDS plus T animals) meant
that treatments were found not to have a significant effect on espin expression, p=0.49.
The large variation in expression detected in the testes of control and EDS plus
testosterone ester treated animals was also responsible for the lack of significance, and














Figure 5-5: Quantification of espin expression in EDS- or EDS plus TE treated rat testes.
Expression was assessed in testes 6 days after treatment by Taqman, and expression
standardised to that in untreated (control) testes. Bars represent average expression ± SEM, for
n=4 animals per treatment (except for control group with n=3 animals). A Kruskal-Wallis test
demonstrates no significant difference (p=0.49) in expression between treatments.
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5.3.2 Western analysis
5.3.2.1 AR
Expression ofAR protein in testes of rats was quantified by fluorescent Western blotting
(Figure 5-6). Panel A shows the fluorescently labelled protein bands of AR (110 kDa,
green) and the loading control P-actin (42 kDa, red). Expression of AR was detected in
all testicular samples, but differences in expression level between treatment groups were
not immediately apparent. By measuring the intensity of fluorescence associated with
AR and P-actin in each well the expression of AR, standardised to P-actin, was
quantified for each sample. The mean AR expression in testes from each treatment
group (n=4) is shown in panel B, expression is presented relative to average expression
in testes of control animals. A significant effect of treatments on AR expression was
found overall (p=0.05) using the Kruskal-Wallis test, and Dunn's multiple comparison
post-hoc test revealed that expression was significantly reduced (p<0.05) specifically in
testes of EDS-treated rats compared to EDS plus TE treated rats. Expression in control
and EDS plus TE testes was relatively similar.
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B
Control EDS EDS + TE
Figure 5-6: Expression of total AR protein in testes of rats treated with EDS, EDS plus TE
or vehicle (control). Panel A shows the fluorescently-labelled protein bands on the Western
membrane associated with AR (110 kDa, green) and p-actin (42 kDa, red), lane L contains
seeBlue ladder. The lanes contain protein from rats treated with EDS (1), EDS plus TE (2), and
control rat testes (3). The graph in panel B shows the expression of AR quantified from the
Western in panel A. AR expression was standardised to p-actin in each well, and the mean AR
expression ± SEM in each treatment group (n=4) is presented relative to expression in control
testes injected with vehicle. Statistical analysis (Kruskal-Wallis test) reported a significant effect
due to treatment (p= 0.05). *; p<0.05.
5.3.2.2 Rhox5
Total expression of Rhox5 in testicular samples, as evaluated by Western blot, is shown
in Figure 5-7. Panel A shows the fluorescence associated with Rhox5 and P-actin bands
on the Western membrane, panel B shows the quantification of protein expression from
measuring the fluorescence of the bands. Protein expression was assessed in four
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samples for each treatment. The Rhox5 (30 kDa) expression in each sample was
standardised to the associated P-actin (42 kDa) expression in the same lane, and
presented relative to the level in control tissues. Expression of Rhox5 in the testes of
EDS-treated rats was -20% less than in control animals, and treatment with EDS plus
TE reduced expression by -45%. Although expression was decreased by treatment with
EDS and EDS plus TE, the changes were not significant (p=0.12, Kruskal-Wallis test).
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Figure 5-7: Expression of Rhox5 protein expression in the testes of adult rats treated with
EDS or EDS plus TE. Panel A shows expression of (3-actin (top row) and Rhox5 (bottom row)
in the testes of adult rats treated for 6 days with EDS (1) or EDS plus TE (2), or injected with
vehicle (control, 3). Panel B shows the standardised Rhox5 expression (Rhox5/|3-actin
expression) for each treatment relative to expression in the testes of animals injected with
vehicle (control). The graph shows mean ± SEM in n=4 samples/treatment. Non-parametric
statistical analysis by Kruskal-Wallis test reported no significant difference between treatments
(p = 0.12).
5.3.2.3 ^3-tubulin
Total expression of P3-tubulin protein in rat testes treated with EDS, EDS plus TE, or
injected with vehicle (control) is presented in Figure 5-8. Panel A shows the
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fluorescently-labelled P3-tubulin and (3-actin on a membrane, whilst panel B shows the
average expression of (33-tubulin normalised to p-actin within the same lane, quantified
from 4 animals/treatment. The P3-tubulin expression in the EDS and EDS plus TE
samples were standardised to expression in control testes, given a value of 1. There was
substantial expression of P3-tubulin protein in all samples. Expression in EDS-treated
testes was -10% greater than in control samples, but expression in EDS plus TE samples
was -30% lower than control testes. Despite these differences no statistically significant
difference between the 3 groups was reported (p=0.23).
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Figure 5-8: Expression of (33-tubulin protein expression in the testes of adult rats treated
with EDS or EDS plus TE. Panel A shows expression of (33-tubulin (red) and (3-actin (green) in
the testes of adult rats treated for 6 days with EDS (A & D), EDS plus TE (B & E), or injected
with vehicle (C & F, control). On the left of the image (lane L) is the Seeblue protein ladder.
Panel B shows the standardised (53-tubulin expression ((33-tubulin/(3-actin expression) for each
treatment relative to expression in the testes of control animals injected with vehicle. The graph
shows mean ± SEM for n=4 samples. Kruskal-Wallis non-parametric analysis revealed no
significant difference between treatments (p = 0.23).
5.3.2.4 p-tubulin
Whilst expression of the p3 isoform of P-tubulin was quantified with a specific antibody
(Figure 5-8), the total expression of all P-tubulin isoforms was assessed using a pan-P-
tubulin antibody (Figure 5-9). Panel A shows the fluorescently labelled protein bands of
p-tubulin and P-actin, and panel B is the quantification of fluorescence from Western
blots on 4 samples / treatment. The quantification presented is the average P-tubulin
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expression normalised to (3-actin within the same lane for each treatment, and presented
as a proportion of the expression in control testes. Quantification showed that
expression of P-tubulin in the testes of EDS and EDS plus TE treated rats was not
significantly different from controls.
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Figure 5-9: Expression of p-tubulin protein expression in the testes of adult rats treated
with EDS or EDS plus TE. Panel A shows expression of p-tubulin (red) and p-actin (green) in
the testes of adult rats treated for 6 days with EDS (A & D), EDS plus TE (B & E), or injected
with vehicle (C & F). On the left of the image (lane L) is the Seeblue protein ladder. The panel
B shows the standardised p-tubulin expression (P-tubulin/p-actin expression) for each treatment
relative to expression in the testes of control animals injected with vehicle. The graph shows
mean ± SEM for n=4 samples. Non-parametric statistical analysis by Kruskal-Wallis test
demonstrated no significant difference between treatments (p = 0.74).
Control EDS EDS + TE
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5.3.2.5 Espin
Fluorescent Western blotting was employed to visualise and quantify expression of espin
protein in the testes of rats injected with vehicle and those treated with EDS or EDS plus
TE (Figure 5-10). Panel A shows the fluorescently stained espin and P-actin on the
Western membrane, panel B shows the quantification of average espin expression in
each treatment. The espin expression presented in the graph is based upon 4 animals per
treatment and was normalised to P-actin expression within the same lane and
standardised to expression in the control testes (given a value of 1). Substantial
expression was seen in all treatments; there was no significant difference in espin
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Figure 5-10: Expression of espin protein in the testes of adult rats treated with EDS or
EDS plus TE. Panel A shows expression of espin (red) and P-actin (green) in the testes of adult
rats injected with vehicle (1) and of adult rats treated for 6 days with EDS (2) or EDS plus TE (3).
Panel B shows the standardised espin expression (espin/p-actin expression) for each treatment
relative to level in the testes of control animals injected with vehicle. The graph shows mean ±
SEM for n=4 samples. Kruskal-Wallis non-parametric analysis showed no significant difference
between treatments (p = 0.60).
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5.3.3 Immunohistochemistry
5.3.3.1 Sdmg-1
Sdmg-1 is a marker of SC cytoplasm expressed at all stages of the spermatogenic cycle
and was visualised using DAB immunohistochemistry in rat testes (Figure 5-11). As
expected, expression of Sdmg-1 was not altered by treatment with EDS with or without
TE. Positive expression is limited to within the seminiferous tubules and was clearly
localised to SC cytoplasm passing between the GC populations resulting in a pattern of
narrow bands running from the basement of the tubules through the epithelium towards
the lumen. In sections collected from rats treated with EDS, mature LC are absent
reducing the volume of the interstitium (in Figure 5-11 panels A, B, C and D) but SC
cytoplasm did not appear grossly different.
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Figure 5-11: Expression of Sdmg-1 in the testes of rats treated with EDS (A & B), EDS
plus TE (C & D), or vehicle control (E & F). Testes were recovered after treatment for 6 days,
and expression of Sdmg-1 was visualised through DAB immunohistochemistry. images shown
are magnified to x20 (A, C, & E) or x40 (B, D, & F). Scale bars represent 100 pM in x20 and 50
pM in x40 images. Note the absence of mature LC and reduced volume of the interstitium in
sections from EDS treated rats.
5.3.3.2 AR
Western blotting for AR detected reduced amounts of AR in the testes of EDS-treated
rats compared to in animals treated with vehicle or EDS plus TE (Section 5.3.2.1).
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Immunostaining of fixed testes confirmed expression of AR in nuclei of SC, PTM, and
LC in control sections (Figure 5-12, panels E and F). Immunopositive LC in control
testes are indicated by arrows in panels E and F. AR expression was still detected in SC
and PTM of rats treated with EDS and EDS plus TE, there was no obvious change in
intensity of immunostaining. As expected, intensity of immunostaining in SC was
stage-dependent with most intense staining in sections of tubules at stages VI-VIII
(Bremner et ah, 1994). In the EDS and EDS plus TE treated animals AR positive cells
surrounding blood vessels were present (panel D) and the interstitium contained fewer
cells and appeared to comprise a smaller proportion of the sections. Staining was
observed in the cytoplasm of elongated spermatids, this is non-specific background
staining as it does not occur when other antibodies to AR are used (Bremner et al.,
1994).
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Figure 5-12: Expression of AR in the testes of rats treated with EDS (A & B), EDS plus TE
(C & D), or vehicle control (E & F) for 6 days. Expression of AR was visualised by DAB
immunohistochemistry. Images presented are magnified x20 (A, C, & E) or x40 (B, D, & F), and
error bar represent 100 pM in x20 and 50 pM in x40 images. Immunostained LC in control
testes are indicated by arrows in panels E and F.
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5.3.3.3 Espin, N-cadherin, and zona occludins -1
Expression of the junctional proteins; espin (in ectoplasmic specialisations, a testis-
specific form of adherens junction described in section 1.2.4.2), N-cadherin (another
component of ectoplasmic specialisations described in section 1.2.4.2) and zonula
occludens-1 (ZO-1, a tight junction associated adaptor protein described in section
1.2.4.1), were localised in the testes of control rats injected with vehicle and rats treated
with EDS or EDS plus TE by fluorescent immunohistochemistry (Figure 5-13). Co-
expression of espin and ZO-1 are shown in panels A, C and E, and expression of N-
cadherin is shown in panels B, D and F, all sections were co-stained with DAPI which
highlights the nuclei of cells. Expression of espin was localised with the basal
ectoplasmic specialisations (indicated by starred arrow in panel C) at the base of
seminiferous tubules as well as the sites of interaction between SC and elongate
spermatids closer to the lumen (apical ectoplasmic specialisations, indicated by plain
arrows in panels A and E). At the periphery of the seminiferous tubules espin staining
was not continuous. ZO-1 expression was also localised to sites at the base of the
seminiferous tubules (also indicated by starred arrow, in panel C), which should
correspond to tight junctional complexes between SC that are important for integrity of
the BTB. Immunopositive staining of N-cadherin was concentrated at the periphery of
the tubules (indicated by starred arrow in panel B) and close to the lumen (indicated by
plain arrow in panel F). The gross pattern of expression of N-cadherin, espin and ZO-1
was not altered by treatment with EDS or EDS plus TE compared to control testes.
Espin and N-cadherin were both localised to apical and basal ES in the seminiferous
tubules (indicated by plain and starred arrows in panels respectively), in line with co-
expression at these sites. However N-cadherin is also observed in a pattern resembling
cytoplasmic staining in SC, in the absence of espin. The 'cytoplasmic' N-cadherin
staining (indicated by arrow heads in panels D and F) is weaker than at the apical and
basal ES, where very strong staining is observed, and is thought to represent non¬
specific background.
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Figure 5-13: Fluorescent immunohistochemistry for expression of espin, ZO-1 and N-
cadherin in testes of adult rats treated with EDS or EDS plus TE. Testes of vehicle treated
rats (panels A & B) and rats treated for 6 days with EDS (panels C & D) or EDS plus TE (panels
E & F) were stained using antibodies specific for espin and ZO-1 (green and red respectively, in
panels A, C, & E) and for N-cadherin (panels B, D, & F). Expression at basal locations (BTB and
basal ES) is indicated by arrows marked by asterisks. Expression at apical ectoplasmic
specialisations is indicated by arrows. Arrowheads alone indicate non-specific 'cytoplasmic' N-
cadherin staining. All sections were counterstained with DAPI nuclear stain (blue) and images
taken at 40x magnification, the scale bar represents 50 pm.
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5.3.3.4 Connexin43
Expression of connexin43 (Cx43), a component of gap junctions, and SMA (PTM cell
marker) were visualised by fluorescent immunohistochemistry (Figure 5-14 & Figure
5-15). Expression of Cx43 was localised to sites between SC and sites of SC-GC
interaction with prominent staining at the base of the seminiferous tubules (indicated in
figures by plain arrows) and near the tubules' lumen where SC and elongate spermatids
make contact (indicated by starred arrows in the figures). Expression and localisation of
Cx43 were not different in control testes compared with those rescued from EDS or EDS
plus TE treated rats. Smooth muscle actin (SMA) was stained to visualise the
peritubular myoid cells at the perimeter of the tubules and its expression was not
disrupted by EDS or EDS plus TE treatment even though these cells are AR positive.
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Figure 5-14: Fluorescent immunohistochemistry for expression connexin43 and SMA in
testes of adult rats treated with EDS or EDS plus TE. Testes of rats injected with vehicle
(panels A-C) and rats treated for 6 days with EDS (panels D-F) or EDS plus TE (panels G-l)
were stained using antibodies specific for connexin43 (red) and SMA (green). Staining in the
apical compartment is indicated by starred arrows, expression at basal locations is indicated by
non-starred arrows. All sections were counterstained with DAPI nuclear stain (blue) and images
taken at 40x magnification, the scale bar represents 50 pm.
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Figure 5-15: Fluorescent immunohistochemistry for expression connexin43 and SMA in
testes of adult rats treated with EDS or EDS plus TE. Testes of rats injected with vehicle
(panels A-C) and rats treated for 6 days with EDS (panels D-F) or EDS and TE (panels G-l)
were stained using antibodies specific for connexin43 (red) and SMA (green). Staining in the
apical compartment is indicated by starred arrows, expression at basal locations is indicated by
non-starred arrows. All sections were counterstained with DAPI nuclear stain (blue) and images
taken at 80x magnification, the scale bar represents 20 pm.
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5.4 Discussion
5.4.1
Previous studies have shown that acute androgen withdrawal due to LC ablation by
EDS-treatment has a negative impact on GC survival and SC function (Bartlett et al.,
1986; Kerr et al., 1993a; McKinnell and Sharpe, 1995; Sharpe et ah, 1994; Sharpe et al.,
1992). In addition, EDS-treatment reduced seminiferous tubule fluid 6 days after LC
ablation and reduced luminal diameters of tubules at stages VI-VIII (Sharpe et al.,
1994). Previous studies in isolated seminiferous tubules revealed that the amount of
seminiferous tubule fluid secreted was stage dependent whilst greater secretion was
demonstrated at stages VI-VIII than during other stages the difference was absent
following EDS-treatment (Sharpe et al., 1992). Androgens, and EDS treatment, did not
affect synthesis of the secreted proteins, instead they altered the secretory pathway itself
(McKinnell and Sharpe, 1995). Since these studies in EDS rats were undertaken,
putative targets for androgen regulation have been identified in investigations including
array studies on mice with manipulated AR expression (Denolet et al., 2006a; Eacker et
al., 2007; Meng et al., 2005) and in mice treated with exogenous steroids (Sadate-
Ngatchou et al., 2004). After the problems encountered with isolated SC (chapter 3) and
the in vivo adenoviral approach (chapter 4), the well established EDS model was used to
evaluate expression of putative androgen responsive genes.
The first gene to be evaluated was AR, PCR and Western analysis of AR expression
showed dramatic reductions in the amounts ofmRNA and total protein in testes of EDS-
treated animals compared to vehicle-treated (control) animals. The reduction in
expression of both was reversed in EDS plus TE treated animals. Analysis of the
Western blot revealed a significant difference in expression between EDS and EDS plus
TE treated animals. The reduction in AR mRNA and protein expression in EDS animals
may partially be explained by loss of AR-positive LC. However expression was rescued
by TE-treatment consistent with androgen-dependent expression in the surviving
testicular cell types (SC and PTM). Surprisingly immunohistochemistry on testes of
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EDS-treated animals revealed persistence of AR expression in SC and PTM cells. This
is in contrast to results in previous studies where both these cell types lost AR
expression within 6 days of EDS-treatment (Atanassova et ah, 2006; Bremner et ah,
1994). The large decline in AR protein detected in the Western blot suggests that AR
expression in the SC and PTM was reduced, but the decline in AR expression may have
been masked in immunohistochemical studies by high non-specific background staining.
High background with positive staining in the cytoplasm of elongated spermatids is not
present when other antibodies against AR are used (Bremner et al., 1994) and may be
prevented by using one of these other antibodies or by using lower concentrations of the
current antibody. Sodium citrate antigen retrieval was used here and by Bremner at al.,
so should not be the explanation for the high background in these sections.
Expression of Rhox5 mRNA was androgen-responsive with highest expression in the
testes of control and EDS plus TE treated animals, and a dramatic (non-significant)
reduction in EDS-treated animals. Total expression of Rhox5 protein did not mirror its
mRNA; EDS-treatment caused a 20% reduction compared to testes of control animals,
but rather than TE-treatment increasing Rhox5 expression it was associated with a
further 20% decrease in protein. Rhox5 has both distal and proximal promoters (section
1.4.4), expression of Rhox5 in the testes and epididymis of rats and mice is expressed
under the regulation of the proximal promoter (Maiti et al., 1996; Sutton et al., 1998).
Despite expression in testis and epididymis being regulated by the same promoter in
both mice and rats their patterns of Rhox5 expression are different. Levels of Rhox5
transcripts in mice are 10-times greater in testes than in epididymis, but in rats
epididymal Rhox5 expression is more than 10 fold greater than in testes (Sutton et al.,
1998). Consistent with the mRNA expression presented above, the androgen-dependent
nature of Rhox5 expression has been described in previous studies. RNase protection
assays on testes ofmice and rat revealed that expression of transcripts from the proximal
promoter, but not the distal promoter, are androgen-dependent being lost in EDS-treated
rats and hypophysectomised mice, and retained in animals treated to replenish
testosterone levels (Sutton et al., 1998). Indeed an androgen-responsive domain
Chapter 5 Gene expression in rat testes: studies using LC depletion with EDS 233
consisting of two androgen-response elements was identified in the proximal promoter
region of the murine Rhox5 gene (Barbulescu et al., 2001). It was the second response
element (ARE-2) linked to luciferase that was used in chapter 3 to quantify AR-
dependent activation in SKI 1 cells by androgens. Rhox5 is expressed in adult mouse SC
in a stage-specific manner at stages VII and VIII that parallels AR expression (Lindsey
and Wilkinson, 1996b; Sutton et ah, 1998) and indicates androgen-responsiveness.
Androgen sensitivity of Rhox5 mRNA expression was also demonstrated in SCARKO
mice lacking AR expression specifically in SC, in these animals Rhox5 mRNA and
protein expression were reduced dramatically (De Gendt et ah, 2004; Tan et ah, 2005).
It is not clear why the pattern of androgen responsive expression observed for Rhox5
mRNA has not been repeated for protein expression, although it is plausible that the
Rhox5 protein is highly stable compared to the mRNA and has not brokendown at this
relatively early time point. In vitro studies on isolated primary mouse SC showed loss
of Rhox5 protein even with addition of testosterone to culture media, which suggests
androgens alone are insufficient to maintain Rhox5 expression (Sutton et ah, 1998).
Studies on MSC1 immortalised SC, transiently transfected with AR cDNA,
demonstrated 5-7 fold increased expression of Rhox5, plus 4 other Rhox genes, in
response to testosterone treatment (Maclean et ah, 2005), this result is in contrast to the
response in primary mouse SC but in-line with the results presented above.
P3-tubulin mRNA was expressed in a similar pattern to AR and Rhox5. In testes of rats
treated with EDS, expression of /33-tubulin was almost completely abolished compared
to expression in control animals and could be restored to a level greater than in control
testes by treatment with EDS plus TE. The pattern of f33-tubulin expression indicates
that it is androgen responsive and is in agreement with a previous array study in which
(33-tubulin was identified as a potential androgen-responsive gene due to its differential
expression in SCARKO and wild-type mice (Denolet et ah, 2006b). (33-tubulin protein
quantified by Western blot did not adopt a similar expression pattern to its mRNA,
instead expression in testes of control and EDS-treated rats were approximately equal
and expression following EDS plus TE treatment was reduced compared to both other
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groups. When a pan (3-tubulin antibody was used expression in all 3 treatments was
approximately equal. The lack of statistical significance between groups suggests the
differences in expression are the result of high variation in expression independent of
treatment.
The intimate interactions between SC and GC via junctional complexes, and the
extensive evidence linking androgen action via SC in supporting GC maturation have
focused attention on proteins that form part of testicular junctional complexes as
potential targets for control by androgens. Reports by Braun and co-workers of
regulation of claudin3 expression, a component of the BTB, by androgens (Meng et al.,
2005) and the appearance of intra-epithelial vacuoles in EDS-treated testes (Bartlett et
al., 1986; Kerr et al., 1993b) support the androgen-dependence of junctional protein
expression. Expression of espin mRNA altered in treated testes with expression in testes
treated with EDS plus TE -50% higher than in control samples, and expression in EDS
exposed testes reduced to approximately 10% of control. Espin expression has
previously been reported as a putative androgen responsive SC product following
quantification of gene expression in SCARKO mice (Abel et al., 2008). As described
below, immunohistochemistry for espin does not support androgen-responsiveness of
espin expression in line with expression of espin in the testes quantified by Western blot,
which was largely unaltered by androgen depletion by EDS, or replacement by TE.
The expression and distribution of the junctional proteins espin, connexin43, N-cadherin
and ZO-1 were visualised by immunohistochemistry in testis sections collected from
animals treated with EDS, EDS plus TE, or vehicle control. In line with the Western
blot result, and previous studies that indicate that espin expression at the basal and
adluminal ES is not dependent on androgen signalling (Beardsley and O'Donnell, 2003;
O'Donnell et al., 2000), expression of espin at the ES was not altered by androgen
depletion induced by EDS-treatment, nor did exogenous testosterone treatment alter
expression either. Intensity and localisation of ZO-1, N-cadherin and Cx43 were not
altered by depletion of testosterone and were not over expressed in response to TE-
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treatment. Lack of change to protein expression of ZO-1 and N-cadherin are in contrast
to results presented by Xia et al, who reported increased expression of both proteins
following androgen depletion in rat testes (Xia et al., 2005). The study also identified
diffusion of N-cadherin away from the BTB after testosterone depletion (Xia et al.,
2005), which was not observed in the present report. The changes in N-cadherin and
ZO-1 expression may not have been sufficiently large in this study to be identified
through immunohistochemistry, Xia et al also used Western blotting to identify the
increased expression however the change was apparent through immunohistochemistry
as well. Altered expression of connexin43 in response to testosterone has not been
reported in previous studies, although stage-specific Cx43 expression with greatest
expression during stages VI-VIII in rats and mice mimics the expression of AR (Risley
et al., 1992). The lack of change in Cx43 expression in response to androgen-depletion
and restoration described in the present study is therefore in common with the available
literature. Although not demonstrated to be androgen-regulated, expression of Cx43 in
SC has been shown to be essential for initiation of spermatogenesis and for proliferation
of spermatogonia, SC-specific knock out of Cx43 expression in mice results in infertility
and cannot be compensated for by other connexins (Brehm et al., 2007).
The final protein whose localisation and expression was determined through
immunohistochemistry was Sdmg-1, the protein is a marker of SC cytoplasm and has
been implicated in protein secretion pathways in fetal testes (Best et al., 2008). In testes
of control animals expression forms narrow bands of intense staining running from the
basement of the tubule inwards towards the lumen of the tubules. The pattern and strong
staining was maintained in the testes of animals treated with EDS or EDS plus TE. A
lack of changes to expression pattern of Sdmg-1 indicates that depletion of androgens
does not impact the distribution of SC cytoplasm and therefore subsequent failure of
spermatogenesis is not a consequence of SC losing contact with associated GC due to
disruption to its cytoplasm. The staining also revealed no evidence of vacuole formation
in the SC of testes treated with EDS or EDS plus TE, early studies reported the
occurrence of such vacuoles 7 days after treatment (Bartlett et al., 1986).
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Changes in mRNA expression for AR, Rhox5, j33-tubulin and espin between treatments
were not statistically significant principally because of the small numbers of animals in
each of the three treatment groups, in particular the control group which was represented
by only two or three animals in each real-time PCR analysis. The four animals studied
in the EDS and EDS plus T groups may also have been insufficient. To increase the
probability of identifying a statistically significance change, larger numbers of animals,
at least five, should be analysed in each of the three groups. Large variation in the
expression levels detected between the animals in each treatment group used during the
study, in combination with the inadequate numbers of animals used, also impeded
statistical significance of the result. High or low levels of mRNA expression were
consistently found for all four transcripts in each animal, indicating that each animal
exhibited either high or low expression of its transcripts in general. The protein
samples, extracted from the same testes as the mRNA, exhibit a much smaller variation
in expression, which meant that an observed change in AR protein expression was
statistically significant. The changes in mRNA expression detected by Q-RT-PCR were
often dramatic, and had it not been for the large inter-animal variation the results may
well have been significant. Larger numbers of animals in each treatment group may
have overcome these problems. A drawback of the EDS model when investigated
through Western blotting and PCR is the inability to differentiate between changes in the
different cells that compose the testes, and to compensate for the loss of the LC. In this
study we sought to identify changes to gene expression that occur only in the androgen-
responsive tubules of the testis, these stage VI-VIII tubules and their proteins make up
only a small proportion of the whole testis. Changes in protein expression investigated
in these studies may have been insufficient to be detected over the background of
proteins expressed in tubules at other stages and in the rest of the testis.
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5.4.2 Conclusions
Treatment of rats with EDS, to deplete LC and eliminate testosterone from their testes,
appears to have been successful in this study on the basis that LCs were absent in
testicular sections and expression of AR, Rhox5, ft3-tubulin and espin mRNAs, and AR
protein were altered as expected in response to androgen depletion and replacement.
Androgen-responsiveness of espin and /33-tubulin mRNA had previously been reported
through arrays and Q-RT-PCR on SCARKO and anti-androgen treated mice, so
evidence of the same manner of response in a model of acute androgen withdrawal
strengthens the evidence for androgen-sensitivity. Despite demonstrating that
expression of Rhox5, espin, and 163-tubulin mRNA are androgen-responsive, expression
of these proteins assessed by Western blotting does not show an androgen-responsive
pattern. The contradiction between reduced mRNA expression and preservation of
protein expression in testes following androgen-depletion could be explained if the
proteins have long half-lives. A protein with a long half-live could be maintained with
only limited degradation for 6 days, after which the testes were collected, despite a
dramatic decline in mRNA transcription and translation of new protein.
Results obtained in these studies do not indicate any impact of androgen signalling on
the expression or distribution ofN-cadherin, ZO-1 or Cx43 proteins within seminiferous
tubules. Along with the results for espin protein, these 4 proteins represent components
from ectoplasmic specialisations (espin and N-cadherin), gap junctions (Cx43), tight
junctions (ZO-1), and desmosome-like junctions (N-cadherin). The lack of consistent
decline in expression of junctional proteins does not indicate disruption to SC-GC
interaction in response to androgen depletion despite previous reports of GC sloughing
in tubules of testosterone suppressed rat (Cameron et al., 1993; O'Donnell et al., 2000)
and loss of claudin3 expression at tight junction in testes with SC-specific knockout of
AR (Meng et al., 2005). Expression of Sdmg-1 was also maintained following androgen
depletion indicating that irrespective of the method by which androgens support
spermatogenesis via the SC, the impact of androgen depletion is not by disrupting the
distribution of the SC cytoplasm. Sdmg-l's involvement in protein secretion pathways
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in fetal testes might have predicted that its expression would be altered in response to
changing testosterone levels in adult testes in light of the reduced protein secretion
observed by Sharpe and co-workers following androgen-depletion (McKinnell and
Sharpe, 1995; Sharpe et al., 1994; Sharpe et al., 1992)
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6 General Discussion
6.1 Introduction
Spermatogenesis is dependent upon functional Sertoli cells to support the GCs with
which they interact. Expression of a functional AR in SC is required for complete
spermatogenesis (Chang et al., 2004; De Gendt et al., 2004; Holdcraft and Braun, 2004).
De Gendt et al. developed a mouse model in which expression of AR was knocked out
throughout the body (ARKO) or specifically in SC (SCARKO). Male ARKO mice have
a female phenotype and undescended, abnormally small testes located in the abdomen or
inguinal region (De Gendt et al., 2004). Spermatogenesis is disrupted in ARKO mice
due to failure to support spermatogonial and meiotic GC maturation (Tan et al., 2005).
In SC-specific AR knockout mice generated by De Gendt et al. and Chang et al. testes
descend normally into the scrotum, however spermatogenesis was disrupted by failures
in meiosis during stages VI - XII, resulting in reduced numbers of round and elongate
spermatids (De Gendt et al., 2004). Spermatogenesis in a third SC-specific AR
knockout model, generated by Holdcraft et al, was also disrupted (Holdcraft and Braun,
2004). During the generation of the AR floxed line used by Holdcraft et al. a
hypomorphic mutant was generated with reduced AR expression in SC and other cells.
In the mice with SC-specific AR depeltion generated using this line the final stages of
spermatid development and release of elongate spermatids from the seminiferous
epithelium were disturbed (Holdcraft and Braun, 2004).
Tubules at stages VII and VIII in mice and rats have been identified as androgen
responsive (Sharpe, 1994) and SC in these tubules exhibit the most intense
immunoexpression ofAR protein (Bremner et al., 1994; Suarez-Quian et al., 1996; Zhou
et al., 2002). Stage-dependent expression of AR has also been documented in human
testes (Suarez-Quian et al., 1999). Several mouse models with exon-specific depletions
in ERa (ERaKO) and ERfi (ERpKO) has been successfully described (Dupont et al.,
2000; Krege et al., 1998; Lubahn et al., 1993). A new mouse line with a ubiquitous
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deletion of ERp throughout their bodies are infertile although gross testicular
morphology appears normal (Antal et al., 2008). In vivo models designed to study
impact of steroids on SC, such as ARKO mice, often compromise steroid action during
fetal or prepubertal development which potentially disturbs gonadal development. In
vitro methods allow easier manipulation of steroid hormone action, but lack the complex
interactions between SC and associated GCs and PTM cells present in vivo. In the
present study three approaches were used to investigate the impact of steroid signalling
on SC gene expression. First an in vitro model (the SKI 1 cell) was assessed, and gene
expression in these cells was quantified with the aim of identifying responsive genes
implicated in control of spermatogenesis. Second methods for specific infection of
mouse SC within the seminiferous tubule using adenoviral vectors were explored; we
intended to use this method to introduce RNAi constructs to knockout AR or ERP
expression specifically in SC. Finally the EDS-treated rat model was used to identify
putative androgen responsive genes and validate changes in expression of genes
identified as androgen-responsive in previous studies conducted using the SCARKO
mouse model.
6.2 Gene expression using an immortalised Sertoli cell line
SKI 1 cells are immortalised SC derived from testes of day 10 mice whose proliferation
and phenotype is sensitive to culture temperature (Walther et al., 1996) due to the
presence of a temperature sensitive large T-antigen expressed in the mice from which
they were derived (Jat et al., 1991). Previous investigations of gene expression in SKI 1
cells have demonstrated differential expression of SGP-2, transferrin, and Steel factor
between cells cultured in permissive and non-permissive conditions (Sneddon et al.,
2005; Walther et al., 1996; Walther et al., 1997).
In line with these previous studies, SKI 1 cells incubated at permissive (34°C) and non-
permissive temperatures (39°C) in this study have different phenotypes: the cells become
flattened and demonstrate a gene expression profile that is more similar to mature SC at
non-permissive temperatures than under permissive conditions. Expression of SGP-2
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and Rhox5 mRNA and protein is increased at non-permissive temperatures and
demonstrates a shift from an immature state where expression of Rhox5 and SGP-2 is
low, to a mature state when expression would be expected to be higher. In vivo
expression of Rhox5 gene in mouse, detected by RNase protection assay, increased on
day 9 post-partum (Lindsey and Wilkinson, 1996b). The expression of SGP-2 protein is
detected in mouse SC from 12 days post-partum and intensity of staining increases
between 12 and 50 days post-partum (Tan et al., 2005). The changes in gene expression
in cells cultured in non-permissive conditions correspond well with gene expression in
day 10 mouse SC, which was the age of the mice from which the cells were derived (Jat
et al., 1991). Shift of phenotype from 'immature' to 'mature' following transfer from
34°C to 39°C provides an attractive model for detailed investigation of the mechanism of
SC development, or to validate previous studies. The expression of Sdmg-1 at both
temperatures might be used as a marker of seminiferous tubule fluid secretion by SC at
immature and mature stages of development and the similarity between the amount of
total protein at the two temperatures suggest gross secretory function is similar in mature
and immature SC. Further investigation of this and other secretory proteins, such as
cyclic protein -2, may reveal further details of SC fluid secretions.
Expression of AR and ERfi mRNA and protein had been previously demonstrated in
SKI 1 cells, and steroid responsiveness had also been demonstrated by quantifying the
amount of a luciferase reporter gene produced under control of androgen or oestrogen
response elements in the presence of androgen and oestrogen ligands (Sneddon et al.,
2005). Therefore we sought to investigate expression of putative steroid-responsive
genes and identify novel targets. Unfortunately the SKI 1 cells used in the current study
lacked significant androgen receptor protein and mRNA and this prevented analysis of
androgen responsive gene expression in their native state. Successful restoration of AR
mRNA and its translation into a functional AR protein was achieved by transient
transfection with a plasmid containing a full length AR cDNA. Expression of an
exogenous Rhox5 promoter-luc construct was successfully stimulated by androgen
treatment in the ^4R-transfected SKI 1 cells, however expression levels of endogenous
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genes including Rhox5 that had already been identified by array analysis as up regulated
by androgens in SC in vivo were not stimulated under the same conditions. Oestrogen
receptor (3 (ERfi) mRNA expression and response to oestrogens has been demonstrated
in SKI 1 cells without the need for transfection with an oestrogen receptor construct; as
no oestrogen responsive genes was successfully identified in SC validation of the
response was limited to stimulation of an exogenous 3xERE-luc construct. Stimulation
of endogenous oestrogen responsive genes, if any are identified, may also be deficient in
SK11 cells in the same manner and for the same reasons as androgen-responsive gene
expression but this merits investigation in the future. If the SKI 1 cell line, or any other
SC-line, is to be used in the future to study response to AR-dependent gene activation
then the androgen response mechanism must be fully functional, and the reasons for the
deficiency in stimulation through endogenous promoters should be identified. The
function of SC is recognised to be strongly dependent on its testicular niche including
interaction with GCs and PTMs (Maguire et al., 1997; McKinnell and Sharpe, 1997;
Pineau et al., 1990; Skinner and Fritz, 1985a; Skinner and Fritz, 1985b; Syed and Hecht,
1997; Tirado et al., 2003), and therefore functions including the response to steroid
stimulation could be compromised in the absence of factors/interactions with GC and
PTM cells. If GCs or PTM cells, or both, are required for full function of SC, modified
methods for investigation of SC response to steroids and other functions will be
required. Alternative methods for the study of SC function include co-cultures of SC
and GC such as described by Syed and Hecht (Syed and Hecht, 1997), culture of isolated
seminiferous tubules (McKinnell and Sharpe, 1995) or ex vivo cultures of explanted
testes (Schlatt et al., 1999). Any of these could be employed if isolated SC cultures
prove insufficient for study of steroid signalling on SC.
Notably, SC cultured in the absence of GC cannot undergo cyclic changes characteristic
of SC in tubules at different stages of spermatogenesis. The cultured SC will never
exhibit stage-specific changes in expression of genes such as: AR, SGP-2, cyclic protein
2, and connexin43 (Bremner et al., 1994; Maguire et al., 1993; Risley et al., 1992; Tan et
al., 2005) all of which have been reported to be expressed to varying levels in tubules at
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different stages of the spermatogenic cycle. SK11 cells in culture have a flattened
appearance in contrast to the cell morphology observed in vivo in seminiferous tubules
of adult testes, further evidence of variation between in vitro and in vivo SCs.
The greatest success in identifying androgen responsive genes in SC has been achieved
using arrays to compare expression between control testes and those with SC-specific
ablation of AR expression (Abel et al., 2008; Denolet et al., 2006a) or after treatment
with anti-androgens (e.g. Flutamide) (Denolet et al., 2006a). To identify putative
oestrogen responsive genes in SC a similar system using a floxed ER/3 allele (Antal et
al., 2008) and the AMH-Cre mouse line could be used to establish a SC-specific ERp
knockout. Expression in the testes of this model could be compared to that in control
testes via array analysis to identify putative targets for investigation of oestrogen-
response in SC.
6.3 Gene expression in Sertoli cells using adenoviral constructs
Adenoviral vectors have been used in previous studies to specifically introduce
transgenes into SC by delivering the virus into the lumen of seminiferous tubules via one
of three routes, 1) direct injection into the tubule lumen, 2) injection into the rete testis,
or 3) canulation of an efferent ductule (Blanchard and Boekelheide, 1997; Kanatsu-
Shinohara et al., 2002; Scobey et al., 2001). These studies successfully induced efficient
SC-specific expression of a phosphorylation deficient mutant of CREB, LacZ or Steel
factor in vivo and in vitro, without expression in associated GCs (Blanchard and
Boekelheide, 1997; Kanatsu-Shinohara et al., 2002; Scobey et al., 2001). The Rhox5
promoter has been used in vivo to knockdown WT-1 expression by driving specific
expression ofRNAi in SCs of transgenic mice (Rao et al., 2006). We carried out a pilot
study to investigate whether an adenoviral vector could be delivered into seminiferous
tubules by injection into an efferent ductule to infected only SC without damaging the
tubules. The intention was to harness the siRNA technology by delivery directly, and
acutely, into the testes of adult mice.
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When adenoviral vectors were injected into the testicular tubule lumens, infection was
SC specific. Previous studies in vivo and in vitro have also reported that GC are not
infected by adenoviral vectors (Blanchard and Boekelheide, 1997; Scobey et ah, 2001).
The specificity of infection cannot be explained by the distribution of CAR, because it is
expressed by both SC and GC at junctions between these cell-types (Wang et al., 2007),
and therefore should provide access for the virus into both cell-types. Expression of
CAR at intercellular junctions in columnar epithelia makes the receptor inaccessible to
the virus, similar restrictions may explain adenoviruses' failure to infect GCs but still
does not explain specific infection of SCs that are adjacent to the GCs (Pickles et al.,
1998; Wang et al., 2007).
Adenoviral vectors enter target cells by attachment to the CAR receptor via fibre knobs
attached to the virus' capsid (Henry et al., 1994). Attachment of viral particles to CAR
protein competes with CAR-CAR interactions within the tight-junctions between
adjacent cells which disrupts the stability of these junctions (Walters et al., 2002; Wang
et al., 2007). The junctions are components of the blood-testis barrier that exists
between adjacent SCs. In addition to direct interference with junctions by competing for
binding with components of the complexes, binding of adenovirus to CAR may induce
signalling cascades involving Rho GTPase, Rac-1, or Cdc42 which open occludin- and
claudin-based tight junction complexes (Wang et al., 2007). A key finding of the current
work, presented in chapter 4, was the development of intraepithelial vacuoles and loss of
GCs resulting from adenoviral infection. Disturbance of junctional complexes due to
infection with the adenoviral vector may be one explanation for the appearance of those
vacuoles. Future work aimed at addressing this possibility could include
immunohistochemistry for proteins previously localised to tight junctions such as ZO-1,
claudin-3 and -11, and occludins. This would allow us to determine whether their
expression is altered or more probably whether their distribution changes following
adenoviral infection in line with loss of interaction between tight junction proteins in
opposing SC cells. Wang and Cheng (2007) discussed the impact of adenoviral
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interaction with CAR found in tight junctions within the blood-testis barrier, but other
junctions exist within the seminiferous tubules which could be targets of the signalling
cascades induced by adenovirus infection. Although the expression level of espin, a
component of ectoplasmic specialisations, was not altered its distribution was disturbed
and this could be one ofmany junctional protein targets of the signalling cascade.
An alternative explanation for the disruption of seminiferous tubule structure in response
to adenoviral infection is that introduction of the virus stimulated an inflammatory
response. Increased expression of inflammatory cytokines, interleukin-1 a and -6, has
been reported in isolated SCs in response to incubation with lipopolysaccharide or
residual bodies in culture (Syed et al., 1993; Syed et al., 1995). As a preliminary
experiment to investigate whether SC might respond to adenoviral infection by initiating
a proinflammatory response, expression of IL-6 mRNA and protein were quantified in
SKI 1 cells incubated with a dose of adenovirus previously identified as cytotoxic.
Increased expression of IL-6 was not detected in response to infection of SKI 1 cells at a
high MOI, although the amount of IL-6 synthesised in the cells grown at the non-
permissive temperature was increased compared to proliferative cells. Future work
could determine whether failure to express increased IL-6 in response to viral infection
was due to a failure of SC to respond with increased expression of IL-la which
stimulates IL-6 expression via autocrine signalling. Although it appears unlikely that
SKI 1 cells can be used to investigate the interleukin-mediated response of SC to
adenoviral infection, if the in vivo infections of testes with the virus were repeated testes
could be preserved differently to allow mRNA extraction and quantitative analysis by Q-
RT-PCR. Analysis of IL-la and -6 protein expression could also be assessed in isolated
tubules cultured in the presence of adenovirus to allow quantification of interleukins in
the seminiferous tubule fluid. Isolated seminiferous tubules would be used to maximise
the probability of detecting changes in interleukin expression as levels would be
expected to be low even following infection and analysis in whole testes or
quantification in blood stream would diminish sensitivity. Detection of interleukin
expression could be related to events such as recruitment of macrophages and
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neutrophils in response to adenoviral infection which was observed in some of the more
severely disrupted testes resulting from injection of the highest concentrations of virus.
The secretion of IL-la and -6 would be compared to the expression of these interleukins
in response to inflammation induced with LPS and residual bodies in previous studies
(Syed et ah, 1993; Syed et ah, 1995).
In addition, some of the damage associated with intra-testicular injection of adenoviral
vectors could be a consequence of the injection process itself or one of the other
components (saline solution or trypan blue) of the injection vehicle. The severity of the
damage sustained by the tubules correlates with the quantity of virus injected into the
testis, with greater disruption associated with larger quantities, which suggests that the
presence of the virus is at least partially responsible for the effects. The volume injected
into each testis was small, 50pl, in comparison to the 100 - 150 pi injected via the same
route by Ogawa et al., although they did report ischemia and complications to GC
transplantation as a consequence of 'excessive internal testicular pressure' caused by
efferent ductule injection (Ogawa et al., 1997). Despite this the same volume of vehicle"
was injected at each dosage used during the study so cannot explain the variation in
damage witnessed. The volumes and sites of injection used in previous studies are
shown in Table 6-1 for comparison, the only other study in mice with a directly
comparable injection site was performed by Kanatsu-Shinohara et al. who used much
lower volumes of vehicle and only observed occasional inflammation in response to
injections. Under appropriate circumstances a short control study could be undertaken
in which 50 pi of the saline/trypan blue vehicle would be injected into testes using an
identical method to the previous injections. Histology of these tissues would be
compared to uninjected and adenovirus infected testes to determine what impact the
injection process and components of the vehicle had on the tubule structure.
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Table 6-1: Comparison of sites of injection and volume of solution injected
Paper Species Site of Injection
Volume injected
(pl)
(Ogawa et ah, 1997) Mouse
Seminiferous tubule 400 - 500
Efferent ductule 100-150




Rete testis 5 - 10
Interstitial space 75







Mouse Efferent ductule 3 or 10
Present study Mouse Efferent ductule 50
Stage specific loss of pachytene spermatocytes and retention of other GCs at four days
after infection suggests a particular sensitivity of zygotene spermatocytes in stage XI-
XII tubules to disruption by viral infection at the time of injection. It would be valuable
to determine whether features specific to zygotene spermatoycytes or SC at stages XI-
XII are altered in response to viral infection. Although deficiencies in the expression of
Cx43 and distribution of espin have been identified in association with infection
additional tubular deficiencies are possible. Factors secreted by SC that affect GC
development such as activin, steel factor and GDNF (Marziali et ah, 1993; Matsui et ah,
1991; Meehan et ah, 2000; Meng et ah, 2000) would be prime candidates for
quantification in SC at stages XI-XII and other stages following adenoviral infection.
Developing a method in which stage-specific secretion could be assessed whilst
maintaining the GC complement and testicular niche would be a challenge.
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If use of SC-GC co-cultures became necessary to improve in vitro studies of SC
function, the capacity of adenoviral infection to infect SC exclusively could be used to
specifically modify SC function in the co-cultures.
6.4 Gene expression in EDS-treated rats
Although it has not been possible to confirm androgen responsive expression of AR,
Rhox5, [13-tubulin or espin mRNA or protein in SK11 cells, androgen-dependent
expression of mRNA for all four genes has been demonstrated in EDS-treated rats.
Androgen-responsive expression of Rhox5, [33-tubulin and espin mRNA have been
detected previously using array analysis of testes from SCARKO mice or testes of
flutamide treated mice compared with controls (Abel et al., 2008; Denolet et al., 2006a).
Historically the EDS-model has been one of several that have demonstrated the
necessity for androgen signalling to maintain normal male fertility. Despite these
findings to date few androgen responsive genes have been positively identified in testes
or isolated testicular cells (Abel et al., 2008; Bremner et al., 1994; Denolet et al., 2006a;
Lindsey and Wilkinson, 1996b; Turner et al., 2001). One common explanation for the
limited data relating to androgen responsive genes in SC is the influence of GCs on this
cell population. Use of isolated Sertoli cells and many of the in vivo methods used to
study androgen response in SC depleted some, or all, of the GC complement and would
have had an additional impact on SC function (Maddocks et al., 1992; Maguire et al.,
1997; McKinnell and Sharpe, 1997; Pineau et al., 1990; Tirado et al., 2003) preventing
identification of the androgen-responsive genes. Unless better cell lines can be
developed, as described in section 6.2, the best ex vivo system available for study of SC
function may be testis explants. The EDS rat model is one of very few in vivo
alternatives to generating transgenic mouse models or treating animals with anti-
androgens. A benefit of the EDS models is that it interferes with androgen signalling
but retains an almost complete GC complement as long as tissues are collected within 6
days of treatment (Turner et al., 2001). The SC also maintain contact with peritubular
myoid cells which also interact with SC to maintain their function (Skinner and Fritz,
1985a; Skinner and Fritz, 1985b). A potential drawback of the EDS model is the
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increased level of FSH that develops following EDS treatment (Bartlett et ah, 1986;
Tena-Sempere et ah, 1993). FSH and testosterone have been shown to regulate similar
processes within the testis including spermatogenesis (Allan et ah, 2004; Kerr et ah,
1992), indeed Abel et al identified genes (Espn, Msil, and Slc7a4) that were
synergistically regulated by both FSH and androgen action in SC. The study
demonstrates that both FSH and androgen signalling via SC act to maintain meiotic
germ cells (Abel et al., 2008). Expression of other genes identified as androgen
responsive in SC; including Rhox5, Aqp8, Tjpl and Gatal; were not influenced by FSH
signalling (Abel et al., 2008). If FSH is able to compensate for the loss of testosterone
levels in the EDS animals then putative androgen responsive genes identified in previous
array studies may be wrongly discounted based on studies in EDS rats.
Puzzlingly, although expression of espin mRNA was reduced dramatically by EDS-
treatment, no change in total protein or pattern of protein expression detected by
immunohistochemistry was detected. Therefore we cannot rule out the possibility that
the lack of detectable changes in Cx43, ZO-1 and N-cadherin protein expression by
immunohistochemistry may mask changes in mRNA expression of these genes through
Q-RT-PCR, and this requires further investigation. Further genes identified by Denolet
et al and Abel et al. in array studies on SCARKO tissue suggest other putative targets for
androgen signalling in SC (Abel et al., 2008; Denolet et al., 2006a), and the expression
ofmRNA for these genes could be assessed using the same EDS-treated rat model. The
genes identified in the arrays include serine protease inhibitors, cell adhesion molecules,
cytoskeletal components, members of the extracellular matrix, and proteins involved in
solute transport (Abel et al., 2008; Denolet et al., 2006a).
Previous studies have reported the impact of androgens on the secretion of proteins that
constitute seminiferous tubule fluid (Sharpe et al., 1994; Sharpe et al., 1992). As Sdmg-
1 has been reported to be involved in fetal secretory pathways (Best et al., 2008) we
investigated this protein as a potential target for androgen action. Secretion of proteins
that contribute to seminiferous tubule fluid can either be constitutive or androgen-
Chapter 6 General Discussion 250
regulated. The major secretory proteins SGP-1 and -2 are both constitutively secreted
and unaffected by androgen action, in contrast cyclic protein 2 (CP-2) plus other SC and
GC proteins, are secreted by regulated pathways in response to androgens (McKinnell
and Sharpe, 1995). Proteins expressed through androgen-regulated pathways exhibit
stage-specific expression, with increased expression during 'androgen-responsive'
stages (McKinnell and Sharpe, 1995). The lack of response to androgen depletion or
replacement when expression of Sdmg-1 is investigated could indicate that Sdmg-1, like
the constitutively expressed SGP-1 and -2, is not regulated by androgens. Further
investigations, including Western blotting, of Sdmg-1 expression pattern in control
testes could confirm whether Sdmg-1 adheres to an expression pattern in common with
SGP-1 and -2 (constitutive expression) or CP-2 (stage and androgen-dependent). A
cursory review of Sdmg-1 immunohistochemical staining suggests that expression is
constitutive and therefore unlikely to be androgen responsive.
6.5 Conclusions
The question of whether isolated SC can be sustained in culture in conditions that are
sufficiently like those experienced by SC in vivo thereby allowing investigation of
androgen-responsiveness and other features of SC biology cannot be answered by the
results of these studies. Although expression of functional AR and ERf3 proteins and
stimulation of exogenous reporter constructs in SKI 1 cells do indicate that this cell has
potential, it has the disadvantage of being generated from an immature (10 days post
partum) mouse. Further studies with this line of cells are required to determine whether
stimulation of endogenous genes by steroid treatment can be achieved by simple
modifications such as stable transfection with AR and/or AR cofactors.
Array data from in vivo models with disruption to androgen signalling has been valuable
in identifying numerous putative androgen-responsive genes, whose mRNA expression
is raised or lowered by loss of androgen-signalling. Refinement of the use of SKI 1 cell
cultures and the EDS-rat model to resolve the lack of endogenous transcriptional
activation in response to AR activation and to overcome issues of statistical significance
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with larger samples sizes respectively would allow the SKI 1 and EDS models to be used
to validate the androgen-responsive nature of these genes' expression. The SKI 1 cells
could also play a similar role in validating oestrogen responsive gene expression, should
such genes be identified perhaps through arrays in ERfl cell-specific knockout model via
a similar scheme as to that used with the cell-selective AR knockouts. The results
collected during these studies have validated the androgen responsive expression ofAR,
Rhox5, espin and y33-tubulin indicated by array analysis in previous studies (Abel et al.,
2008; Denolet et al., 2006a).
Use of adenoviral vectors for infection of SC in vivo without significant disruption to
seminiferous tubules is not possible because adenoviral infection results in formation of
vacuoles in the seminiferous epithelium and loss of GCs at specific stages of
development, and at the highest doses collapse of tubule structure and immune cell
invasion. Adenoviral vectors specifically infect SC in seminiferous tubules, and
efficiently infect SC in vitro resulting in expression of a transgene in the absence of a
cytotoxic effect. The adenoviral vector therefore may be useful for specific infection of
SC in co-cultures of SC and GC if required for future studies. The results presented in
these studies have precluded the use of adenoviral vectors introduced by intratesticular
for targeted knockdown of AR, or ER[3, in SC. Use of other viral vectors, such as
lentivirus, should be considered in place of adenovirus to introduce RNAi specifically
into SC. A previous study compared the use of viral vectors, including both adenovirus
and lentivirus, for introduction of transgene specifically into SC. The study concluded
that lentiviral vectors were preferable to adenoviral vectors because lentivirus was
associated with SC-specific expression over a six-month period without disruption to
spermatogenesis, in contast to adenoviruses which caused a significant reduction in
testis size (Ikawa et al., 2002). Viral vectors that require dividing cells to infect would
not be suitable for these studies because adult SC are differentiated and have ceased
proliferation (Sharpe et al., 2003).
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